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BLOOD PRESSURE REDUCTION FOLLOWING THE ACCUMULATON OF 
SHORT PHYSICAL ACTIVITY SESSIONS VERSUS A CONTINUOUS 
PHYSICAL ACTIVITY SESSION IN PREHYPERTENSION 
 
Despite limited research, the accumulation of physical activity has been 
recommended for the treatment of prehypertension.  The purpose of this study 
was 1) to compare the duration and magnitude of blood pressure (BP) reduction 
following the accumulation of physical activity (PAaccum) vs. a single continuous 
physical activity session (PAcont), 2) to investigate the BP response during the 
rest periods between short sessions within the PAaccum, and 3) to investigate 
sympathetic modulation (SM) as a possible mechanism for BP reduction in 
prehypertension.  Procedures include 1) BP screening, 2) maximal graded 
exercise test, 3) treatments (PAaccum, 4x10-min walk at 50% VO2peak; PAcont, 40-
min walk at 50% VO2peak; and control), and 4) 12-hr ambulatory BP, and SM 
measurements via heart rate variability.  In this randomized within-subjects 
design, 20 prehypertensive completed the study.  Systolic (S) BP was reduced -
5.4+1.7 mm Hg for 11 hrs following PAaccum and -5.6+1.6 mmHg for 7 hrs 
following PAcont.  Diastolic (D) BP was reduced -3.4+1.3 mmHg for 10 hrs 
following PAaccum and -3.1+1.3 mmHg for 7 hrs following PAcont.  In PAaccum, the 
change in sympathetic modulation was correlated with both SBP and DBP 
reductions.  In PAcont, the change in sympathetic modulation was correlated with 
 vii
DBP reduction.  SBP was decreased following the third short session within the 
PAaccum compared to the baseline.  No significance was found in either DBP or 
SM during the rest periods between short sessions.  In conclusion, the 
accumulation of PA appears more effective than a continuous session in the 
management of prehypertension.  There is an additive effect of successive short 
sessions within the accumulation of physical activity on blood pressure reduction.  
Sympathetic modulation was associated with BP reduction following each PA 
treatment. 
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MANUSCRIPT 
THE ACCUMULATION OF PHYSICAL ACTIVITY LEADS TO A GREATER 
BLOOD PRESSURE REDUCTION THAN A SINGLE CONTINUOUS SESSION 
IN PREHYPERTENSION  
 
 
 
Short title: Accumulation of physical activity  
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ABSTRACT 
Objectives  Despite limited research, the accumulation of physical activity 
(PAaccum) has been recommended for the treatment of prehypertension.  The 
purpose of this study was 1) to compare the duration and magnitude of blood 
pressure (BP) reduction following PAaccum vs. a single continuous physical activity 
session (PAcont), and 2) to investigate sympathetic modulation as a possible 
mechanism for BP reduction following each acute session. 
Methods  Adults with prehypertension (n=20) completed in a randomized cross-
over design.  Ambulatory BP and heart rate variability (HRV; via Holter 
monitoring) were measured for 12 hrs following: a) PAaccum (4x10-min walks 
(one/hr for 4 hrs) at 50% of VO2peak), b) PAcont  (40-min walk at 50% of 
VO2peak), and c) control treatments.  BP and HRV following each activity 
treatment were compared with the respective periods from the control treatment.  
HRV was correlated with BP reduction.   
Results  Systolic (S) BP was reduced for 11 hrs following PAaccum (P<0.01)  
versus for 7 hrs following PAcont (P<0.05).  Diastolic (D) BP was reduced for 10 
hrs following PAaccum (P<0.05) versus for 7 hrs following PAcont (P<0.05).  In 
PAaccum, the changes in normalized low (r=0.517, P<0.01) and high frequency 
(r=-0.503, P<0.05) power were correlated with SBP reduction and the changes in 
normalized low (r=0.745, P<0.001) and high frequency (r=-0.738, P<0.001) 
power, and changes in low:high frequency ratio (r=0.756, P<0.001) were 
correlated with DBP reduction.  In PAcont, the difference in low:high frequency 
ratio (r=0.543, P<0.05) was correlated with DBP reduction.   
 2 
Conclusion  The accumulation of PA appears more effective than a single 
continuous session in the management of prehypertension.  Sympathetic 
modulation was associated with BP reduction following each physical activity 
session. 
  
 3 
Key Words: Ambulatory Blood Pressure, Post-exercise Hypotension, 
Fractionization of Exercise, Heart Rate Variability 
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INTRODUCTION 
In 2003, 45 million adults with prehypertension were added to the patient 
population in need of treatment for high blood pressure [1].  Lifestyle modification 
[1, 2], including regular exercise and/or physical activity, is the only 
recommended treatment for prehypertension.  Lifestyle modification is also the 
only recommended treatment for the prevention of prehypertension progressing 
to hypertension [3].  Regular exercise and/or physical activity is considered to be 
one of the most promising lifestyle modifications for the treatment of hypertension 
[4].  Yet, research on exercise and/or physical activity as a treatment for 
prehypertension is incomplete [5]. 
Scientific evidence supports the effectiveness of regular exercise in the 
treatment of hypertension [6-8].  More recently, however, the accumulation of at 
least 30 minutes of moderate intensity physical activity on most, if not all days of 
the week has been recommended as the new “exercise” guidelines for both 
prehypertension and hypertension [1, 2].  Yet, the evidence on the effectiveness 
of physical activity on blood pressure reduction has come from studies 
investigating continuous exercise sessions [1, 2, 9] rather than from the study of 
the accumulation of physical activity.  The limited scientific evidence supporting a 
recommendation of the accumulation of physical activity as a treatment for 
prehypertension precipitated our recent work in the physical activity treatment of 
prehypertension and hypertension [10].    
Previously, we [10] investigated the effects of the accumulation of one day 
of lifestyle physical activity in prehypertension and hypertension.  The 
 5 
accumulation one day of lifestyle physical activity over a 12-hour period was 
found to reduce systolic blood pressure in adults with prehypertension (6.6 ± 2.3 
mmHg for 6 hours) and hypertension (12.9 ± 4.3 mmHg for 8 hours).  The results 
of our study were noteworthy for the treatment of both prehypertension and 
hypertension.  However, the restraints of this field study were 1) the participants 
accumulated 4-6 hours of lifestyle physical activity, which is well beyond the 
recommendations [1, 2]; 2) the types of lifestyle physical activity were not 
controlled, which makes it difficult to interpret the specific activity attributed to the 
blood pressure reduction; and 3) the post-activity monitoring period was limited to 
only 6-8 waking hours, which may have affected the duration of the blood 
pressure reduction.  Consequently, our next step was to take the field study into 
the laboratory for a more controlled investigation and to investigate possible 
mechanisms of the blood pressure reduction. 
A sustained reduction in blood pressure following a single bout of aerobic 
exercise has been defined as post-exercise hypotension [11, 12].  The study of 
post-exercise hypotension provides evidence not only for the chronic effect of 
training [13], but for the possible mechanisms of the exercise treatment.  The 
mechanisms of post-exercise hypotension are not fully understood at this time; 
however, sympathetic modulation has been investigated [11, 12].  Sympathetic 
modulation describes changes in the balance between sympathetic and 
parasympathetic influences, or the sympathovagal balance [14].  The autonomic 
mechanisms of post-exercise hypotension during the activities of daily living have 
not been investigated.   
 6 
The purpose of this study was 1) to compare the volume of blood pressure 
reduction (including the duration and magnitude of the blood pressure reduction) 
following the accumulation of physical activity to the blood pressure reduction 
following a single continuous physical activity session; and 2) to observe the 
association between the reduction in blood pressure and the changes in 
sympathetic modulation following each physical activity treatment in adults with 
prehypertension.  The following was hypothesized: 1) the reduction in systolic 
and diastolic blood pressure, measured by the area under the curve for the 
duration of blood pressure reduction, following the accumulation of physical 
activity would not be different from the reduction in blood pressure following a 
single continuous physical activity session in adults with prehypertension; and 2) 
the magnitude of systolic and diastolic blood pressure reduction would be 
associated with the change in sympathetic modulation, calculated by the 
difference in variables of heart rate variability between control and each physical 
activity treatment in adults with prehypertension; (a) the magnitude of systolic 
and diastolic blood pressure reduction would be positively correlated with the 
change in low frequency power of heart rate variability; (b) the magnitude of 
systolic and diastolic blood pressure reduction would be negatively correlated 
with the change in high frequency power of heart rate variability; and (c) the 
magnitude of systolic and diastolic blood pressure reduction would be positively 
correlated with the change in ratio of low to high frequency power of heart rate 
variability (that is, an increase in parasympathetic tone and a decrease in 
sympathetic tone).   
 7 
METHODS 
Study Design 
Fig 1 illustrates the randomized cross-over study design.  The two 
physical activity sessions were separated by at least 7 days to avoid a training 
effect [15, 16].  The following variables were measured during the 12-hour period 
following each treatment: 1) blood pressure using ambulatory blood pressure 
monitoring, 2) heart rate variability using Holter monitoring for sympathetic 
modulation, and 3) energy expenditure using an accelerometer.   The study was 
approved by the Bloomington Campus Committee for the Protection of Human 
Subjects at Indiana University.  Each participant was given informed consent 
prior to participation in the study.  The study was carried out at the Clinical 
Exercise Physiology Laboratory in the Department of Kinesiology at Indiana 
University. 
 
Subjects 
Adults with prehypertension were recruited for this study.  Inclusion criteria 
consisted of a mean screening blood pressure of 120-139 mmHg for systolic 
blood pressure and/or 80-89 mmHg for diastolic blood pressure.  Exclusion 
criteria included 1) significant cardiovascular disease, 2) significant dysrhythmia; 
3) brachial artery bruits, 4) cardiac or renal transplant, or 5) medications such as 
anti-arrhythmic drugs or low dose muscarinic receptor blockers including atropine 
and scopolamine that affect the heart rate variability [17].  Clearance by the 
subjects’ primary physician was required prior to participation in the study.  The 
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number of subjects was estimated based on power analysis (power:>0.80; effect 
size using partial eta squared:>0.41) [18] using the previous study for blood 
pressure with a similar study design [10] testing a physical activity treatment in 
adults with prehypertension.     
 
Blood Pressure Screening 
Three blood pressure measurements were taken in the seated position 
with a mercury sphygmomanometer on 2 separate days, 3 days apart (a total of 
six measurements) using an appropriate sized cuff [10, 15, 16].  Each participant 
was seated for at least 5 minutes in a chair, feet on the floor, and arm supported 
at heart level [1].  The participant was asked to avoid caffeine, exercise, and 
smoking for at least 30 minutes prior to measurement [1].  On the first day blood 
pressure was taken in both arms to detect possible differences due to peripheral 
vascular disease [10, 15, 16].  The arm with the highest blood pressure was used 
for the screening [19].   
 
Maximal Graded Exercise Test 
 The purpose of the maximal graded exercise test was to measure physical 
work capacity to ensure the intensity of the physical activity sessions.  A fasting 
blood draw and a standard resting 12 lead electrocardiogram (EKG) were 
obtained to establish risk for the graded exercise test.  The graded exercise test 
was performed on a motor driven treadmill at a speed between 2.5 and 4.0 mph.  
The speed remained constant throughout the test while the grade increased 
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1.0% every minute until a maximal voluntary effort was achieved.  Blood 
pressure (by auscultation) and heart rate (by EKG) were measured every minute.  
The EKG was monitored continuously.  Expired gases were measured online 
breath-by-breath using a 2900 Metabolic Measurement Cart (SensorMedics, 
Corp., Yorba Linda, CA).  Peak oxygen uptake (VO2peak) was defined as the 
highest oxygen uptake (VO2) obtained from the maximal exercise test.   
 
Treatments 
 The treatments included 1) the accumulation of four short sessions of 
physical activity over a four-hour period, 2) a single continuous physical activity 
session, and 3) a control.  The mode of physical activity was walking on a 
motorized treadmill and the intensity of physical activity was 50% VO2peak.  VO2 
was measured during the 2nd through the 4th minutes of each session to confirm 
the physical activity intensity.  If the VO2 were not within ±10% of the target VO2, 
the work rate was adjusted and VO2 was measured during the 6th through the 
8th minutes of the next work interval to confirm the new physical activity intensity.  
HR (via EKG) and blood pressure (via auscultation) were measured throughout 
the physical activity treatments.  We attempted to end all three treatments at the 
same time.   
Single Continuous Physical Activity Treatment:  The single continuous 40-minute 
physical activity began between 1130 and 1230 hours.  
Accumulation of Physical Activity Treatment:  The duration of each short session 
of physical activity was 10 minutes; the first began between 0900 and 0930 
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hours, the second between 1000 and 1030 hours, the third between 1100 and 
1130 hours, and the last between 1200 and 1230 hours.   
Control Treatment:  For the control treatment the participant reported to the lab 
between 1200 and 1230 hours, approximately 15 minutes before the time when 
the monitors would have been activated for the physical activity treatments.  
Control data were collected for the same 12-hour time period as the other two 
treatments [10, 15]. 
 
Ambulatory Blood Pressure Monitoring 
 The Accutracker II (Suntech Medical Instruments, Inc., Raleigh, NC), 
validated in accordance to the standards of the British Hypertension Society and 
the American Association for Medical Instrumentation [20], was used for all 
ambulatory measurements.  The sampling interval was 15 ± 5 minutes for a 12-
hour period following the treatments (1300-0100 hours).  One repeat 
measurement was taken if the first measurement was unsuccessful.  The monitor 
was programmed to take no readings following the 12-hour collection period.  
The cuff inflation for each measurement was 30 mmHg greater than the previous 
reading, and the cuff deflation was set at 3 mmHg/second [1].   
 Ambulatory blood pressure data were manually reviewed for missing and 
erroneous readings as previously described [10, 15, 16].  Readings were purged 
if 1) data was missing, 2) systolic blood pressure was lower than diastolic blood 
pressure, 3) systolic blood pressure was >240 mmHg or <50 mmHg, 4) diastolic 
blood pressure was >140 mmHg or <40 mmHg, 5) HR was >150 beats/minute or 
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<40 beats/minute, and/or 6) systolic blood pressure, diastolic blood pressure and 
heart rate deviated ± 50 and ± 20 mmHg, 30 beats/minute respectively from 
surrounding values.  The numbers of recordings taken and edited were reported.  
 Ambulatory blood pressure data was averaged each hour for the 12-hour 
period following each treatment.  The duration of blood pressure reduction was 
determined by calculating the cumulative sum of the blood pressure reduction for 
each hour as previously reported [10].  The cumulative sum of blood pressure 
reduction was then plotted for each hour with the 95% confidence limits for the 
slope.  The duration of the blood pressure reduction was considered to be the 
time period in which the blood pressure reduction remained within the 95% 
confidence limits of the regression.  Once the duration was determined, the 
magnitude of the blood pressure reduction was averaged over the duration of the 
reduction found for each activity treatment and was compared to the respective 
periods from the control treatment [10]. 
 The areas of the blood pressure reduction were used to compare the 
efficacy of the accumulation vs. the continuous physical activity treatments.  The 
area of the blood pressure reduction was defined as the area between the 
physical activity and control blood pressure curves for the duration of blood 
pressure reduction [10, 15].  The area between the blood pressure curve and the 
time axis (x-axis) was calculated by summing the area of successive trapezoids, 
corresponding to each blood pressure reading.  The total area below the physical 
activity treatment curve was subtracted from the total area under the control 
curve to obtain the area between the curves.   
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Holter Monitoring 
 The Aria Digital Recorder (Del Mar Reynolds Medical, Inc., Irvine, CA) 
was used to observe sympathetic modulation through heart rate variability.  The 
EKG data were collected for the 12-hour period following each treatment.  The 
data from the Aria Digital Recorder were scanned on a computer-assisted Holter 
system (Impresario, Solo Holter analysis software, Del Mar Reynolds Medical, 
Inc., Irvine, CA) for variables of heart rate variability.  Manual editing of the R-R 
interval data was performed to ensure correct identification and classification of 
every QRS complex [17].  Artifact and ectopic beats were removed for the R-R 
interval calculation.  The data were then used for the power spectral analysis of 
heart rate variability. 
Frequency-domain measures of heart rate variability were assessed using 
the fast Fourier transform.  The total power was calculated by the standard 
deviation of the R-R interval (<0.1 Hz).  Heart rate variability of the total nominal 
12-hour record was computed using the whole range of high frequency power 
(0.15-0.40 Hz), low frequency power (0.04-0.15 Hz), and very low frequency 
(0.003-0.04 Hz) power.  Normalized values (expressed as %) were calculated for 
low frequency power and high frequency power.  Normalized units represent the 
relative value of each power component in proportion to the total power minus 
the very low frequency component.  The ratio of low frequency to high frequency 
was also determined.  The changes in values of heart rate variability were 
calculated as (values of the control treatment – values of each physical activity 
treatment).  To determine the association with the blood pressure reduction, 
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these variables of heart rate variability were averaged for the duration of blood 
pressure reduction.  
 
Accelerometer 
Energy expenditure was measured to statistically control for variations in 
activities of daily living as a covariate if significant difference was found among 
the 12 hours of monitoring following the three treatments.  An RT3 (Stayhealthy, 
Inc., Monrovia, CA), three-dimensional (tri-axial) accelerometer, was used for a 
12-hour collection period following all three treatments.  The Output from each 
accelerometer was reported along with a composite three-dimensional signal 
called vector magnitude.  The software provides an estimation of activity and 
total energy expenditure based on age, height, weight, and gender of the 
individual.  The RT3 was programmed (using mode 3) to sample data every 
second and to average data over a one-minute period.  Energy expenditure was 
averaged for the 12-hour period. 
 
Preparation of Subjects  
 The ambulatory blood pressure cuff was worn on the non-dominant arm.  
Seven EKG electrodes (three for ambulatory blood pressure monitor and four for 
Holter monitor) were placed on the chest.  The RT3 was firmly attached to a belt 
on the hip at the anterior axillary line of the dominant leg.  Participants were 
asked to document the following: 1) time of sleep, 2) time at work, 3) time of 
meals, and 4) time and type of leisure physical activity.  They were also asked to 
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do the similar routines for the activities of daily living following all treatments.  
Instructions included 1) not to exercise, 2) not to take a shower, 3) not to use an 
electric blanket, 4) not to operate a lawn mower, a vacuum cleaner or any 
equipment which causes vibration, 5) to replace electrodes with new electrodes 
when electrodes became loose, and 6) to relax and straighten out the arm during 
the recording interval for the entire 12-hour period.    
 
Statistical Analysis 
 Data was expressed as means ± standard error of the mean (SE).  
Statistical analyses were performed using descriptive statistics, paired t-tests, 
and analysis of variance (ANOVA) for repeated measures.  Descriptive statistics 
were performed on the variables of sex, age, body mass index (BMI), screening 
systolic blood pressure and diastolic blood pressure, and VO2peak.  A one-way 
ANOVA with repeated measures was used to test the differences in energy 
expenditure from the accelerometry for the activities of daily living following each 
treatment.  Paired t-tests were used to test the difference in the magnitude of the 
blood pressure reduction (mean blood pressure for the respective duration) 
between each physical activity and the control treatment, and to compare the 
area of the blood pressure reduction between the two activity treatments.   
Pearson correlations were used to evaluate the contribution of 
confounding variables (such as amount of physical activity, age and BMI) on 
magnitude of the blood pressure reduction.  Pearson correlations were also used 
to investigate the association between the magnitude of blood pressure reduction 
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and the change in sympathetic modulation.  The level of significance was 
P<0.05.  The SPSS software (SPSS 13.0) was used for all statistical analyses.   
 
RESULTS 
Subjects  
Twenty-six adults were screened for the study; five were found to be 
ineligible during the blood pressure screening process (four presented with 
normal blood pressure and one presented with hypertension).  Twenty-one adults 
with prehypertension who were qualified based on the screening process.  One 
participant did not complete the study because of time constraints.  Twenty 
adults with prehypertension completed the study.  Demographics of the 
participants are summarized in Table 1.   
 
Physical Activity Stimulus 
The 20 participants who completed the study performed a maximal 
voluntary effort on the exercise test as verified by reaching 107.7 ± 1.3% 
predicted maximal heart rate.  Each physical activity treatment was separated by 
16.7 ± 2.3% days.  The intensities of both activity treatments were similar 
(accumulation = 51.9 ± 0.6% of VO2peak; continuous = 51.7 ± 0.6% of VO2peak).   
 
Energy Expenditure following all Three Treatments 
The energy expenditure was measured to determine the consistency of 
the activities of daily living during the 12-hour monitoring period following each 
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treatment session.  No significant difference (P=0.894) was found among the 
three treatment sessions: the energy expenditures for 12 hours following the 
control, the accumulation of physical activity, and the single continuous physical 
activity treatment sessions were 351.1 ± 38.3 kcal, 348.5 ± 32.6 kcal, and 335.1 
± 36.3 kcal, respectively.  Therefore, blood pressure data were not examined 
using energy expenditure as a covariate. 
 
Blood Pressure Reduction 
 Ambulatory blood pressure monitoring data are summarized in Table 2.  
There was no significant difference in the number of blood pressure 
measurements and the percent of blood pressure measurements analyzed 
among the three ambulatory sessions.  The cumulative sums of the hourly mean 
systolic blood pressure and diastolic blood pressure reduction for the 
accumulation of physical activity and the single continuous physical activity were 
plotted to determine the duration of the blood pressure reduction in Fig 2.  The 
durations of the systolic and diastolic blood pressure reductions were both 7 
hours following the single continuous physical activity.  The durations of the 
systolic and diastolic blood pressure reductions following the accumulation of 
physical activity, however, were 11 hours and 10 hours respectively.  
 The hourly mean systolic and diastolic blood pressures following all three 
treatments as well as the area between the treatment and control blood pressure 
curves are illustrated in Fig 3.  Both the 7-hour mean systolic blood pressure (-
5.6 ± 1.6 mmHg; P=0.002) and 7-hour mean diastolic blood pressure (-3.1 ± 0.2 
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mmHg; P=0.020) following the single continuous physical activity session were 
significantly decreased from the blood pressure following the control treatment 
for the corresponding time periods.  Similarly, the 11-hour mean systolic blood 
pressure (-5.4 ± 1.7 mmHg; P=0.005) and 10-hour mean diastolic blood pressure 
(-3.4 ± 1.3 mmHg; P=0.022) following the accumulation of physical activity were 
also decreased from the blood pressures following the control treatment for the 
corresponding time periods.  In addition, the area of the systolic blood pressure 
reduction following the accumulation of physical activity treatment was 
significantly greater (P=0.045) than the area of the systolic blood pressure 
reduction following the single continuous physical activity treatment.  No 
significant difference was found in the area of diastolic blood pressure reduction 
between the two activity treatments.   
    
Association between the Magnitude of Blood Pressure Reduction and the 
Change in Sympathetic Modulation 
The association between the magnitude of blood pressure reduction and 
the change in sympathetic modulation as measured by heart rate variability is 
illustrated in Fig 4 and Fig 5.  For the continuous physical activity (Fig 4), the 
difference in low/high frequency ratio was only significantly correlated with the 
magnitude of diastolic blood pressure.  For the accumulation of physical activity 
(Fig 5), however, the differences in normalized low frequency and high frequency 
between the control and the physical activity treatments were significantly 
correlated with the magnitude of the systolic blood pressure while the differences 
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in normalized low frequency, high frequency, and low/high frequency ratio were 
significantly correlated with the magnitude of the diastolic blood pressure.    
 
DISCUSSION 
 The purpose of this study was 1) to compare the magnitude and duration 
of blood pressure reduction following the accumulation of physical activity to the 
blood pressure reduction following a single continuous physical activity session; 
and 2) to observe the association between the reduction in blood pressure and 
the changes in sympathetic modulation following two physical activity treatments 
in adults with prehypertension.  This is the second study to investigate the blood 
pressure reduction as a primary outcome following the accumulation of physical 
activity in prehypertension [10].  Strengths of our study include the target 
population and the study design and methods.  In our study unexpected, yet 
provocative findings were obtained.  The main findings were 1) a greater 
reduction in systolic blood pressure following the accumulation of physical activity 
than following a single continuous physical activity session in adults with 
prehypertension, and 2) the association between the reduction in systolic and 
diastolic blood pressure and the changes in sympathetic modulation (a decrease 
in sympathetic tone and an increase in parasympathetic tone) independent of 
confounding variables such as physical activity, age, and BMI.   
Prehypertension has been identified as a critical population, who requires 
intervention to treat as well as to prevent progression to hypertension [1].  
Although lifestyle modification, including the accumulation of physical activity, is 
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the only recommended treatment for prehypertension at this time [1], supporting 
literature is limited [10].  Only one study [10] exists focusing on the efficacy of the 
accumulation of physical activity as a treatment for prehypertension.  Thus, our 
study of adults with prehypertension is warranted. 
 Our study design and methods are distinctive in 1) the acute treatment 
model, 2) the target population, 3) the accumulation of several short physical 
activity sessions, and 4) building on our previous field study.  First, the acute 
rather than chronic training treatment model was chosen for this study.  Acute 
studies can be justified solely on the fact that no long-term or training study exists 
focusing on prehypertension.  In addition, the acute effects of exercise in blood 
pressure reduction are considered to contribute to the chronic or training effects 
in hypertension [13].  The utilization of an acute paradigm also allows for a more 
efficacious study with possible variations in the physical activity stimulus.   
 In prehypertension, the accumulation of physical activity has been 
recommended [1] as a treatment despite limited evidence of its effectiveness 
[10].  In a recent meta-analysis of exercise training on blood pressure [5], 33 
studies were identified as focusing on prehypertensive groups.  Further 
inspection of these studies revealed, however, that the targeted population was 
not limited to prehypertensive subjects even though their average blood pressure 
was in the range of prehypertension.  All of these groups were comprised of 
mixed prehypertension with normotension or prehypertension with hypertension.  
Thus, the results of this meta-analysis [5] can be challenged because the target 
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population was not within the definition of prehypertension.  It is important to 
investigate the efficacy of physical activity specific to adults with prehypertension.   
 Supporting evidence is also limited on the efficacy of the accumulation of 
physical activity in the treatment of prehypertension and hypertension.  Two 
training studies [21, 22] attempted, but did not document or control for the 
accumulation of the activity.  Our current study not only focused on a comparison 
of the accumulation of physical activity vs. continuous sessions, but controlled 
the mode, intensity, and duration of physical activity well.   
 In the analysis of the data, the determination of the duration of the blood 
pressure reduction and the utilization of the area of the blood pressure reduction 
are among the strengths developed from our previous study [10, 15].  Utilizing 
the 95% confidence limits for the accumulative sum of the reduction allows for an 
objective determination of duration.  In addition, the area under the curve, which 
represents the total volume (magnitude x duration) of the blood pressure 
reduction, was used to standardize the two treatments for comparison of the 
blood pressure reduction.  Both of these variables were used to compare the 
blood pressure reduction between the two physical activity treatments yielding 
more precise results.   
 The restraints of our previous field study [10] on lifestyle physical activity 
in prehypertension and hypertension were controlled in the present laboratory 
design.  First, we utilized a 40-minute physical activity treatment instead of 4-6 
hours.  Second, we presented a single, common and popular mode [23] of 
physical activity, walking.  Third, the monitoring period following the physical 
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activity treatments was extended from 6 hours to12 hours to provide a longer 
time to monitor the duration of blood pressure reduction before sleep.  Average 
nighttime blood pressures for hypertensive adults who exhibit nocturnal dipping 
are within normal pressures and do not exhibit a reduction following exercise 
[15].  We have found that adults with prehypertension exhibit the similar 
nocturnal dipping pattern.  Because the duration of any blood pressure reduction 
would be limited by the nighttime hours, we extended the monitoring time from 6 
hours to12 hours.   An additional advantage to extending the monitoring period 
was to control for the diurnal variation of the blood pressure.  Blood pressure is 
highest in the afternoon/evening hours and lowest in the nighttime [24].  By 
focusing our monitoring time to a period known to exhibit high pressures, a 
reduction in blood pressure would be more easily detected because a reduction 
in blood pressure is related to elevation of the initial pressures [7].  This design 
optimized the diurnal nature of the blood pressure as well as the timing of the 
blood pressure reduction.  In the real world, the physical activity would be 
accumulated throughout the day rather than the four hour period studied in this 
investigation and still may have reduce blood pressure when applied in a chronic 
application [25].   
The blood pressure reduction found in the present study was unexpected.  
We expected the blood pressure reduction to be similar for both activity 
treatments, based on previous literature in fractionization [25-28].  Fractionization 
[29] is the term used to describe the comparison between a single continuous 
exercise/ physical activity session to several short bouts of the exercise/ physical 
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activity.  Fractionization has been utilized to observe variables of health and 
fitness, such as maximal oxygen uptake (VO2max) [25, 26] and blood lipids [27, 
28].  Several short bouts of exercise were reported to be as effective as one 
continuous exercise in these variables [25-28].  Although blood pressure is one 
of major risk factors of the coronary heart disease, it has not been the focus of 
the fractionization literature as a primary outcome.  
Blood pressure has been observed as a secondary outcome in 
fractionized exercise training studies where 2-3 short sessions were compared to 
one continuous exercise [25, 26].  Murphy and Hardman [25] randomly assigned 
12 women to 1) 3 x 10-minute walks, 2) 1 x 30-minute walk at 70-80 % of 
maximal heart rate or 3) control group for 10 weeks.  Although the blood 
pressure reduction found in this study was not statistically significant, it exhibited 
similar trends to ours; the 3 x 10-minute group reduced systolic blood pressure 
by 7.4 ± 7.3 mmHg whereas the 1 x 30-minute group reduced systolic blood 
pressure by 4.6 ± 5.9 mmHg.  Murphy and Hardman [25] did not find a significant 
blood pressure reduction, which may be attributed to their lack of statistical 
power.  Asikainen et al. [26] also investigated blood pressure reduction after 15-
weeks of training; two short bouts vs. one continuous walking (65% of VO2max).  
Similarly, no significant blood pressure reduction was found in each exercise 
group compared to the control group, but diastolic blood pressure was reduced 
(3.0 mmHg) when the exercise groups were combined.  On the other hand, 
subjects in both of these training studies included normotensive and hypertensive 
subjects, exhibiting a wide range of blood pressures.  The inclusion of non-
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responding normotensive subjects may have confounded the results.  Not only 
was blood pressure a primary outcome in our study, adults with prehypertension 
were the target population, thus optimizing our findings.   
Chronic exercise is well known for its ability to restore impaired autonomic 
nervous system function in various populations [17, 30], including hypertension 
[31].  The mechanisms of blood pressure reduction following acute exercise are 
not fully understood at this time, however, sympathetic modulation has recently 
received more focus as one of the possible mechanisms [11, 12].  Sympathetic 
modulation has been examined only for a relatively short (15-180 minutes) period 
of time [32] following acute exercise.  Recently, the change in sympathetic 
modulation was observed several hours after cessation of acute submaximal 
exercise [33].  In addition, the blood pressure reduction following acute exercise 
persists up to 11-12 hours in hypertension [2].  Thus, we observed 7-hour to12-
hour heart rate variability and found significant association between the reduction 
in blood pressure and the change in sympathetic modulation.  The involvement of 
the autonomic nervous system as a possible mechanism for the blood pressure 
reduction following a single bout of exercise has been found in other studies [34-
36].  
The accumulation of physical activity led to a greater systolic blood 
pressure reduction than a single continuous physical activity in prehypertension.  
Results of our study indicate as little as four 10-minute walking sessions per day 
is effective in reducing systolic and diastolic blood pressure in prehypertension.  
A 5 mmHg reduction in systolic blood pressure has been reported to substantially 
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reduce mortality; 14% reduction in stroke, and 9% reduction in coronary heart 
disease [1].  An immediate and favorable response associated with one day of 
physical activity may encourage the public to participate in physical activities in 
one’s daily routine.  Several 10-minute walking sessions might fit more easily into 
one’s daily routine than a single long continuous session.  For the future studies, 
chronic training effects of the accumulation of physical activity as well as 
adherence to physical activity need to be investigated in prehypertension.   
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FIGURE 1. Design including dependent variables and participants flow of the 
study. 
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Fig. 1
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TABLE 1.  DEMOGRAPHICS OF SUBJECTS 
 
Variables  
N 20 
Sex (men/women) 15/5 
Race 
18 Caucasian 
2 Asian 
Age (years) 47.2 ± 2.9 
Weight (kg) 84.5 ± 4.4 
Height (cm) 176.3 ± 1.7 
Body mass index (kg/m2) 27.0 ± 1.2 
VO2peak  (ml/kg/min) 34.5 ± 1.6 
Screening systolic blood pressure 
(mmHg) 131.9 ± 1.1 
Screening diastolic blood pressure 
(mmHg) 82.5 ± 1.4 
 
Values were expressed as mean ± S.E.  
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TABLE 2.  AMBULATORY BLOOD PRESSURE MONITORING  
 
 Control 
Treatment 
Accumulation 
of Physical 
Activity 
Single 
Continuous 
Physical Activity
Starting Time 12:42 ± 0:05 12:48 ± 0:05 12:56 ± 0:04 
Number of Blood 
Pressures Taken 
55.2 ± 1.3 52.4 ± 1.2 53.4 ± 1.1 
Percent of Blood 
Pressures Analyzed 
93.8 ± 1.6 92.0 ± 2.3 91.6 ± 1.8 
 
Values were expressed as mean ± S.E. 
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FIGURE 2.  Regression (solid line) and 95% confidence limits (dotted line) for the 
slope of the initial blood pressure (blood pressure) reduction following a single 
continuous physical activity (upper graph) and the accumulation of physical 
activity (lower graph) and in adults with prehypertension.  See text for the 
calculation used to determine the plot.  The duration of blood pressure reduction 
(↑) was determined to be the time where the accumulated hourly blood pressure 
reduction remained within the 95% confidence limit.   
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Fig. 2 
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FIGURE 3.  Hourly systolic and diastolic blood pressure following the single 
continuous physical activity session (●) and control treatment (○) (upper graph) 
and following the accumulation of physical activity (●) and control treatment (○)  
(lower graph) in adults with prehypertension. 
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Fig. 3
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FIGURE 4.  The association between the reduction in blood pressure and the 
changes in sympathetic modulation following a single continuous physical activity 
session.  The changes in sympathetic modulation were calculated as (values of 
heart rate variability from the control treatment – values of heart rate variability 
from a single continuous physical activity session).    
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 Fig. 4 
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FIGURE 5..  The association between the reduction in blood pressure and the 
changes in sympathetic modulation following the accumulation of physical 
activity.  The changes in sympathetic modulation were calculated as (values of 
heart rate variability from the control treatment – values of heart rate variability 
from a single continuous physical activity session).    
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Fig 5. 
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MANUSCRIPT 
Accumulation of Physical Activity: Blood Pressure Reduction between 
Sessions  
 
 
Running Title: Accumulation of physical activity 
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ABSTRACT 
The accumulation of physical activity, recommended as a treatment for 
both prehypertension and hypertension, has been found to effectively reduce 
blood pressure (BP) in prehypertension and hypertension.  Yet, the BP response 
among several short sessions within the accumulation of physical activity has not 
been examined in the treatment for prehypertension and hypertension.  
Purpose: The purpose of the study was 1) to investigate the BP reduction during 
the rest periods following each successive short session within the accumulation 
of physical activity over a three-hour period in prehypertensive adults; and 2) to 
observe the role of sympathetic modulation during the rest periods following each 
short session.  Methods: Prehypertensive adults (131.9±1.05/83.0±1.63 mm Hg) 
participated in the study.  BP, using ambulatory monitoring, and sympathetic 
modulation via heart rate variability (HRV; Holter monitoring) were measured 
during a baseline and the rest periods following three short physical activity 
sessions (3 x 10-minute treadmill walks at 50% of VO2peak; at least 50-minute 
apart).  Sympathetic modulation was reported as normalized low-frequency, high-
frequency power and the ratio of low to high frequency power of HRV.  Variables 
of BP and HRV were averaged for the baseline period and for the rest periods 
following each short session.  One-way ANOVA with repeated measures was 
used to test the differences over time in the BP and HRV (p<0.05).  Tukey test 
was used for post-hoc comparison. Results: A significant main effect was found 
in systolic BP (p=0.039) while none was found in diastolic BP (p=0.666).  Systolic 
BP was significantly decreased following the third short session.  No significance 
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was found in any of the sympathetic modulation variables.  Conclusion: 
Successive walking sessions presented additive effects on systolic BP reduction 
while they did not affect either diastolic BP or sympathetic modulation  in 
prehypertension. 
 
Key Words: Ambulatory Blood Pressure, Postexercise Hypotension, 
Fractionization of Exercise, Heart Rate Variability, Prehypertension 
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Paragraph Number 1  Hypertension, the most common primary diagnosis in the 
U.S. (4), is associated with an increased incidence of all-cause and 
cardiovascular mortality (5, 29).  In 2003, 45 million adults with prehypertension 
were added to the patient population in need of treatment for high blood pressure 
(5).  Lifestyle modification (2, 5), including regular physical activity, is the only 
recommended treatment for prehypertension.  It is also the only recommended 
treatment for the prevention of prehypertension progressing to hypertension (27).  
The physical activity recommendation for the treatment of both prehypertension 
and hypertension includes the accumulation of 30 minutes or more of moderately 
intense physical activity on most, preferably all, days of the week (2, 5).  Yet, the 
scientific evidence has neglected the accumulation aspects of physical activity in 
the treatment of hypertension (2, 5, 29).  The American College of Sports 
Medicine Position Stand on exercise and hypertension (2) has stated that there is 
limited evidence regarding the accumulation of several short sessions of physical 
activity on blood pressure reduction.  It is this limited scientific evidence that has 
led to our work in the accumulation of physical activity as a treatment for 
prehypertension (17, 19). 
 
Paragraph Number 2  We have investigated the effects of the accumulation of 
physical activity in prehypertension (17, 19) and hypertension (17).  First, we (17) 
examined the effects of the accumulation of lifestyle physical activity in 
prehypertension and hypertension.  The accumulation of lifestyle physical activity 
over a 12-hour period significantly reduced systolic blood pressure in adults with 
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prehypertension (-6.6 ± 2.3 mm Hg for 6 hours) and hypertension (-12.9 ± 4.3 
mm Hg for 8 hours).  For the second study (19), we took this field study (17) into 
the laboratory for a more controlled investigation.  We compared the blood 
pressure reduction following the accumulation of physical activity (four 10-minute 
walks at 50% of peak oxygen uptake (VO2peak)) to the blood pressure reduction 
following a single continuous physical activity session (one 40-minute walk at 
50% of VO2peak) in prehypertension.  We also examined the sympathetic 
modulation as a possible mechanism for blood pressure reduction following the 
accumulation of physical activity.  Our findings were provocative.  Greater 
reductions in both systolic and diastolic blood pressures were found following the 
accumulation of physical activity (-5.4 ± 1.7 mm Hg of systolic for 11 hours; -3.4 ± 
1.3 mm Hg of diastolic for 10 hours) than following a single continuous physical 
activity session (-5.6 ± 1.6 mm Hg of systolic for 7 hours; -3.1 ± 0.2 mm Hg of 
diastolic for 7 hours) in adults with prehypertension.  From our two previous 
studies (17, 19), the accumulation of physical activity on blood pressure 
reduction was found to be effective.  Yet, the blood pressure response between 
the short sessions during the accumulation of physical activity has not been 
examined.   
 
Paragraph Number 3 The investigation of the rest periods between the short 
sessions during the accumulation of physical activity/exercise has had limited 
scrutiny.  The accumulation of physical activity has been compared to the 
continuous activity in fractionated exercise designs to observe variables of fitness 
 49 
and health outcomes such as maximal oxygen uptake (VO2max) (3, 15), excess 
post-exercise oxygen consumption (EPOC) (1, 10), blood lipids (7, 15, 16), and 
blood pressure (16, 19).  Despite many studies utilizing fractionated exercise, the 
rest periods between the activity sessions were observed only in a few studies 
focusing on EPOC (1, 10).  In these EPOC studies, each short session was 
compared and found to yield similar responses (1, 10).  In our previous studies, 
the blood pressure was effectively decreased following the accumulation of 
physical activity (17, 19);  yet, the blood pressure patterns for the rest periods 
between the short sessions during the accumulation of physical activity has not 
been observed.    
 
Paragraph Number 4  In one of our previous studies (19) on the accumulation of 
physical activity, sympathetic modulation was associated with the reduction in 
blood pressure.  A sustained reduction in blood pressure following a single bout 
of aerobic exercise has been defined as post-exercise hypotension (11).  The 
mechanisms of post-exercise hypotension are still not fully understood.  
Sympathetic modulation has recently received more focus as one of the possible 
mechanisms of post-exercise hypotension (9, 14).  Sympathetic modulation 
describes changes in the balance between sympathetic and parasympathetic 
influences, or the sympathovagal balance (8, 21).  Although sympathetic 
modulation has been reported to be associated with post-exercise hypotension 
during the activities of daily living following the accumulation of physical activity 
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(19), sympathetic modulation has not been examined between the short 
sessions.   
 
Paragraph Number 5 The purpose of the study was 1) to investigate the blood 
pressure reduction during the rest periods following each successive short 
session within the accumulation of physical activity over a 3-hour period in adults 
with prehypertension, and 2) to study sympathetic modulation during the rest 
periods following each short physical activity session over a 3-hour period in 
adults with prehypertension.  We hypothesized 1) the systolic and diastolic blood 
pressures following each successive short physical activity session would be 
lower than the blood pressure of previous sessions in adults with 
prehypertension, and 2) the sympathetic modulation, measured by power 
spectral analysis of the heart rate variability, would be different following each 
successive short physical activity session in adults with prehypertension; (a) the 
normalized low frequency power of heart rate variability would be lower following 
each successive short physical activity session, (b) the normalized high 
frequency power of heart rate variability would be higher following each 
successive short physical activity session, (c) the low to high frequency power of 
heart rate variability would be lower following each successive short physical 
activity session.   
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METHODS 
Paragraph Number 6 The study design is shown in Figure 1.  Adults with 
prehypertension participated in the study.  Ambulatory blood pressure and Holter 
monitoring began for a baseline period prior to the physical activity sessions, 
continued during physical activity and rest periods, and continued for 12 hours 
following the end of the last physical activity session.  For physical activity, 
subjects were asked to walk on a motor-driven treadmill for 10 minutes at 50% of 
peak oxygen uptake (VO2peak) four times in a 4-hour period.  Subjects were 
seated for the rest period between the first three activity sessions.  After the 
fourth session, instead of a seated rest period, subjects left the laboratory and 
engaged in their activities of daily living for 12 more hours.  The blood pressure  
reduction and sympathetic modulation following the end of physical activity 
stimulus were reported for a 12-hour period in other study (19).  In the present 
study we evaluated blood pressure reduction and sympathetic modulation during 
the rest periods following three successive short sessions.  The study was 
approved by the Bloomington Campus Committee for the Protection of Human 
Subjects at Indiana University.  Written informed consent was obtained from 
each subject prior to participation in the study.  The study was carried out at the 
Clinical Exercise Physiology Laboratory in the Department of Kinesiology at 
Indiana University. 
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 Subjects 
Paragraph Number 7  Adults with prehypertension were recruited for this study.  
Inclusion criteria consisted of 120-139 mm Hg of a mean systolic screening blood 
pressure and/or 80-89 mm Hg of a mean diastolic blood pressure taken from at 
least two readings on two separate days, three days apart.  Exclusion criteria 
included 1) significant cardiovascular disease, 2) significant dysrhythmia (24, 25), 
3) brachial artery bruits (24, 25), 4) cardiac or renal transplant (24, 25), or 5) 
medications such as anti-arrhythmic drugs or low dose muscarinic receptor 
blockers including atropine and scopolamine that affect the heart rate variability 
(22).  Clearance by the participants’ primary physician was required prior to 
participation in the study.   
 
Paragraph Number 8  The number of subjects was estimated based on power 
analysis (power:>0.80; effect size using partial eta squared:>0.41) (12) using the 
previous study for blood pressure with a similar study design (17) testing a 
physical activity treatment in adults with prehypertension.   
 
Blood Pressure Screening 
Paragraph Number 9  For all participants three blood pressure measurements 
were taken in the seated position on two separate days, three days apart (a total 
of six measurements) using a mercury sphygmomanometer (17).  Each 
participant was seated for at least five minutes in a chair, feet on the floor, and 
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arm supported at heart level (5).  The participant was asked to avoid caffeine, 
exercise and smoking for at least 30 minutes prior to measurement (5).  An 
appropriate sized cuff (cuff bladder encircling at least 80% of the arm) was used 
to ensure accuracy (5).  On the first day blood pressure was taken in both arms 
to detect possible differences due to peripheral vascular disease (28).  The arm 
with highest blood pressure was used for the screening (28).   
 
Maximal Graded Exercise Test 
Paragraph Number 10 The purpose of maximal graded exercise test was to 
measure physical work capacity to ensure the intensity of the physical activity 
sessions.  A fasting blood draw and a standard resting 12 lead electrocardiogram 
(EKG) preceded the maximal graded exercise test to establish risk for the graded 
exercise test.  The graded exercise test was performed on a treadmill with a 
speed between 2.5 and 4.0 mph.  The speed remained constant throughout the 
test while the grade increased 1.0% every minute until a maximal voluntary effort 
was achieved.  Blood pressure (by auscultation) and heart rate (by EKG) was 
measured every minute.  The EKG was monitored continuously.  Expired gases 
were measured on-line breath-by-breath using a 2900 Metabolic Measurement 
Cart (SensorMedics, Corp., Yorba Linda, CA).  VO2peak was obtained during the 
symptom-limited maximal exercise test.  VO2peak is defined as the highest VO2 
obtained from the symptom-limited maximal exercise test.   
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Treatments 
Paragraph Number 11 A 15-minute baseline period preceded the treatment.  
The focus of the treatment for this study was the three rest periods following the 
first three short sessions of physical activity over a three-hour period.  The mode 
of physical activity was walking on a motorized treadmill and the intensity of each 
physical activity session was at 50% VO2peak.  Oxygen uptake (VO2) was 
measured during the 2nd through the 4th minutes of each walk to confirm the 
intensity of physical activity.  The work rate was adjusted if it was not within 
±10% of the target VO2.  Then, VO2 was measured during the 6th through the 8th 
minutes of the next work interval to confirm the new physical activity intensity.  
Heart rate (via EKG) and blood pressure (via auscultation) was measured 
throughout the physical activity treatment.   
 
Paragraph Number 12 Baseline Period:  The participant reported to the lab 
between 0830 and 0900 hours approximately 15 minutes before the time when 
the monitors would be activated for the study.  After the participant wore the 
monitors, the participant was in the seated position for a 15-minute baseline 
period. 
 
Paragraph Number 13 Accumulation of Short Physical Activity Treatment:  The 
duration of each short physical activity session was 10-minute; the first between 
0900 and 0930 hours, the second between 1000 and 1030 hours, and the third 
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between 1100 and 1130 hours.  Each short session was followed by the 50-
minute rest period in the seated position. 
 
Ambulatory Blood Pressure Monitoring 
Paragraph Number 14 The Accutracker II (SunTech Medical Instruments, Inc., 
Raleigh, NC) was used for the ambulatory blood pressure measurements.  The 
Accutracker II has been validated in accordance to the standards of the British 
Hypertension Society and the American Association for Medical Instrumentation 
(23).  The ambulatory blood pressure cuff was worn on the non-dominant arm.  
Electrode wires and blood pressure tubing were taped securely to the chest.  The 
cuff inflation for each measurement was 30 mm Hg greater than the previous 
reading, and the cuff deflation was set at 3 mm Hg·second-1 (5).  The sampling 
intervals were 1) every 5 minutes for the 15-minute baseline period; 2) every 5 
minutes for the first 20 minutes of the 50-minute rest period among three short 
sessions of physical activity; and 3) every 10 minutes for the remainder of the 50-
minute rest period among three short sessions of physical activity.  No repeat 
measurements were taken.   
 
Paragraph Number 15  Ambulatory blood pressure data was manually reviewed 
for missing and erroneous readings (17).  Readings were purged if 1) data was 
missing; 2) systolic blood pressure was lower than diastolic blood pressure; 3) 
systolic blood pressure was >240 mm Hg or <50 mm Hg; 4) diastolic blood 
pressure was >140 mm Hg or <40 mm Hg; 5) heart rate was >150 beats⋅minute-1 
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or <40 beats⋅minute-1; 6) systolic and diastolic blood pressure deviated ±50 mm 
Hg and ±20 mm Hg, respectively from surrounding values; and/or 7) heart rate 
deviated ±30 beats⋅minute-1 from the surrounding values.  Ambulatory blood 
pressure data was averaged during the baseline period and for the last 40 
minutes of the rest periods between each short session of physical activity.   
 
Holter Monitoring 
Paragraph Number 16 The Aria Digital Recorder (Del Mar Reynolds Medical, 
Inc., Irvine, CA) was used to observe sympathetic modulation through power 
spectral analysis of heart rate variability.  The EKG was analyzed for the baseline 
period and the post-treatment period following each short session of physical 
activity.  The data from Aria Digital Recorder was scanned on a computer-
assisted Holter system (Impresario, Solo Holter analysis software, Del Mar 
Reynolds Medical, Inc., Irvine, CA) for variables of heart rate variability.  Manual 
editing of the R-R interval data was performed to ensure correct identification and 
classification of every QRS complex (22).  Artifact and ectopic beats were 
removed for the R-R interval calculation.  The data was then used for the power 
spectral analysis of heart rate variability. 
 
Paragraph Number 17 Frequency-domain measures of heart rate variability 
were assessed using the fast Fourier transform.  The total power was calculated 
by the standard deviation of the R-R interval (<0.1 Hz).  Heart rate variability of 
the total nominal record was computed using the whole range of high frequency 
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power (0.15-0.40 Hz), low frequency power (0.04-0.15 Hz), and very low 
frequency power (0.003-0.04 Hz).  Normalized (%) values were calculated.  
Normalized units represent the relative value of each power component in 
proportion to the total power minus the very low frequency component.  The ratio 
of low frequency power to high frequency power was determined.  Normalized 
low frequency power, high frequency power, and the ratio of low to high 
frequency were averaged for the baseline period and for the last 40 minutes of 
the rest periods between each short session of physical activity.   
 
STATISTICAL METHODS 
Paragraph Number 18  Data was expressed as means ±  standard error of the 
mean (SE).  Statistical analyses were performed by use of descriptive statistics, 
and analysis of variance (ANOVA) with repeated measures.  Paired t-test was 
used for post hoc comparisons.  Descriptive statistics were performed to describe 
the characteristics of subjects.  The variables were sex, age, body mass index 
(BMI), screening systolic and diastolic blood pressures, and VO2peak.  One-way 
ANOVA with repeated measures was used to test if the variables of blood 
pressure and sympathetic modulation differed over time.  Tukey test was used 
for post-hoc comparisons.  The level of significance was set at p<0.05.  The 
SPSS software (SPSS 13.0) was used for all statistical analyses.   
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RESULTS 
Subjects 
Paragraph Number 19 Twenty six adults were screened for the study; five were 
found to be ineligible during the blood pressure screening process; four have 
normal blood pressure and one has hypertension.  Twenty one adults with 
prehypertension who were qualified based on screening blood pressure 
participated in the study.  One participant did not complete the study because of 
time constraints.  Twenty adults with prehypertension completed the study.  
Demographics of the subjects are summarized in Table 1.   
 
Exercise Stimulus 
Paragraph Number 20 The 20 participants who completed the study performed 
a maximal voluntary effort on the exercise test as verified by reaching 
107.7±1.3% predicted maximal heart rate (220-age).  The intensity of physical 
activity was 51.9±0.6% of VO2peak. 
 
Blood Pressure Reduction 
Paragraph Number 21 The average ambulatory blood pressures for three rest 
periods are illustrated in Figure 2.  The beginning times for the analyses of the 
ambulatory measurements were 9:00 ± 0:03 for baseline, 9:42 ± 0:04 following 
the first short session, 10:41 ± 0:03 following the second short session and 11:42 
± 0:04 following the third short session.  The number of ambulatory blood 
pressure measurements was three in the baseline period and six in the rest 
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period following each short sessions of physical activity treatment.  The average 
blood pressures for baseline and rest periods are listed in Table 2.   
 
Paragraph Number 22  The average baseline blood pressures and average 
blood pressures for the rest periods following each short physical activity session 
was analyzed by one-way ANOVA with repeated measures.  A significant main 
effect was found in systolic blood pressure (p=0.039) while no main effect was 
found in diastolic blood pressure (p=0.630).  Further analyses revealed that 
systolic blood pressure was significantly decreased following the third short 
session (-4.0 ± 1.7 mm Hg) compared to each session. 
 
Sympathetic Modulation 
Paragraph Number 23 Sympathetic modulation measured by heart rate 
variability was averaged for baseline and for the rest periods following each short 
physical activity session.  The values of normalized high frequency power, 
normalized low frequency power, and the ratio of low to high frequency power 
are summarized in Table 3.  No significance was found in any of these variables 
of heart rate variability. 
 
DISCUSSION 
Paragraph Number 24 The purpose of the study was 1) to investigate the blood 
pressure reduction during the rest periods following each successive short 
session within the accumulation of physical activity over a 3-hour period in adults 
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with prehypertension, and 2) to study sympathetic modulation during the rest 
periods following each short physical activity session over a 3-hour period in 
adults with prehypertension.  We hypothesized 1) the systolic and diastolic blood 
pressures following each successive short physical activity session would be 
lower than the blood pressure of previous sessions in adults with 
prehypertension, and 2) the sympathetic modulation, measured by power 
spectral analysis of the heart rate variability, would be different following each 
successive short physical activity session in adults with prehypertension.  Our 
study is the first one to examine the blood pressure response during the rest 
periods between several short sessions in the accumulation of physical activity 
as a treatment for prehypertension.   
 
Paragraph Number 25  In 2003, 45 million adults with prehypertension (5) were 
added to the patient population in need of treatment for high blood pressure; 
which represents 31% of the US population (26).  Lifestyle modification (2, 5), 
including regular physical activity, is the only recommended treatment for 
prehypertension.  It is also the only recommended treatment for the prevention of 
prehypertension progressing to hypertension (27).  Yet, supporting literature on 
regular physical activity as a treatment for prehypertension is limited (6).  Thus, 
our focus on adult with prehypertension was warranted. 
 
Paragraph Number 26 The physical activity stimulus we presented to the 
subjects was effective in lowering systolic and diastolic blood pressures which 
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was associated with increased parasympathetic and decreased sympathetic 
activity.  As a result of 4 x 10-minute sessions of physical activity over a four hour 
period (19), systolic blood pressure decreased 5.4 ± 1.7 mmHg for 11 hours; 
diastolic blood pressure decreased 3.4 ± 1.3 mmHg for 10 hours.  Furthermore, 
the differences in normalized low frequency power (r=0.517, P<0.01) and high 
frequency power (r=-0.503, P<0.05) were correlated with the systolic blood 
pressure reduction.  The differences in normalized low (r=0.745, P<0.001), high 
frequency (r=-0.738, P<0.001), and the ratio of low to high frequency (r=0.756, 
P<0.001) were correlated with the diastolic blood pressure reduction.  In the 
present study we found a difference in systolic blood pressure over time using 
ANOVA with repeated measures, whereas no difference in diastolic blood 
pressure was found.  Tukey post-hoc comparison indicated a significant 
reduction in systolic blood pressure following the third session.  The 
accumulation of the first two sessions was not a sufficient stimulus to induce a 
statistically significant blood pressure reduction; however, the addition of the third 
session decreased systolic blood pressure.  Thus, it clearly demonstrates an 
additive effect of successive sessions on blood pressure reduction. Furthermore, 
the reductions in blood pressure following the accumulation of physical activity 
that we observed in our previous studies (17, 19) might be due to this additive 
effect of successive sessions.  There was no relationship between the reduction 
in systolic blood pressure during the rest periods and the resultant blood 
pressure reduction, however. 
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Paragraph Number 27  Our finding in blood pressure reduction was different 
from other studies investigating the rest periods between each short session (1, 
10).  Other investigators (1, 10) who observed the rest periods between 
successive sessions of exercise found similar responses between two sessions.  
In these studies (1, 10), EPOC was studied during the rest periods following two 
short sessions vs. one long session.  Kaminsky et al. (10) investigated EPOC 
following a 50-minute exercise session compared to two 25-minute exercise 
sessions at 70% VO2max.  The two 25-minute runs were separated by 30 
minutes of sitting rest.  The magnitude of EPOC was similar for the two rest 
periods following the short sessions; and similar to the magnitude following the 
continuous session.  Almuzaini et al. (1) also reported the EPOC following a 30-
minute exercise session to two 15-minute exercise sessions, separated by 6 
hours.  A 20-minute measurement of EPOC followed each short session.  EPOC 
measurements following two short sessions were not different from each other 
and were not different from the EPOC following the continuous session.  
Although both Kaminsky et al. and Almuzaini et al. found no additive effect in 
EPOC between the rest periods of the short sessions (1, 10), we found the 
additive effect of successive sessions in blood pressure reduction.  This 
difference in successive sessions in our study might be due to the specific 
variable we measured, blood pressure, or due to the number of rest periods we 
utilized.   
 
 63 
Paragraph Number 28 In our study the duration of the rest period was 50 
minutes and the duration of the monitoring period was the last 40 minutes of the 
rest period.  This 50-minute rest period enabled the optimal time for ambulatory 
blood pressure monitoring.  Had we extended the rest periods to 2-3 hours, our 
ambulatory monitoring following the accumulation of physical activity (19) would 
have been reduced 4-7 hours, compromising the ability to detect a blood 
pressure reduction for the entire stimulus before the subjects went to bed. The 
first 10 minutes of the 50 minutes was not included in the rest period data 
because it may have been elevated as a result of the exercise (Figure 2).   
Looking at our hourly data from our previous exercise studies (17, 18, 25), we 
found that the reduction in blood pressure for the first hour following exercise is 
not as great as the subsequent hours.  Thus, we may have compromised our 
ability to detect a significant blood pressure reduction during the rest period if we 
had included the first 10 minutes. 
 
Paragraph Number 29  The mechanisms of post-exercise hypotension are not 
fully understood at this time; however, sympathetic modulation has recently 
received increased focus as a possible mechanism (9, 14).  Sympathetic 
modulation during the 50-minute rest period did not appear to be affected by 
short sessions of physical activity in our study even though we found changes in 
systolic blood pressure.  These findings are similar to those reported by 
Legramante and colleagues (13).  They found no significant changes in 
sympathetic modulation although they elicited a significant 11.9 mm Hg reduction 
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in systolic blood pressure and a 5.3 mm Hg reduction in diastolic blood pressure.  
In their study (13), both post-exercise (graded exercise to 87% of predicted heart 
rate max) blood pressure and heart rate variability were measured for 5 minutes 
between 60 to 90 minutes following exercise.  On the other hand, we did find that 
sympathetic modulation was associated with the reduction in blood pressure 
following the accumulation of physical activity when averaged over the 11-hour 
period of the systolic blood pressure reduction (19).  It seemed reasonable to be 
able to detect a change in sympathetic modulation for the 50-minute rest period 
between each short session.  Yet, Pober and colleagues (20) found no significant 
increase in parasympathetic activity at 1, 3, and 6 hours after 60 minutes of cycle 
ergometry at 65% of VO2peak.   They did, however, find a significant increase in 
sympathetic activity at 6 and 22 hours following the exercise.  Thus, it appears as 
though the change in sympathetic modulation lags behind the change in early 
stage of post-exercise hypotension (1-2 hours following the exercise).  If the lag 
is a true phenomenon, perhaps sympathetic modulation is not the mechanism of 
early stage of post-exercise hypotension. 
 
Paragraph Number 30 Three 10-minute walking sessions were effective in 
reducing systolic blood pressure in prehypertension.  This immediate and 
favorable response associated with a few physical activity sessions may 
encourage the public to participate in a more active lifestyle.  Furthermore, the 
accumulation of several 10-minute walking sessions may be more effective than 
continuous exercise because the multiple short sessions may promote 
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adherence and may fit better into a busy schedule for most Americans.  In 
summary, successive short physical activity sessions presented an additive 
effect on systolic blood pressure reduction whereas they did not affect diastolic 
blood pressure and sympathetic modulation in adults with prehypertension.  
Continued investigation of the mechanisms of blood pressure reduction is 
warranted. 
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FIGURE 1.  Study design 
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FIGURE 2.  Blood pressure during the baseline and the three rest periods 
following the short physical activity sessions in prehypertension.  Baseline blood 
pressure was averaged for 15 minutes.  Physical activity sessions are illustrated 
by shaded area.  The data points following the shaded physical activity session 
were blood pressure in the rest periods following the short sessions.  ● 
represents systolic blood pressure and ○ represents diastolic blood pressure.  
Bars represent standard errors. 
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TABLE 1.  DEMOGRAPHICS OF SUBJECTS 
 
Variables  
Number 20 
Sex (men/women) 15/5 
Race 18 Caucasian 
2 Asian 
Age (years) 47.2 ± 2.9 
Weight (kg) 84.5 ± 4.4 
Height (cm) 176.3 ± 1.7 
Body mass index (kg⋅m-2) 27.0 ± 1.2 
VO2peak  (ml⋅kg⋅-1⋅min-1) 34.5 ± 1.6 
Screening systolic blood pressure 
(mm Hg) 
131.9 ± 1.1 
Screening diastolic blood pressure 
(mm Hg) 
83.0 ± 1.6 
 
Values were expressed as mean ± S.E.  
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TABLE 2.  AMBULATORY BLOOD PRESSURE  
 
 Baseline Rest period 
following 
the 1st 
Session 
Rest period 
following 
the 2nd 
session 
Rest period 
following the 
3rd session 
Systolic Blood 
Pressure 
(mmHg) 
126.6 ± 2.4 123.9 ± 2.5 123.5 ± 2.3 122.6 ± 2.4* 
Diastolic Blood 
Pressure 
(mmHg) 
81.0 ± 1.9 81.2 ± 2.4 82.3 ± 1.9 81.6 ± 1.7 
 
Values of blood pressure were averaged for the 15-minute baseline period and 
the last 40 minutes of the rest period following short physical activity sessions.   
Values were expressed as mean ± S.E.  
* denotes significant differences from baseline blood pressure at p<0.05. 
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TABLE 3.  SYMPATHETIC MODULATION BY HEART RATE VARIABILITY 
 
 Baseline Rest period 
following 
the 1st 
session 
Rest period 
following 
the 2nd 
session 
Rest period 
following the 
3rd session 
Normalized 
low Frequency 
power (%) 
80.0 ± 1.3 80.1 ± 2.3 80.1 ± 2.6 78.6 ± 3.4 
Normalized 
high 
frequency 
power (%) 
17.9 ± 1.1 17.8 ± 2.1 17.8 ± 2.3 19.1 ± 3.1 
Ratio of low to 
high 
frequency 
4.9 ± 0.4 6.0 ± 0.8 6.3 ± 0.9 6.7 ± 1.0 
 
Values of heart rate variability were averaged for the 15-minute baseline period 
and the last 40 minutes of the rest period following short physical activity 
sessions.   
Values were expressed as mean ± S.E. 
 79 
APPENDICES
 80 
APPENDIX A – REVIEW OF THE LITERATURE 
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The purpose of this study is (1) to compare the blood pressure reduction 
following the accumulation of short bouts of exercise and one long bout of 
exercise in adults with prehypertension, and (2) to compare the blood pressure 
reduction following each successive short bout of exercise in adults with 
prehypertension.  In addition, sympathetic modulation will be investigated as a 
possible mechanism for the blood pressure reduction following exercise in adults 
with prehypertension.  The literature related to this study is reviewed in this 
amendment under the following topics: (a) Hypertension-A Serious Public Health 
Problem; (b) Regulation of Blood Pressure; (c) Etiology of Hypertension; (d) 
Treatment and Prevention of Hypertension; (e) Accumulation of Exercise on 
Blood Pressure Reduction; (f) Post Exercise Hypotension, (g) Power Spectral 
Analysis of Heart Rate Variability; (h) Ambulatory Blood Pressure Monitoring, (i) 
Physical Activity Monitoring, and (j) Summary. 
 
HYPERTENSION- A SERIOUS PUBLIC HEALTH PROBLEM 
High blood pressure, or hypertension is a major risk factor for stroke (78), 
coronary artery disease (78), congestive heart failure (135), and end-stage renal 
disease (64).  Approximately 50 million individuals in the United States (U.S.) 
diagnosed with hypertension (defined as a systolic blood pressure ≥140 mm Hg, 
a diastolic blood pressure ≥90 mm Hg or current treatment with antihypertensive 
medication)  (13).  In the U.S., the prevalence of hypertension has increased by 
13.1% in the last decade (43).  The estimated annual direct and indirect costs of 
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hypertension are 55.5 billion dollars in the U.S.(5).  The risk of developing this 
costly disease increases with advancing age.   
Lifetime risk of developing hypertension is 90% in individuals with normal 
blood pressure  (<140 mm Hg systolic or <90 mm Hg diastolic) at 55 to 65 years 
of age (133).  Moreover, the risk of cardiovascular disease associated blood 
pressure begins as low as 115 mm Hg systolic blood pressure.  Suboptimal 
systolic blood pressure (>115 mm Hg) is responsible for 62% of cerebrovascular 
disease (i.e., stroke), 49% of ischemic heart disease, and is the primary 
attributable risk for death throughout the world (146).  In addition, there is a two-
fold increase in relative risk from cardiovascular disease with systolic blood 
pressure of 130 to 135 mm Hg and with diastolic blood pressure of 85 to 89 mm 
Hg compared with a blood pressure of 120/80 mm Hg.  Thus, emphasis has 
been made to lower blood pressure to prevent hypertension and to reduce the 
risk of cardiovascular disease. 
 
Classification of Blood Pressure 
The 7th Report of the Joint National Committee on Prevention, Detection, 
and Treatment of High Blood Pressure, or the JNC 7 (14), has provided a new 
blood pressure classification system for adults aged 18 years or older.  This 
system is summarized in Table 1.  The classification of blood pressure is based 
on the mean of two or more properly measured seated blood pressure readings 
on each of two or more office visits.  In the JNC7 report, a new category 
designated prehypertension has been added.  This new classification of 
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hypertension has been introduced to identify those individuals in whom early 
intervention by adopting healthy lifestyle would lead to reduce blood pressure 
and to decrease the rate of progression of hypertension or to prevent 
hypertension entirely.  Another change in classification from the 6th Report of the 
Joint National Committee on Prevention, Detection, and Treatment of High Blood 
Pressure is to combine stage two and three hypertension.   
 
 
Table 1. Classification of blood pressure for adults aged 18 years or older*  
 
Classification Systolic Blood 
Pressure (mm Hg) 
 Diastolic Blood 
Pressure 
(mm Hg) 
Normal <120 and <80 
Prehypertension 120-139 or 80-89 
Hypertension (Stage 1) 140-159 or 90-99 
Hypertension (Stage 2) >160 or >100 
 
*Based on the mean of two or more properly-measured seated blood pressure 
readings on each of two or more physician office visits. 
From the 7th Report of the Joint National Committee on Prevention, Detection, 
and Treatment of High Blood Pressure, JNC 7 (2003) (14) 
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Historically, a greater emphasis has been placed on diastolic than systolic 
blood pressure as a predictor of cerebrovascular and coronary heart disease 
(24).  Indeed, until the 1990s, diastolic blood pressure was used as an inclusion 
criterion in hypertension studies (19), while subjects with isolated systolic 
hypertension were excluded from such studies.  It is currently emphasized that a 
systolic blood pressure >140 mm Hg is a much more important cardiovascular 
disease risk factor than diastolic blood pressure in individuals older than 50 years 
(59, 120). 
In summary, hypertension is an important risk factor for cardiovascular 
disease.  The prevalence of hypertension increases with advancing age.  The 
risk of cardiovascular disease begins blood pressure as low as 115/75 mm Hg.  
Thus, the prevention and treatment of hypertension are major public health 
challenge for society.   
 
REGULATION OF BLOOD PRESSURE 
The regulation of blood pressure is traditionally described in terms of 
homeostasis.  Homeostasis indicates blood pressure continuously perturbed by 
external stimuli although it always displays the tendency to return to a reference 
set point.  There are a number of systems involved in the regulation of blood 
pressure.  The primary factors include the autonomic nervous system for the 
short-term blood pressure regulation and the kidneys for the long-term blood 
pressure regulation.   
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Role of Autonomic Nervous System in Short-Term Blood Pressure 
Regulation 
One of the most important functions of the autonomic nervous system in 
the circulation is its capability to cause rapid alterations in blood pressure.  The 
entire vasoconstrictor and cardioaccelerator functions of the sympathetic nervous 
system are stimulated as a unit.  At the same time, there is reciprocal inhibition of 
the parasympathetic vagal inhibitory signals to the heart.  These responses can 
be found in 1) baroreceptor reflexes, 2) chemoreceptor reflexes, 3) atrial and 
pulmonary reflexes, and 4) central nervous system ischemic response. 
 
1) Baroreceptor Reflex 
The baroreceptor reflex is the most well known mechanism for the regulation of 
blood pressure.  This is a classic negative feedback reflex system.  
Baroreceptors are nerve endings lying in the walls of the arteries.  A few 
baroreceptors are located in the wall of almost every large artery of the thoracic 
and neck regions.  But, baroreceptors are abundant in the wall of the carotid 
sinus and the wall of the aortic arch.  The baroreceptor reflex regulates 
instantaneous blood pressure fluctuation such as seen in postural changes.  The 
baroreceptor reflex is also an important response to acute blood loss (e.g., 
hemorrhage).  The regulations of blood pressure involving baroreceptor reflex 
are described in Figure 1. 
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Figure 1. Baroreceptor reflex in regulation of blood pressure 
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In resting conditions muscle sympathetic nerve activity is under strong 
regulation by the arterial baroreceptor and cardiopulmonary receptor reflexes.  
During exercise, the baroreceptor reflex is reset to a higher operating point and 
sympathetic activity is increased (84, 137).  After exercise, these reflexes are 
reset to lower pressures such that sympathetic outflow from the central nervous 
system is lower than pre-exercise pressure.  In established hypertension, the 
baroreceptor reflex is reset to maintain elevated blood pressures.  This resetting 
is caused by interactions with higher nervous center and humoral factors such as 
angiotensin II (148). 
 
2) Chemoreceptor Reflex 
Closely associated with the baroreceptor reflex is a chemoreceptor reflex 
that is also involved in blood pressure regulation.  The chemoreceptors are 
chemosensitive cells sensitive to decrease the partial pressure of oxygen (Po2), 
increased the partial pressure of carbon dioxide (Pco2), or increased 
concentration of hydrogen ion.  The chemoreceptors excite nerve fibers that pass 
along adjacent to the baroreceptor fibers through Hering’s nerves and the vagus 
nerves into the vasomotor center. 
Chemoreceptors are in close contact with the arterial blood flow.  When 
arterial blood pressure falls below a critical point, the chemoreceptors are 
stimulated by the decreased Po2 and increased Pco2.  The signals transmitted 
from the chemoreceptors into the vasomotor center excite the vasomotor center 
to elevate the blood pressure.  The chemoreceptor reflex is, however, not a 
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powerful regulator due to the fact that the chemoreceptors are not stimulated 
strongly until the arterial blood pressure falls below 80 mm Hg (37, 45). 
 
3) Atrial and Pulmonary Artery Reflexes 
 Both the atria and the pulmonary arteries have stretch receptors, or low 
pressure receptors.  These low pressure receptors play an important role to 
minimize arterial pressure changes in response to changes in blood volume.  
They elicit reflexes parallel to the baroreceptor reflexes to make the total reflex 
system much more potent for the regulation of blood pressure (37). 
 Stretch of the atria also causes reflex dilation of the afferent arterioles in 
the kidneys.  Signals are transmitted simultaneously to the hypothalamus to 
decrease the secretion of anti-diuretic hormone.  The decreased afferent 
arteriolar resistance causes the glomerular capillary pressure to rise, with 
resultant increase in filtration of fluid into the kidney tubules.  The diminution of 
anti-diuretic hormone attenuates the reabsorption of water from the tubules.  
Thus, urine output is increased and blood volume is regulated (37). 
 
4) Central Nervous System Ischemic Response 
Most nervous regulation of blood pressure is achieved by reflexes 
originating in the baroreceptors, the chemoreceptors, and the low pressure 
receptor, all of which are located in the peripheral circulation.  In cerebral 
ischemia the neurons in the vasomotor center itself respond directly to the 
ischemia and become excited.  This blood pressure elevation in response to 
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cerebral ischemia is known as the central nervous system ischemic response.  
This ischemic response does not become very active until the arterial blood 
pressure falls below 60 mm Hg (37). 
 
The Role of the Kidneys in Long-Term Blood Pressure Regulation 
 In the long-term regulation of blood pressure, the kidneys work through 
two mechanism: 1) Renal-volume control system and 2) Renin-angiotensin 
system. 
 
1) Renal-Volume Control System 
Blood pressure rises when the body retains too much extracellular fluid 
(see Figure 2).  The rising pressure has a direct effect to cause the kidney to 
excrete the excess extracelluar fluid.  This phenomenon is called pressure 
diuresis (or pressure natruresis).  Pressure diuresis represents the ability of the 
kidneys to respond to changes in blood pressure by altering the renal excretion 
of salt and water.  At an arterial blood pressure of 50 mm Hg, the urinary output 
is zero.  At 100 mm Hg, it is normal and at 200 mm Hg it is about six to eight 
times normal.   
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Figure 2. The sequential steps of the regulation of blood pressure in relation to 
extracellular fluid 
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The two determinants of the renal-volume control system are 1) renal 
output of salt and water, and 2) salt and water intake (38).  When the net intake 
of water and salt (defined as the intake minus the nonrenal output such as sweat) 
exactly equals renal output urinary output of both water and salt remains normal, 
and the arterial pressure is normalized.  When arterial blood pressure falls below 
the normalized point, the decreased pressure has a direct effect on the kidneys 
to reduce the urinary output of water and salt. 
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2) Renin-Angiotensin System 
The kidneys regulate blood pressure not only through changes in 
extracellular fluid volume but also through the renin-angiotensin system.  The 
renin-angiotensin system was first discovered and described in the 1930’s.  This 
system, unlike the baroreceptor reflex, represents a slow response.  Complexity 
of the renin-angiotensin allows multiple options of treatment for hypertension.  
The renin-angiotensin system (see Figure 3) primarily adjusts blood volume. 
The kidney plays a major role in the renin-angiotensin system.  The initiating step 
is the release of renin.  The three factors controlling renin release are 1) the 
afferent arteriole blood pressure in the juxtaglomerular apparatus, 2) Na+ and Cl- 
concentrations in the macula densa, and 3) increased sympathetic drive to 
granular cells respectively.  The result of each is an increase in renin.  The renin, 
in turn, stimulates the increase in angiotensin II.  Angiotensin II stimulates 
constriction of arterioles throughout the systemic circulation.  It also stimulates 
release of aldosterone from the adrenal cortex (zona glomerulosa), increasing 
salt and water retention and blood volume.  It also turns on the adrenal medulla, 
releasing epinephrine and norepenephrine. 
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Figure 3.  Renin-angiotensin system in regulation of blood pressure 
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In summary, there are a number of systems involved in the regulation of 
blood pressure.  The autonomic nervous system is involved in the short-term 
blood pressure regulation and the kidneys are involved in the long-term blood 
pressure regulation.  Physiological and clinical significance of each identified 
factor is not entirely clear.   
 
ETIOLOGY OF HYPERTENSION 
Primary (essential or idiopathic) hypertension accounts for 90-95% of all 
cases of hypertension.  Primary hypertension is defined as high blood pressure 
in which secondary causes such as chronic kidney disease, drug induced/related 
hypertension, primary aldosteronism, Cushing’s syndrome or steroid therapy, 
pheochromocytoma, coarctation of the aorta, and/or thyroid/parathyroid disease 
are not present.   
 
Primary Hypertension (essential or idiopathic hypertension) 
 Hypertension can develop in response to an increase in cardiac output 
and/or a rise in total peripheral resistance.  The interplay of various factors 
affecting cardiac output and/or total peripheral resistance may precipitate 
hypertension.  These factors include 1) genetic predisposition, 2) increased 
sympathetic nervous activity, and 3) obesity. 
 
 94 
1) Genetic Predisposition (30-60%) 
 Hypertension is a multigenetic disease.  In particular, the renin-
angiotensin genes play an important role in the pathogenesis of hypertension.  
Upregulation of the transcription of angiotensinogen, and angiotensin-converting 
enzyme genes increases blood pressure through the increased concentration of 
angiotensin II (53, 67).  Other candidate genes, such as angiotensin II type 1 
receptor, endothelins, atrial natriuretic peptide, renin, e-NOS, insulin receptor, 
and low density lipoprotein receptor have been reported to play a role in 
pathogenesis of human hypertension (53). 
 
2) Increased Sympathetic Nervous Activity  
 In early hypertension there is a state of increased cardiac output via 
increased stroke volume and heart rate.  This state is, in part, neurogenic 
because of its normalization after pharmacological blockade of the autonomic 
nervous system.  This state is gradually transferred into the cardiovascular 
pattern of normal cardiac output and elevated total peripheral resistance.  The 
conversion from a high to normal cardiac output is secondary to decreased 
cardiac compliance and beta-adrenergic responsiveness. 
 Sympathetic activity is frequently activated, at least in early stages in 
primary hypertension.  Evidence was supported by the elevated spillover of 
norepinephrine from sympathetic neuroeffector junction, and direct 
measurements of sympathetic nerve activity.  The increased spillover was 
evident in the heart, kidney, and subcortical region of the forebrain, which would 
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explain the hemodynamic characteristics of early hypertension, increased heart 
rate, cardiac output and renal vascular resistance. 
 Sympathetic nervous system has been investigated for the long-term 
regulation of blood pressure (38).  The kidney itself can be controlled by other 
factors such as neural and humoral factors.  The renal sympathetic nerves can 
promote anti-natruresis and can affect renal-volume control system directly 
through renal tubular innervation and indirectly by neurally mediated increases in 
renin release and renal vascular resistance (72). 
 It has been documented that hypertensive adults have more frequent 
neurovascular compression (NVC) of the rostral ventrolateral medulla, which is 
the major center of the sympathetic nervous system regulating the cardiovascular 
system.  In its early stage, hypertension is accompanied by sympathetic 
activation, then sympatho-renal interactions in conjunction with genetic and 
environment factors and the tropic effects on vascular muscle may play important 
roles in the long-term regulation of arterial pressure. 
 
3) Obesity  
Obesity, and especially abdominal obesity, is associated with the 
development of hypertension.  In the Framingham study, each 10% weight gain 
is associated with a 6.5 mm Hg increase in systolic blood pressure (7).  The 
relation between blood pressure and body weight is not restricted to morbid 
obesity, but is continuous throughout the range of body weight (40).  The 
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mechanisms underlying the association between obesity and hypertension are 
not fully understood.   
In obesity, alterations in intrarenal vasoactive substances would be a 
factor contributing to the development of hypertension, and the disturbed insulin 
sensitivity could impair myogenic response of preglomerular vessels.  Insulin 
stimulates nitric oxide production in the endothelium.  Impaired nitric oxide 
production would lead to increased vascular tone and hypertension.  Cellular 
hypertrophy or mitogen-activated protein (MAP) kinases and NAD(P)H oxidases 
produce reactive oxidative stress.  Angiotensin II increases vascular superoxide 
anion production by activation of membrane-bound NAD(P)H oxidase.  Increased 
vascular superoxide anion production can lead to reduced bioavailability of nitric 
oxide and impaired endothelium-dependent relaxation, a characteristic of disease 
states such as hypertension (32). 
 The etiology of primary hypertension is not fully understood yet.  There are 
many factors associated with hypertension.  In this review, genetic 
predisposition, increased sympathetic nervous activity, and obesity are discussed 
as major factors contributing to the development of hypertension. 
 
TREATMENT AND PREVENTION OF HYPERTENSION 
Treatment of Hypertension 
The primary goal of treatment of hypertension is to achieve the maximum 
reduction in the total risk of cardiovascular morbidity and mortality (14, 15, 24, 
145).  It is also recommended that blood pressure be treated below 140/90 
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mmHg or below 130/80 mmHg in patients with diabetes or chronic kidney 
disease.  Treatments of hypertension include 1) lifestyle modifications and 2) 
pharmacological treatment.   
 
1) Lifestyle Modifications 
Several health organizations recommend the use of lifestyle modifications 
as the primary and adjunctive treatment for hypertension (15, 24, 143, 145).  
There are minimal cost and side effects associated with lifestyle modifications.  
Major lifestyle modifications recommended to lower blood pressure include 
weight reduction, diet, exercise, and moderation of alcohol consumption (see 
Table 2).  Multiple lifestyle modifications can achieve better results to reduce 
blood pressure and cardiovascular risk (147). 
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Table 2. Lifestyle medications to manage hypertension 
 
Modification Recommendation Approximate 
Systolic BP 
Reduction 
Weight 
Reduction 
Maintain normal body weight  
(BMI 18.5-24.9 kg/m2) 
5-20 mm Hg/10 kg 
Adopt DASH 
Eating Plan 
Consume a diet rich in fruits, 
vegetables, and low fat dairy products 
with reduced content of saturated and 
total fat 
8-14 mm Hg 
Dietary 
Sodium 
Reduction 
Reduced <100mmol/day (2.4g sodium 
or 6g sodium chloride 
2-8 mm Hg 
Physical 
Activity 
Engage in regular aerobic physical 
activity (at least 30 min per day, most of 
days of the week) 
4-9 mm Hg 
Moderation 
of Alcohol 
Consumption 
Limit consumption to no more than 2 
drinks per day (1 oz or 30 mL 
ethanol;eg, Men: <2 drinks/day; women 
and lighter weight 24 oz beer, 10 oz 
wine, or 3oz 80 proof whiskey)) in most 
men and no more than 1 drink per day 
in women and lighter-weight person  
2-4 mm Hg 
 
Table 2 modified from JNC7 (14).  BMI: body mass index, BP: blood pressure, 
DASH: Dietary Approaches to Stop Hypertension 
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In this review, exercise, a lifestyle modification, is further discussed.  
Exercise is an integral component of lifestyle modifications for treatment of 
hypertension (4) because exercise reduces blood pressure and decreases 
cardiovascular mortality independent of blood pressure and other risk factors 
(112).  For example, normotensive and hypertensive individuals also improve 
plasma lipoprotein-lipid profiles and improve insulin sensitivity with exercise 
training (42).  The exercise prescription for treatment of hypertension is 
composed of more than 30 minutes of continuous or accumulated endurance 
physical activity (40 to 60% of maximal oxygen uptake, VO2max) on most, 
preferably all, days of the week (4, 15).  The magnitude of blood pressure 
reductions resulted from aerobic exercise training is related to baseline blood 
pressure (26).  In other words, the decrease in blood pressure appears to be 
more pronounced in hypertensive (4.94 mm Hg in systolic and 3.73 mm Hg in 
diastolic blood pressure) than in normotensive (4.04 mm Hg in systolic and 2.33 
mm Hg in diastolic blood pressure)individuals (142).  The blood pressure 
reduction following aerobic exercise training in hypertensive adults is 
independent of weight loss (138, 142).  Resistance exercise is not the 
recommended mode to control blood pressure due to a pressor effect (138).   
 
2) Pharmacological Treatment 
 In this review, pharmacological treatment for hypertension is briefly 
summarized.  Several classes of medications have been shown to reduce blood 
pressure as well as the complications of hypertension.  The classes of 
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antihypertensive medications are (1) angiotensin-converting enzyme inhibitors, 
(2) angiotensin-receptor blockers, (3) calcium channel blockers, (4) drugs with 
central and peripheral sympatholitic actions, (5) arteriolar dilators, and (6) 
thiazide-type diuretics.  Based on recommendations of drug therapy made by the 
JNC 7, the initial drug choices for stage one hypertensive adults without 
compelling indications are thiazide-type diuretics.  Angiotensin-converting 
enzyme inhibitors, angiotensin-receptor blockers, beta blockers, or calcium 
channel blockers, and/or combination may be considered.  For stage two 
hypertensive adults two drug combinations for most (usually thiazide-type diuretic 
and other antihypertensive medications). 
 
Prevention of Hypertension 
Prevention of hypertension is imperative because the lifetime risk of 
developing hypertension is very high in the U.S (15).  Despite the effort to control 
hypertension, only 31% of individuals with hypertension in the U.S. have the 
disease under control (i.e., with a systolic blood pressure <140 mm Hg and a 
diastolic blood pressure <90 mm Hg) (43).  The treatment of hypertension alone 
might be scarce due to adverse drug effects, and lack of awareness and 
management of hypertension (117).  Thus, prevention of hypertension becomes 
an important goal in overall efforts to control blood pressure and to reduce the 
incidence of cardiovascular diseases associated with hypertension (117, 134, 
141). 
 101 
The relationship between cardiovascular disease and blood pressure is 
strong, independent and continuous.  Beginning at 115 mm Hg systolic and 75 
mm Hg diastolic blood pressure the mortality from both ischemic heart disease 
and stroke is doubled with each increment of 20 mm Hg in systolic or 10 mm Hg 
in diastolic blood pressure (71).  Therefore, prehypertension has been introduced 
to prevent hypertension and cardiovascular disease entirely (15).  A small 
decrement in systolic blood pressure is likely to result in a substantial reduction in 
the blood pressure related cardiovascular disease.  It has been estimated 5 mm 
Hg systolic blood pressure reduction would result in a 14% overall reduction in 
mortality due to stroke, a 9% reduction in mortality due to coronary heart disease 
and a 7% decrease in all-cause mortality (141).   
There are several identified factors underlying hypertension including non-
modifiable factors such as age, gender, and race, as well as modifiable factors 
including overweight, physical inactivity, excess alcohol intake, and inadequate 
intake of fruits and vegetables.  Lifestyle modifications (see Table 2) have been 
primary recommended to prevent hypertension (15, 117, 141).   In this review, 
exercise is further discussed.  Exercise has been advocated as an important 
component for prevention of hypertension (4, 15) but has limited supporting 
evidence.  Exercise as a means to prevent hypertension has been formulated 
based on epidemiological evidence (10, 91) and a few clinical studies (25, 142).  
Epidemiologic studies suggest an inverse relationship between physical activity 
or fitness and blood pressure (10, 91).  Aerobic exercise training has been shown 
to reduce blood pressure for normotensive individuals (10, 91).  Clinical studies 
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are warranted to investigate the effects of exercise on prevention of hypertension 
for individuals with prehypertension.     
 
ACCUMULATION OF EXERCISE ON BLOOD PRESSURE REDUCTION 
Exercise has been advocated as an important component for the 
prevention and treatment of hypertension (4, 15).  Indeed, physical inactivity is an 
independent risk factor for hypertension and cardiovascular disease.(97).  Trends 
toward participation of exercise, however, appear to be stabilizing or diminishing, 
as the adherence rate of exercise programs is only 50% (21, 107).  Since the 
most often-cited reason for not adhering to an exercise program is the lack of 
time (73), the accumulation of moderate physical activity, on most if not all days 
of the week, has been recommended as the exercise treatment for hypertension 
as well as prevention (4, 15).  Despite these recommendations being made, 
there is a lack of evidence supporting the effectiveness of the accumulation of 
physical activity on the prevention as well as treatment of hypertension. 
Physical activity is defined as any bodily movement that is produced by 
skeletal muscle contraction and that substantially increases energy expenditure 
(130).  Exercise, as a subset of physical activity (130), is planned, structured and 
repetitive bodily movement done to improve or maintain one ore more 
components of physical fitness.  In this review, the terms exercise and physical 
activity will be used interchangeably.  The accumulation of physical activity has 
been advocated as an important component for the prevention of hypertension.  
There is lack of the clinical trials supporting the effectiveness of accumulating 
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physical activity on prehypertension.  Only one study to date has demonstrated 
this recommendation may also be a treatment for hypertension (85). 
Moreau et al. (85) found a reduction in systolic blood pressure following 12 
weeks (by 6 mm Hg) and 24 weeks (by another 5 mm Hg) of a walking program 
(3 km/day) in 24 post-menopausal women with prehypertension and stage 1 
hypertension.  However, they did not report exercise intensity and duration, and it 
was not reported whether the 3 km was walked all at once or accumulated over a 
number of walking bouts throughout the day.  Thus, the effect of accumulation of 
physical activity compared to a single long bout of physical activity on blood 
pressure reduction could not be determined from this study.  This issue has been 
systemically reviewed by Hardman (47). 
The accumulation of physical activity has been investigated by 
fractionation of exercise.  Fractionation of exercise is used to investigate 1) 
different patterns (one continuous or long versus several short bouts of exercise 
with the same total duration), and 2) different intensities of exercise 
(moderate/hard versus low intensity of exercise) with the similar energy 
expenditure.  Hardman (47) evaluated evidence comparing the effects of 
fractionation of exercise on health outcome.  While it appears that fractionated 
exercise improves functional capacity (VO2max) (47), there is little information on 
the effects of fractionated exercise on other health outcomes including blood 
pressure.  Hardman recommends that further research is warranted in 
fractionated exercise on health outcome (47). 
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Many studies have compared the effects of a single bout of exercise to 
those of multiple bouts of exercise on parameters of health and fitness, such as 
VO2max (2, 62), blood lipids (35), glucose/insulin dynamics , bone mass (110), 
and exercise adherence (113).  For example, Kaminsky et al. (62) and Almuzaini 
et al. (2) found that the acute effects of two short bouts of exercise on excess 
post-exercise oxygen consumption were greater than those of one long bout of 
exercise.  In addition, Gill et al. (35) and Murphy et al. (87) found that several 
short bouts of exercise were as effective as one long bout of exercise on 
postprandial lipidemia.  However, no studies have compared the effects of single-
bout exercise to fractionated exercise on blood pressure as a major outcome.   
Blood pressure was reported in fractionated exercise study by Murphy and 
Hardman (86) as a secondary outcome.  They investigated training effects of 
short and long bouts of brisk walking in sedentary women.  Women were 
randomly assigned to three 10 minute walks (n=12), one 30minute walk (n=12) at 
70 to 80 % of maximal heart rate for 10 weeks or control group (no walk, n=10).  
Pre- and post-exercise training blood pressures were measured.  Although the 
short bouts of exercise group reduced blood pressure by 7.4 ± 7.3 mm Hg, while 
the long bout exercise group reduced blood pressure by 4.6 ± 5.9 mm Hg, the 
difference between groups was not statistically significant.  The blood pressure 
reduction was not statistically significant possibly due to lack of statistical power.  
The number of subject was 12 in exercise training group.  Thus, the fractionated 
exercise study used blood pressure as a primary outcome is warranted. 
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POST EXERCISE HYPOTENSION 
Post exercise hypotension is a phenomenon of a sustained reduction in 
resting blood pressure following a single bout of exercise (63).  Post exercise 
hypotension was first documented by L. Hill during the 90 min following a 400 
yard dash (54).  Only after Fitzgerald's anecdotal report of the effect of jogging on 
his own labile hypertension (28), the researchers began to thoroughly investigate 
this phenomenon.  Post exercise hypotension is clinically significant because it 
provides health benefits associated with transiently lowered blood pressure (4).  
Further, post exercise hypotension might be attributed to blood pressure 
reduction with exercise training by accumulating hypotensive effects following 
each acute bout of exercise (125).   
Post exercise hypotension occurs in response to several types of large 
muscle dynamic exercise such as walking, running, cycling, and swimming at 
submaximal intensities between 40% and 70% of peak aerobic capacity for 20 to 
60 minutes (63).  Post exercise hypotension is observed in both normotensive 
and hypertensive subjects but is generally greater in magnitude in hypertensive 
subjects (63, 75).  Post exercise hypotension has been reported to persist for 2 
to 4 hours under laboratory conditions in normotensive individuals (63).  Post 
exercise hypotension is sustained for a prolonged period of time under free-living 
conditions up to 11 to 12 hours for systolic blood pressures (5-8 mm Hg) and/or 
up to 6 to 8 hours for diastolic blood pressure (6-8 mm Hg) (63, 77, 99, 138, 139) 
in hypertensive individuals.  Post exercise hypotension appears to be unaffected 
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by gender, age (75) or exercise intensity (99).  The mechanisms contributing to 
the post exercise hypotension is inconclusive yet.   
 
Potential Mechanisms of Post Exercise Hypotension 
Mean arterial pressure is a product of cardiac output and total peripheral 
resistance.  The potential mechanisms of post exercise hypotension must result 
from the manipulation of cardiac output and/or total systemic vascular resistance.  
In this review, the reduction of cardiac output (41) as a mechanism for post 
exercise hypotension is not further discussed.  The decrease in local and total 
systemic vascular resistances results in vasodilation (17, 46).  The vasodilation is 
associated with sympathetic vascular regulation by a neural and a vascular 
components (45).  The neural component of this vasodilation is a reduction in the 
outflow of sympathetic vasoconstrictor nerve activity to skeletal muscle vascular 
beds (sympathoinhibition).  The vascular component refers to the attenuation of 
vascular response to sympathetic vasoconstriction, as well as the potential 
influence of local and circulating vasodilator substances.  In this review of 
possible mechanisms of post exercise hypotension, the focus has made in this 
vasodilation on 1) sympathoinhibition and 2) vasodilator substances. 
 
1) Sympathoinhibition 
The influence of sympathetic nerve activity was studied during post 
exercise hypotension (30, 44-46, 63, 75).  The muscle sympathetic nerve activity 
(MSNA) directly measures an indication of vascular tone.  Plasma noradrenalin 
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concentration is used as an indirect measure of spill over from the sympathetic 
activity.  Heart rate variability is also used as an indication of the autonomic 
nervous system control. 
During post exercise hypotension, it has been shown that the sympathetic 
nerves that control vasoconstriction in the leg are inhibited (44).  Muscle 
sympathetic nerve activity is controlled by the baroreceptor reflexes and 
cardiopulmonary receptor reflexes in a resting state.  The baroreceptor reflex is 
reset to a higher set point and sympathetic activity is increased during exercise 
(84, 137).  These reflexes are reset to lower pressures than pre-exercise 
pressures after exercise.  Thus, sympathetic outflow from the central nervous 
system is low following exercise.  Early studies in animals suggested that this 
sympathoinhibition might be the result of activation of endogenous opioid 
receptor pathways in the central nervous system (126).  The central nervous 
system mechanisms involved in baroreceptor reflex resetting during exercise and 
post exercise hypotension are unknown. 
 
2) Vasodilator Substances 
In addition to reductions in sympathetic outflow, vascular responsiveness 
to adrenergic receptor stimulation is impaired during post exercise hypotension 
(44, 56).  The mechanism of this impaired vascular responsiveness seen in post 
exercise hypotension is unknown.  Impaired sympathetic outflow into vascular 
resistance could be the result of competition at the arterial smooth muscle such 
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as the release of local vasodilator substances or by modulation of the alpha 
adrenergic pathway either by presynaptic or postsynaptic inhibition (45). 
Nitric oxide may be partly responsible for the impaired responsiveness to 
sympathetic outflow.  Factors associated with dynamic exercise, such as cyclic 
wall stress induced by increased blood flow and catecholamines, stimulate the 
release of nitric oxide from the vascular endothelium.  In healthy humans nitric 
oxide production may be increased after acute exercise (61).  It is well 
established that nitric oxide attenuates the vasoconstrictor response to alpha 
adrenergic receptor stimulation.  However, there are a number of other potential 
vasodilators such as prostaglandins, adenosine, potassium, increased CO2 
and/or decreased O2 that could potentially modify alpha adrenergic 
responsiveness (45). 
In conclusion, post exercise hypotension occurs in both normotensive and 
hypertensive subjects.  Post exercise hypotension is clinically significant in 
hypertension due to its duration and magnitude of the transient reduction in blood 
pressure seen in free-living condition as well as in laboratory setting.  For post 
exercise hypotension to be used as a lifestyle modification for the prevention of 
hypertension, the duration and magnitude of hypertension should be established 
for adults with prehypertension.  The mechanisms of post exercise hypotension 
are studied although they are still inconclusive.  Further investigation is 
warranted to investigate the mechanisms of post exercise hypotension in free-
living condition.   
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POWER SPECTRAL ANALYSIS OF HEART RATE VARIABILITY 
A significant relationship between the autonomic nervous system and 
cardiovascular mortality has been documented (74).  Heart rate variability is the 
analysis of variations of the intervals between consecutive normal heart beats.  
The clinical relevance of heart rate variability was first introduced when Hon and 
Lee observed that fetal distress was preceded by alternations in RR intervals 
before any significant heart rate change (55).  In 1978, the association between 
the acute myocardial infarction mortality and reduced heart rate variability was 
first shown (144).  An association between lethal arrhythmias and signs of either 
increased sympathetic or reduced vagal activity has been also reported (9).  The 
heart rate variability became clinically important tool because it was found to be a 
strong and independent predictor of acute myocardial infarction mortality (9, 65, 
128).   
Although the variations in heart rate may be evaluated by time domain 
methods and frequency domain methods, frequency domain methods are further 
discussed in this review.  Power spectral analysis of heart rate variability (heart 
rate variability) is a non-invasive measurement to assess the quantification of 
autonomic nervous system fluctuations in health and diseases including 
hypertension (1, 36, 81, 122).  Heart rate variability is influenced by the 
interaction among spontaneous nervous input to the sinoatrial (SA) node, 
sympathetic and vagal efferent nerve activity, and humoral factors.  The RR 
interval variations exist in resting conditions represent a fine tuning of the beat-to-
beat control mechanisms.  Vagal afferent stimulation leads to reflex excitation of 
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vagal efferent activity and inhibition of sympathetic efferent activity.  The opposite 
reflex is controlled by the stimulation of sympathetic afferent activity.  Efferent 
vagal activity also appears to be under tonic control by cardiac afferent 
sympathetic activity.  Efferent sympathetic and vagal activities directed to the SA 
node are characterized by discharge with each cardiac cycle.  Cardiac cycle can 
be modulated by central (e.g. vasomotor and respiratory centers) and peripheral 
(e.g. oscillation in arterial pressure and respiratory movements) oscillators.  
These oscillators generate rhythmic fluctuations in efferent neural discharge 
which manifest as short and long-term oscillation.   
Although cardiac cycle is modulated by various systems, heart rate and 
rhythm are largely under the control of the autonomic nervous system.  
Parasympathetic activity is mediated by acetylcholine release, which has a very 
short latency period and high turnover rate.  This relatively rapid response of 
acetylcholine enables the parasympathetic nervous system to regulate cardiac 
function on a beat to beat basis.  Sympathetic activity is mediated by 
noradrenaline, which is reabsorbed and metabolized relatively slowly.  Thus, 
changes in heart rate mediated by sympathetic activity are relatively slow.  
Because of these differences in neurotransmitter function the parasympathetic 
and sympathetic nervous systems tend to operate at different frequencies and 
variation in heart rate.   
Spectral analysis is performed for both short-term (2 to 5 minutes) and 
long-term (24 hours).  Spectral components are total power, high frequency 
(0.15-0.40 Hz) which reflects cardiac vagal activity, respiratory mechanical and 
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vagal-mediated influence (mainly vagal), low frequency (0.04-0.15 Hz), which 
reflects cardiac sympathetic and vagal activity as well as vascular sympathetic 
activity.  Because of this dual modulation, measurement of low frequency 
component does not provide a direct quantitative index of sympathetic activity.   
Thus, the term sympathetic modulation (106, 122), rather than 
sympathetic activity should be used in the analysis of heart rate variability.  There 
are more variables such as the ratio of low frequency to high frequency, which is 
index of sympathovagal balance (22)as well as very low frequency (0.003-0.04 
Hz), and ultra low frequency (<0.003 Hz) used in the study of heart rate variability 
(122).  The physiological roles in very low and ultra low frequency components 
are not clear, but the decreases in the very low and ultra low frequency 
components were reported in post myocardiac mortality. 
 
Other Factors Affecting Heart Rate Variability 
Certain medications affect heart rate variability.  Beta-adrenergic blockade 
prevents the rise in the low frequency component observed in the morning hours. 
Anti-arrhythmic drugs, low dose muscarinic receptor blockers, such as atropine 
and scopolamine (136), may produce a paradoxical increase in vagal efferent 
activity, as suggested by a decrease in heart rate (122).  Little is known about the 
effects of the environment (e.g. type and nature of physical activity and of 
emotional circumstances) during long-term electrocardiogram recordings. 
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Power Spectral Analysis of Heart Rate Variability in Hypertension and 
Exercise 
Previous investigations using power spectral analysis of heart rate 
variability have led to findings of autonomic alterations in hypertensive individuals 
(27, 39, 92, 95, 96, 106, 122, 132).  Increased sympathetic and reduced 
parasympathetic activity (27, 39) are among the characteristics of autonomic 
dysfunction found in hypertension.  A progressive increase in low frequency 
power (indicating increased sympathetic activity) and a decrease in high 
frequency (indicating decreased parasympathetic activity) power of heart rate 
variability with increasing severity of hypertension have been also reported (92).  
Moreover, augmented heart rate variability is associated with new onset of 
hypertension (116).  Augmented sympathetic activity in normotensive individuals 
with a family history of hypertension (20) as compared to normotensive 
individuals with no family history was has been reported.   
Exercise training is well known for its ability to restore impaired autonomic 
nervous system (6, 34, 36, 122).  In epidemiology study moderate and vigorous 
physical activity was also associated with higher heart rate variability (109).  In 
cross-sectional studies using power spectral analysis of heart rate variability 
investigators found an enhanced vagal tone in athletes (8, 79).  Exercise training 
induced to restore autonomic nervous function measured by power spectral 
analysis of heart rate variability in various populations including hypertensive (49, 
57, 58, 80, 83, 93, 114, 115, 123, 129, 131).  These exercise training studies are 
summarized in Table 3.   
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Table 3.  Summary of selected studies investigation HRV in exercise training 
 
Author of 
Study 
Population Types of 
Exercise 
Investigation 
parameter 
Clinical 
Findings
Hautala (49) 20 healthy 70-80% of 
HRmax 
Long-term 
(24-hour) 
↑ HF  
 
Howarka 
(57) 
8 diabetics 65% of maximal 
performance 
Short-term  
(5 min) 
↑ LF  
↑ HF  
↑ Total 
Iwasaki (58) 11 sedentary  Progressive 
training 
Short-term  
(6 min) 
↑ LF  
 
Malfatto (80) 22 post 
myocardial 
infarction  
Cardiac 
Endurance 
training 
Short-term  
(5 min) 
↓ LF:HF 
 
Melanson 
(83) 
11 sedentary 
men 
80% of VO2max Short-term  
(5 min) 
↑ HF  
 
Pagani (93) 11 hypertensive 20 min jogging Short-term  
(20 min) 
↑ HF  
↓ LF 
Schuit (114) 27 elderly 70-80% of 
HRmax 
Long-term 
(24-hour) 
↑ LF  
 
Seals (115) 11 healthy 70-80% of HRR Short-term  
(5 min) 
↑ Total 
Taylor (123) 9 hypertensive 30% of MVC  Short-term (10 
min) 
↑ HF  
 
Tulppo (129) 20 sedentary 70-80% of 
HRmax 
Long-term 
(24-hour) 
↑ HF  
↓ LF 
 
Uusitalo 
(131) 
47 elderly 40-60% of 
VO2max 
Short-term  
(5 min) 
↓ LF 
 
 
HRmax: maximum heart rate; VO2max: maximal oxygen consumption; HRR: 
heart rate reserve; LF: low frequency power of heart rate variability; HF: high 
frequency power of heart rate variability; LF:HF; the ratio of low to high frequency 
power; Total: total power of heart rate variability; ↑: increase; ↓: decrease 
 
 
 114 
Reduced sympathetic activity is one of the possible mechanisms of post 
exercise hypotension (12, 18, 30, 45, 66, 75).  There are only a few studies using 
short-term power spectral analysis of heart rate variability to assess autonomic 
function during post exercise hypotension (69, 76) under laboratory condition.  
MacDonald et al. showed increased parasympathetic activity during subsequent 
bouts of exercise after acute exercise (70% of VO2peak for 30 minutes) using 
short-term heart rate variability (76).  Legramante et al., however, failed to see 
the changes in sympathetic modulation 60 to 90 minutes following maximal 
exercise test (69).  Studies using long-term heart rate variability, however, would 
be of interest in post exercise hypotension studies because post exercise 
hypotension persists up to 11 to 12 hours under free-living conditions (63, 77, 99, 
138, 139).  Furthermore, changes in cardiac autonomic regulation was found 
several hours after cessation of acute exercise measured by heart rate variability 
(48, 102).   
In summary, power spectral analysis of heart rate variability has been 
commonly used to quantify the relative dominance of vagal and sympathetic 
influence on the heart.  Exercise induces the restoration of autonomic regulation.  
There are limited studies using power spectral analysis of heart rate variability to 
investigate autonomic regulation during post exercise hypotension.   
 
AMBULATORY BLOOD PRESSURE MONITORING 
While auscultation of the Korotkoff sounds remains the established 
standard technique for blood pressure measurement in clinical medicine (119), 
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ambulatory blood pressure monitoring is widely used in both clinical and research 
settings in order to achieve more information about an individual’s blood pressure 
during activities of daily living.  Diurnal blood pressure profiles exhibit higher 
values when individuals are awake and mentally and physically active, and lower 
values when sleeping and resting (15).  Ambulatory blood pressure values are 
typically lower than those obtained in a clinical office (15, 24, 145), with a 24-hour 
average ambulatory blood pressure of 125/80 mm Hg corresponding to an office 
value of 140/90 mm Hg (24, 145).  Ambulatory blood pressure monitoring should 
not be regarded as a substitute for office blood pressure measurement (15, 16, 
24, 145) due to limited data available regarding prognostic value. 
There are many advantages of ambulatory blood pressure monitoring.  
Measuring blood pressure in a clinical setting is confounded by the occurrence of 
“white-coat hypertension” (15, 24, 145), the elevated clinic blood pressure in the 
presence of normal ambulatory blood pressure.  “White-coat hypertension” 
occurs in as many as 20 to 35% of hypertensive patients (101).  Ambulatory 
blood pressure monitoring can differentiate between white-coat hypertension and 
actual hypertension (15, 24, 143, 145).  Ambulatory blood pressure monitoring 
also correlates with hypertensive target organ damage more closely than does 
office blood pressure (15, 24, 82, 145), and predicts additional risk of 
cardiovascular events after adjustment for office blood pressure (15, 24, 118, 
145).  In addition, ambulatory blood pressure monitoring has been used as a 
research tool.  For example, the duration and magnitude of post exercise 
hypotension have been identified in free-living condition (31, 98, 100, 139).  
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There are a number of factors to affect ambulatory blood pressure 
measurements such as the monitors themselves.  Standard protocols exist for 
evaluating the accuracy of blood pressure measurements (Association for the 
Advancement of Medical Instrumentation (AAMI), 1987; British Hypertension 
Society (BHS), 1990; European Society of Hypertension, 2002) (89).  These 
protocols had a common objective to establish the standards of accuracy and 
performance and to facilitate the comparison of one device with another.  To 
meet AAMI criteria, the mean difference between the device and the mercury 
standard must be <5 mm Hg or the standard deviation must be <8 mm Hg.  To 
meet BHS criteria, devices must achieve a grade of at least a ‘B’ for both systolic 
and diastolic measurements.  A grade of ‘A’ denotes greatest agreement and ‘D’ 
denotes least agreement with the mercury standard.  Ambulatory blood pressure 
monitoring devices have been validated for use in specific groups and in different 
circumstances based on these protocols.   
The Accutracker II (SunTech Medical Instruments,  Morrisville, NC) has 
been validated using the standard protocols by AAMI and BHS (4, 89, 124), with  
the mean differences by the Accutracker II and  the observers -2.2+0.8/-3.5+0.9 
mm Hg (124).  Inter-device variability of the Accutracker II was small but 
significant although all the devices met the BHS criteria.  The day to day 
reproducibility of the Accutracker II has been examined in control conditions (70).  
Intraclass correlation coefficients for daytime (6:00a.m. to 10:00p.m.) and 
nighttime (10:00p.m. to 6:00a.m.) averages were 0.95, 0.96, and 0.86 for systolic 
blood pressure, and 0.90, 0.90, and 0.83 for diastolic blood pressure, 
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respectively.  The Accutracker II fulfilled the AAMI criteria although it was graded 
A for systolic and C for diastolic blood pressure using the BHS system (90, 124).   
The reproducibility of ambulatory blood pressure measurements has been 
reported to be higher than clinic measurements (60, 105, 127). The 
reproducibility of ambulatory blood pressure measurements has been performed 
on two to four separate days of 24-hour measurements (52, 88) or on one to two 
days of 48-hour measurement (51, 105).  The ranges of the correlation 
coefficients between two 24-hour ambulatory blood pressure measurements are 
0.81 to 0.91 depending on the ambulatory variable measured (52).  Systolic 
ambulatory blood pressure measurement is more reliable than diastolic 
ambulatory blood pressure measurement (108).  Day-to-day differences in 
average 24-hour blood pressure have also been reported (94) likely a result of  
biological variability, daily activity, or stress, however.  Further, a significant 
elevation in systolic and diastolic pressures has been reported for the first two to 
eight hours of one 48 hour monitoring session (51, 105). 
There are other factors affecting ambulatory blood pressure monitoring.  
Ambulatory blood pressure monitoring can produce artifacts due to inappropriate 
cuff size and interference with sleep (119).  There is a transient increase in 
systolic blood pressure averaging 5 to 15 mm Hg due to these artifacts (119).  
Strategies for optimizing ambulatory blood pressure monitoring include 
appropriate subject selection and instruction as well as editing criteria (94).  
Because the time of day to begin the ambulatory monitoring influences the 
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outcome, the time of day to begin the monitoring should be considered an 
additional factor to be controlled (140).   
In summary, ambulatory blood pressure monitoring is widely used in both 
clinical and research settings in order to observe blood pressure during activities 
of daily living.  The validity of each ambulatory blood pressure monitor needs to 
be evaluated by standard protocols for an accurate outcome.  Ambulatory blood 
pressure measurements are more reliable than are clinic measurements.  Other 
factors such as appropriate cuff and time of day to begin monitor have been 
identified to improve the reliability of ambulatory blood pressure measurements.       
 
PHYSICAL ACTIVITY MONITORING 
Accelerometers directly and objectively measure and quantify physical 
activity throughout the day.  Accelerometers, which convert measured kinetic 
energy into electrical energy and translate it into acceleration data, are more 
often  used in research because they provide more information about  physical 
activity, such as the intensity, frequency and duration.  Accelerometers  are also 
more sensitive to  low-intensity activities (50, 68, 121).  This greater sensitivity 
comes at a price, however, as it can be a source of artifact, with background 
vibration (e.g., when moving in a  vehicle) being recorded as movement (68). 
A triaxial accelerometer is based on three orthogonally mounted uniaxial 
(vertical, anterioposterior, mediolateral axes) accelerometers.  Bouten et al. 
(1994) (11) reported that the sum of the integrals from all three axes was most 
strongly correlated to an activity energy expenditure measured by indirect 
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calorimetry (r=0.95) rather than three individual axes.  The units of 
accelerometers (activity count or vector magnitude), however, are not 
standardized.  Furthermore, several accelerometers provide energy expenditure 
from different regression equations, which contributes to their source of error.  
Freedson and Miller have recommended using movement counts rather than 
energy expenditure, which is computed from a regression equation and is 
therefore a possible source of error (33). 
The RT3 is a newer version of the Tritrac from the same company.  The 
RT3 is a small (68 X 48 X18 mm), lightweight (65.2 g), battery-powered triaxial 
accelerometer, with three orthogonal axes (vertical, X; anterioposterior, Y; and 
mediolateral, Z).  The four operation options of RT3 are following: 1) mode 1 and 
3 sample and store activity counts on individual axes but use different epoch 
durations, 1-s epoch for mode 1- and 60-s epoch for mode 3, 2) mode 2 and 4 
sample and store vector magnitude (Vm = [X2 + Y2 + Z2]0.5) activity counts but use 
different epoch durations, 1-s epoch for mode 1 and 60-s epoch for mode 3.  In 
RT3, the conversion of acceleration counts to caloric expenditure is calculated 
using exactly the same equations as the Tritrac.  In contrast to the Tritrac, the 
RT3 uses an integrated triaxial accelerometer that integrates measurement of the 
three vectors into a single chip.  
The validity and reliability of the RT3 have been investigated only in a few 
studies.  The Tritrac, the previous version of RT3, has been successfully 
correlated against oxygen uptake in the laboratory (r=0.86) (11) and in the field 
(r=0.62) (23).  The intraclass correlation of inter-instruments, RT3 accelerometers 
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for activity accounts is 0.99 regardless of axes (103).  Rowlands  et al. (111) 
recently validated RT3 for the assessment of physical activity.  The physical 
activity using RT3 was significantly correlated to oxygen uptake in boys (r=0.87) 
and in men (r=0.85).  Vector magnitude was superior to estimate energy 
expenditure in boys but not in men.  The vector magnitude is a composite three-
dimensional signal.  RT3 counts were significantly higher than Tritrac counts.  
This difference is largely due to the anteroposterior vector, which has high 
variability.  Powell and Rowlands (104) reported that inter-monitor variability of 
RT3 was <6% during locomotion.  Inter-monitor variability at each activity 
increased as intensity increased.  The validity of RT3 to predict oxygen 
consumption is as good as Tritrac, although the activity counts from the two 
monitors are not comparable.  When assessing locomotion, body size adds 
significantly to the variance explained in oxygen consumption by activity counts 
(111). 
In conclusion, the RT3 has been reported reliable.  Intermonitor variability 
exists, however. The vertical axis of the RT3 accelerometer showed the least 
variability and was the most reliable.   
 
SUMMARY 
Hypertension has long been known to be a major modifiable risk factor for 
cardiovascular diseases stroke (78), coronary artery disease (78), congestive 
heart failure (135), and end-stage renal disease (64).  Aerobic exercise is well 
established as a lifestyle modification for treatment of hypertension.  Several 
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health organizations, including the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure (14), the American 
Heart Association (29), and the American College of Sports Medicine (3), have 
published policy statements recommending the daily accumulation of physical 
activity to prevent and/or to treat hypertension.  There is lack of evidence 
supporting the daily accumulation of physical activity as a new exercise 
prescription for the prevention of hypertension  
A sustained reduction in resting blood pressure following a single bout of 
aerobic exercise has been defined as post exercise hypotension.  The 
mechanisms of post exercise hypotension are not fully understood, yet.  
Sympathetic modulation is one of the possible mechanisms of post exercise 
hypotension (45, 75).  Excess sympathetic activity is also found in heart failure 
and myocardial infarction (9, 65, 144).  Thus, the investigation of sympathetic 
modulation as a possible mechanism of post exercise hypotension has merit of 
clinical utility.  No study exists to explore the sympathetic mechanisms of post 
exercise hypotension during the activities of daily living. 
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APPENDIX B - PILOT STUDY 
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The accumulation of physical activity rather than one continuous physical 
activity has been recommended for the treatment of hypertension and 
prehypertension although the efficacy of the accumulation of physical activity is 
not well established for the treatment of prehypertension.  The purpose of the 
pilot study was 1) to compare the duration and magnitude of blood pressure 
reduction following the accumulation of physical activity and one continuous 
physical activity, and 2) to observe sympathetic modulation as a possible 
mechanism for blood pressure reduction in prehypertension.   
Pilot data was collected on two adults with prehypertension.  One was a 
55 years old woman who had a systolic blood pressure of 127 mm Hg and a 
diastolic blood pressure of 78 mm Hg.  The other subject was a 34 years old man 
who had a systolic blood pressure of 133 mm Hg and a diastolic blood pressure 
of 82 mm Hg.  Blood pressure using ambulatory blood pressure monitoring and 
sympathetic modulation using Holter monitoring were measured for 12 hours 
following one continuous physical activity (40 min), following the accumulation of 
four short (10 min) sessions of physical activity and following a control.  The 
intensity of both physical activity treatments was same.  All activity was 
performed on a motor driven treadmill.   
These data are illustrated in Figure 2.  The duration of blood pressure 
reduction following the two treatments appears the same (accumulation =3 hr; 
long=3 hr), but the magnitude may be greater following one long bout than 
following the accumulation of four short bouts.  
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FIGURE 1.  Ambulatory systolic blood pressure response (mean+SE) of two 
adults with prehypertension following the accumulation of four short bouts of 
physical activity and one long bout of physical activity. 
 
 
 
Sympathetic modulation was summarized in Table 1.  Normalized high 
frequency power (parasympathetic activity) showed a progressive increase from 
control to the accumulation of four short bouts of physical activity and to the 
single long bout of physical activity.  Normalized low frequency power and the 
ratio of low to high frequency power exhibited decreases following both 
treatments.
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TABLE 1. Sympathetic modulation by heart rate variability following the 
accumulation of four short bouts of physical activity (Short) and one long bout of  
(Long) physical activity treatments  
 
Normalized Low 
Frequency Power (%) 
Normalized High 
Frequency Power (%) 
Ratio of Low to High 
Frequency Power 
Control Short Long Control Short Long Control Short Long
89.9 71.5 81.7 9.1 18.2 16.56 9.89 3.92 4.94 
 
 
These data are promising.  Blood pressure reductions were detected in 
both the accumulation of short bouts of physical activity as well as one long bout 
of physical activity treatments.  Hence, the efficacy of physical activity as a 
treatment for hypertension can be investigated in this paradigm.    
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APPENDIX C - RAW DATA TABLES 
  
TABLE 1. DEMOGRAPHICS OF SUBJECTS 
ID Sex Age (yrs) Height (cm) Weight (kg) BMI (kg⋅m-2) VO2peak (ml⋅kg-1⋅min-1) 
R2000 M 25 177.9 85.7 44.1 26.4 
R2001 M 35 178.5 111.2 50.4 30.2 
R2002 M 32 177.6 90.9 49.4 37.2 
R2003 M 51 178.0 88.1 47.1 29.7 
R2004 F 64 156.0 46.4 40.7 28.1 
R2005 M 28 177.1 113.7 39.6 34.8 
R2006 M 55 185.0 78.9 53.3 34.6 
R2007 F 58 175.0 66.0 49.6 29.4 
R2008 F 62 170.1 71.7 40.9 25.8 
R2009 M 47 181.0 74.4 45.2 48.7 
R2010 M 36 175.8 81.1 49.7 41.2 
R2011 M 66 180.0 82.0 56.8 34.6 
R2012 F 66 178.0 73.0 50.9 24.9 
R2013 M 46 163.0 81.0 44.2 43.9 
R2014 M 50 180.2 91.6 54.7 39.4 
R2015 F 61 165.0 63.4 44.4 26.6 
R2017 M 45 181.3 88.4 50.8 46.0 
R2018 M 40 184.8 138.1 46.3 29.0 
R2019 M 43 186.7 86.2 47.2 43.6 
R2020 M 33 175.3 77.7 46.2 35.6 
Mean  47.2 176.32 84.47 27.00 34.48 
SD  13.06 7.63 19.61 5.23 7.31 
SE  2.92 1.71 4.39 1.17 1.64 
 
BMI = body mass index, VO2peak = peak oxygen uptake 
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 TABLE 2. SCREENING BLOOD PRESSURE  
ID SBP (mm Hg) DBP (mm Hg) 
R2000 138 84 
R2001 130 85 
R2002 132 86 
R2003 132 82 
R2004 130 69 
R2005 137 74 
R2006 123 81 
R2007 134 89 
R2008 130 70 
R2009 140 88 
R2010 129 82 
R2011 125 88 
R2012 131 87 
R2013 130 74 
R2014 127 88 
R2015 134 80 
R2017 126 81 
R2018 137 87 
R2019 135 86 
R2020 138 88 
Mean 131.8 82.5 
SD 4.72 7.29 
SE 1.05 1.63 
 
SBP = systolic blood pressure, DBP = diastolic blood pressure 
Blood pressure was averaged based upon a total of six measurements.
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TABLE 3. ORDER OF TREATMENTS AND NUMBER OF DAYS BETWEEN 
PHYSICAL ACTIVITY TREATMENTS  
ID Order of treatments 
# of days between 
PA treatments 
R2000 1-3-2 7 
R2001 2-1-3 7 
R2002 1-3-2 28 
R2003 2-1-3 10 
R2004 3-1-2 21 
R2005 3-2-1 8 
R2006 1-2-3 27 
R2007 3-1-2 7 
R2008 2-3-1 7 
R2009 2-1-3 21 
R2010 1-3-2 28 
R2011 3-1-2 41 
R2012 1-3-2 23 
R2013 3-1-2 7 
R2014 3-1-2 16 
R2015 2-1-3 35 
R2017 1-2-3 11 
R2018 1-3-2 7 
R2019 3-1-2 8 
R2020 3-2-1 14 
Mean  16.7 
SD  10.40 
SE  2.33 
 
PA = physical activity 
1 = control treatment, 2 = the accumulation of physical activity treatment, 3 = a 
continuous physical activity treatment 
  
TABLE 4. CARDIORESPIRATORY DATA 
ID VO2peak (ml⋅kg-1⋅min-1) 
max HR 
(bpm) 
50% VO2peak 
(ml⋅kg-1⋅min-1) 
VO2  
(ml⋅kg-1⋅min-1) 
VO2 
(ml⋅kg-1⋅min-1) PA Intensity (%) 
   Target Short Ex Long Ex Short Ex Long Ex 
R2000 26.4 199 13.20 13.2 13.6 13.2 51.4 
R2001 30.2 188 14.92 14.9 15.5 15.5 51.9 
R2002 37.2 191 18.59 18.6 20.5 19.5 55.0 
R2003 29.7 181 14.83 14.8 15.5 15.0 52.1 
R2004 28.1 179 14.05 14.1 14.5 14.2 51.6 
R2005 34.8 200 17.41 17.4 17.5 17.5 50.3 
R2006 34.6 179 17.30 17.3 17.4 17.2 50.3 
R2007 29.4 189 14.70 14.7 15.1 16.3 51.2 
R2008 25.8 166 12.90 12.9 13.2 13.4 51.1 
R2009 48.7 188 24.35 24.4 26.2 24.0 53.8 
R2010 41.2 186 20.60 20.6 20.5 20.8 49.6 
R2011 34.6 178 17.29 17.3 16.6 17.0 48.0 
R2012 24.9 175 12.43 12.4 13.8 12.7 55.7 
R2013 43.9 188 21.96 22.0 21.3 22.5 48.6 
R2014 39.4 197 19.68 19.7 20.0 20.8 50.8 
R2015 26.6 176 13.31 13.3 14.9 16.6 55.9 
R2017 46.0 190 23.00 23.0 22.6 23.5 49.2 
R2018 29.0 172 14.52 14.5 15.1 14.7 52.1 
R2019 43.6 199 21.78 21.8 25.2 23.1 57.9 
R2020 35.6 190 17.80 17.8 18.3 18.0 51.3 
Mean 34.46 185.6 17.23 17.86 17.78 51.89 51.74 
SD 7.14 9.31 3.57 3.76 3.54 2.52 2.84 
SE 1.60 2.08 0.80 0.84 0.79 0.56 0.63 
 
VO2peak = peak oxygen uptake, HR = heart rate, PA = physical activity, VO2 = oxygen uptake 
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 TABLE 5. AMBULATORY BLOOD PRESSURE MONITORING FOR 12-HOUR 
MEASUREMENTS 
  
 
CONTROL 
ID Starting Time Sampled Used % 
R2000 12:58 68 59 86.8 
R2001 12:56 53 50 94.3 
R2002 12:51 53 49 92.5 
R2003 12:40 53 51 96.2 
R2004 13:00 55 54 98.2 
R2005 13:00 54 46 85.2 
R2006 12:20 50 49 98.0 
R2007 11:50 64 60 93.8 
R2008 12:16 51 48 94.1 
R2009 12:24 50 49 98.0 
R2010 12:32 66 58 87.9 
R2011 12:29 64 45 70.3 
R2012 12:42 50 50 100.0 
R2013 12:53 53 53 100.0 
R2014 12:53 54 50 92.6 
R2015 12:23 54 54 100.0 
R2017 12:59 51 50 98.0 
R2018 12:25 54 53 98.1 
R2019 12:53 56 53 94.6 
R2020 13:39 51 50 98.0 
Mean 12:42:09 55.2 51.6 93.83 
SD 0:23 5.60 4.01 7.05 
SE 0:05 1.25 0.90 1.58 
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 TABLE 5. (CONTINUED) AMBULATORY BLOOD PRESSURE MONITORING 
FOR 12-HOUR MEASUREMENTS 
  
 
ACCUMULATION 
ID Starting Time Sampled Used % 
R2000 12:50 51 46 90.2 
R2001 13:18 53 49 92.5 
R2002 12:57 48 47 97.9 
R2003 12:46 59 35 59.3 
R2004 13:04 53 49 92.5 
R2005 13:03 52 44 84.6 
R2006 12:01 53 51 96.2 
R2007 12:26 60 60 100.0 
R2008 12:18 55 52 94.5 
R2009 12:24 56 56 100.0 
R2010 12:31 53 50 94.3 
R2011 12:44 64 44 68.8 
R2012 13:04 49 49 100.0 
R2013 12:59 50 49 98.0 
R2014 12:53 37 36 97.3 
R2015 12:22 53 53 100.0 
R2017 13:04 54 50 92.6 
R2018 12:40 51 47 92.2 
R2019 12:58 52 49 94.2 
R2020 13:47 47 45 95.7 
Mean 12:48:27 52.5 48.1 92.04 
SD 0:23 5.46 5.76 10.44 
SE 0:05 1.22 1.29 2.33 
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TABLE 5. (CONTINUED) AMBULATORY BLOOD PRESSURE MONITORING 
FOR 12-HOUR MEASUREMENTS 
  
 
CONTINUOUS 
ID Starting Time Sampled Used % 
R2000 13:09 52 47 90.4 
R2001 12:48 57 49 86.0 
R2002 12:47 53 50 94.3 
R2003 12:47 52 46 88.5 
R2004 13:00 55 51 92.7 
R2005 13:07 58 50 86.2 
R2006 12:26 51 50 98.0 
R2007 12:39 51 49 96.1 
R2008 12:19 54 54 100.0 
R2009 13:01 51 43 84.3 
R2010 12:51 58 55 94.8 
R2011 13:02 68 44 64.7 
R2012 12:47 46 46 100.0 
R2013 13:20 50 48 96.0 
R2014 13:03 54 47 87.0 
R2015 12:32 57 54 94.7 
R2017 13:35 46 43 93.5 
R2018 12:43 55 48 87.3 
R2019 13:08 49 48 98.0 
R2020 13:51 51 51 100.0 
Mean 12:56:45 53.4 48.7 91.63 
SD 0:22 4.89 3.41 8.12 
SE 0:04 1.09 0.76 1.82 
 
 TABLE 6A. HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING A CONTROL TREATMENT 
 Hourly Mean Blood Pressure (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 143 143 159 141 136 122 134 145 
R2001 130 144 140 132 139 133 133 126 
R2002 139 139 135 135 134 134 139 129 
R2003 122 137 120 126 132 134 134 128 
R2004 122 117 98 111 108 109 115 107 
R2005 166 162 172 153 160 131 128 134 
R2006 122 126 134 134 121 129 119 109 
R2007 139 131 130 130 129 128 120 134 
R2008 117 132 129 144 127 132 118 119 
R2009 140 141 140 150 153 151 158 140 
R2010 136 134 137 130 130 148 135 127 
R2011 133 136 125 139 126 129 133 127 
R2012 138 147 158 149 141 146 134 140 
R2013 130 131 147 131 133 126 130 136 
R2014 136 149 119 118 119 129 146 153 
R2015 136 151 139 130 146 136 136 125 
R2017 140 140 133 131 136 140 141 146 
R2018 129 129 124 123 134 139 137 134 
R2019 133 119 130 130 112 128 122 129 
R2020 152 136 139 135 138 131 142 142 
Mean 135.0 137.2 135.3 133.6 132.6 132.7 132.6 131.3 
SD 11.16 10.82 15.97 10.38 12.52 9.43 10.48 11.49 
SE 2.49 2.42 3.57 2.32 2.80 2.11 2.34 2.57 
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 TABLE 6A. (CONTINUED) HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING A CONTROL TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) 
Following a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 163 151 149 112 
R2001 128 129 113 110 
R2002 132 120 117 109 
R2003 127 124 124 120 
R2004 120 112 102 102 
R2005 113 112 82 93 
R2006 118 127 122 118 
R2007     
R2008 111 102 113 109 
R2009 150 153 156 137 
R2010 127 123 130 123 
R2011 136 113 108 111 
R2012 130 132 106 95 
R2013 149 127 132 118 
R2014 139 145 149 145 
R2015 128 143 141 114 
R2017 140 135 139 119 
R2018 140 139 140 110 
R2019 128 125 107 111 
R2020 142 128 122 121 
Mean 132.7 128.3 123.8 114.5 
SD 13.14 13.78 19.19 12.31 
SE 2.94 3.08 4.29 2.75 
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 TABLE 6B. HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING A CONTROL TREATMENT 
 Hourly mean blood pressure (mm Hg) following a treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 93 93 99 99 102 99 101 92 
R2001 91 94 94 80 79 72 85 71 
R2002 91 96 87 88 90 91 85 88 
R2003 87 73 83 87 93 87 90 84 
R2004 61 70 58 61 61 62 68 62 
R2005 81 82 90 79 88 76 79 75 
R2006 69 66 70 76 77 70 70 69 
R2007 91 90 88 83 82 87 85 92 
R2008 76 74 70 74 68 70 68 70 
R2009 86 89 90 94 99 99 101 89 
R2010 87 89 88 86 87 82 78 80 
R2011 86 82 86 86 94 100 89 80 
R2012 83 83 85 86 88 86 85 87 
R2013 87 79 82 83 80 85 84 87 
R2014 90 80 75 75 76 85 88 86 
R2015 75 82 80 74 77 73 77 71 
R2017 79 80 81 80 86 87 82 81 
R2018 71 75 75 71 78 77 77 81 
R2019 77 72 82 71 69 67 75 73 
R2020 86 82 77 84 78 77 93 88 
Mean 82.3 81.5 81.8 80.6 82.5 81.5 83.0 80.2 
SD 8.55 8.43 9.40 8.78 10.35 11.00 9.39 8.62 
SE 1.91 1.88 2.10 1.96 2.31 2.46 2.10 1.93 
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 TABLE 6B. (CONTINUED) HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING A CONTROL TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) Following 
a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 103 100 73 72 
R2001 75 68 61 62 
R2002 84 78 78 74 
R2003 86 77 78 77 
R2004 69 63 64 59 
R2005 59 58 42 48 
R2006 76 74 72 70 
R2007     
R2008 63 63 67 64 
R2009 96 99 97 87 
R2010 80 67 82 79 
R2011 88 82 61 72 
R2012 74 76 61 50 
R2013 89 80 77 69 
R2014 75 75 72 75 
R2015 71 79 71 66 
R2017 82 91 87 72 
R2018 75 76 73 55 
R2019 66 67 56 56 
R2020 83 76 65 69 
Mean 78.5 76.2 70.3 67.0 
SD 11.15 11.21 12.21 10.18 
SE 2.49 2.51 2.73 2.28 
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 TABLE 7A. HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING THE ACCUMULATION OF PHYSICAL ACTIVITY 
TREATMENT 
 Hourly Mean Blood Pressure (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 127 134 142 141 135 136 144 136 
R2001 125 130 118 124 136 128 123 122 
R2002 121 124 142 124 123 110 121 114 
R2003 122 120 129 120 125 118 128 131 
R2004 94 100 101 104 102 106 125 108 
R2005 141 145 147 133 114 111 105 106 
R2006 114 122 120 114 120 123 116 117 
R2007 139 136 142 129 135 135 133 141 
R2008 138 113 129 135 136 132 130 138 
R2009 143 138 150 143 144 154 161 150 
R2010 126 137 130 128 130 129 126 130 
R2011 117 135 148 129 139 129 131 145 
R2012 117 125 126 136 134 115 111 120 
R2013 126 127 124 138 113 118 131 123 
R2014 111 122 122 112 116 129 132 130 
R2015 122 133 117 117 118 133 137 142 
R2017 128 135 130 145 136 144 139 140 
R2018 130 131 129 133 132 133 128 132 
R2019 125 127 128 132 130 128 120 133 
R2020 138 135 138 138 132 133 141 136 
Mean 125.2 128.4 130.6 128.7 127.5 127.1 128.9 129.7 
SD 11.59 10.06 12.34 11.00 10.69 11.78 12.30 12.21 
SE 2.59 2.25 2.76 2.46 2.39 2.63 2.75 2.73 
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 TABLE 7A. (CONTINUED) HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING THE ACCUMULATION OF 
PHYSICAL ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) Following a 
Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 137 147 153 139 
R2001 116 97 104 90 
R2002 109 106 111 112 
R2003 131 97 114 114 
R2004 102 98 96 84 
R2005 113 100 101  
R2006 102 126 120 123 
R2007 140 138 138 145 
R2008 126 125 113 114 
R2009 145 149 144 136 
R2010 131 142 130 115 
R2011 137 125 128 115 
R2012 128 109 98 102 
R2013 125 122 115 108 
R2014 134    
R2015 141 128 138 105 
R2017 128 113 106 110 
R2018 152 136 139 138 
R2019 120 132 123 107 
R2020 137 131 127 135 
Mean 127.6 122.0 120.8 116.1 
SD 13.95 17.14 16.56 16.91 
SE 3.12 3.83 3.70 3.78 
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 TABLE 7B. HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING THE ACCUMULATION OF PHYSICAL ACTIVITY 
TREATMENT 
 Hourly Mean Blood Pressure (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 83 84 88 76 82 78 82 77 
R2001 87 93 71 75 90 80 72 74 
R2002 89 77 94 84 83 81 79 71 
R2003 88 89 90 82 82 87 87 88 
R2004 56 61 54 60 54 63 68 66 
R2005 78 76 82 69 51 53 49 59 
R2006 74 77 77 71 72 78 67 74 
R2007 92 94 92 88 94 93 89 94 
R2008 82 65 74 79 84 80 80 72 
R2009 92 90 101 92 94 106 99 99 
R2010 83 81 71 82 77 72 78 85 
R2011 82 75 77 83 78 84 86 78 
R2012 79 75 82 82 94 80 69 74 
R2013 74 77 78 81 63 77 83 75 
R2014 77 79 77 75 75 87 78 85 
R2015 78 73 68 71 71 73 72 79 
R2017 74 77 80 68 81 80 86 80 
R2018 79 63 67 70 69 72 76 77 
R2019 72 68 74 82 75 78 78 74 
R2020 82 76 76 88 78 80 90 90 
Mean 80.0 77.4 78.5 77.9 77.3 79.0 78.3 78.4 
SD 8.10 9.18 10.74 8.10 11.95 10.67 10.64 9.43 
SE 1.81 2.05 2.40 1.81 2.67 2.38 2.38 2.11 
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 TABLE 7B. (CONTINUED) HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING THE ACCUMULATION OF 
PHYSICAL ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) Following a 
Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 80 86 90 89 
R2001 68 44 59 52 
R2002 67 69 71 76 
R2003 85 75 71 82 
R2004 54 53 49 43 
R2005 61 52 52  
R2006 64 79 74 72 
R2007 89 90 92 94 
R2008 70 77 64 69 
R2009 95 97 93 86 
R2010 78 86 76 64 
R2011 74 72 71 67 
R2012 82 65 59 64 
R2013 70 75 79 63 
R2014 87    
R2015 77 75 76 48 
R2017 76 59 66 55 
R2018 79 64 68 65 
R2019 77 75 71 54 
R2020 86 82 81 83 
Mean 75.9 72.4 71.6 68.0 
SD 10.05 13.72 12.36 14.68 
SE 2.25 3.07 2.76 3.28 
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 TABLE 8A. HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING A CONTINUOUS PHYSICAL ACTIVITY 
TREATMENT  
 Hourly Mean Blood Pressure (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 135 130 140 130 142 145 141 150 
R2001 140 137 137 139 127 125 121 131 
R2002 123 128 131 128 127 129 126 130 
R2003 121 136 131 122 117 113 125 124 
R2004 109 109 109 117 119 118 110 124 
R2005 138 137 135 125 138 134 137 136 
R2006 118 123 132 124 124 126 128 119 
R2007 113 124 127 127 111 117 119 122 
R2008 127 122 121 128 145 146 138 131 
R2009 132 135 135 152 150 153 161 153 
R2010 123 121 137 136 120 118 131 134 
R2011 132 119 135 132 129 136 136 128 
R2012 127 119 125 120 130 132 125 127 
R2013 127 131 128 136 126 137 131 137 
R2014 118 122 120 117 132 122 126 138 
R2015 114 115 113 115 120 131 125 106 
R2017 131 154 134 126 136 136 136 130 
R2018 110 132 132 123 127 133 142 141 
R2019 123 115 123 119 118 121 132 129 
R2020 136 140 133 139 143 144 146 139 
Mean 124.8 127.5 128.8 127.7 128.9 130.6 131.8 131.4 
SD 9.27 10.64 8.27 9.10 10.56 10.92 10.97 10.51 
SE 2.07 2.38 1.85 2.04 2.36 2.44 2.45 2.35 
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 TABLE 8A. (CONTINUED) HOURLY SYSTOLIC BLOOD PRESSURE FOLLOWING A CONTINUOUS PHYSICAL 
ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) Following 
a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 140 148 138 102 
R2001 110 115 115 120 
R2002 137 133 124 122 
R2003 146 126 124 94 
R2004 143 123 126 104 
R2005 135 133 120 106 
R2006 125 129 142 129 
R2007 119 117 122 129 
R2008 125 117 134 133 
R2009 150 145 138 140 
R2010 130 136 137 138 
R2011 131 128 118 111 
R2012 118 120 109 94 
R2013 135 132 129 117 
R2014 135 126 124 122 
R2015 112 129 124 120 
R2017 114 113 111 117 
R2018 130 121 123 122 
R2019 131 131 124 115 
R2020 138 124 130 120 
Mean 130.2 127.3 125.7 117.7 
SD 11.29 9.29 8.81 13.09 
SE 2.53 2.08 1.97 2.93 
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 TABLE 8B. HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING A CONTINUOUS PHYSICAL ACTIVITY 
TREATMENT 
 Hourly Mean Blood Pressure (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 94 95 88 78 84 80 86 93 
R2001 77 70 75 76 73 80 76 68 
R2002 82 82 83 84 81 81 81 81 
R2003 90 87 97 89 78 90 89 87 
R2004 63 53 54 63 65 70 58 66 
R2005 76 69 68 62 80 74 76 73 
R2006 78 73 75 72 73 73 81 77 
R2007 83 83 81 89 71 79 84 87 
R2008 80 73 78 74 79 87 80 72 
R2009 84 89 85 100 91 93 90 90 
R2010 81 84 80 73 77 76 79 86 
R2011 76 84 87 73 73 84 88 73 
R2012 84 78 80 78 86 87 80 79 
R2013 82 89 83 87 81 90 80 94 
R2014 76 72 75 73 89 85 79 84 
R2015 68 67 60 70 70 72 68 67 
R2017 86 87 92 80 83 90 82 75 
R2018 69 75 80 71 67 76 80 75 
R2019 70 65 70 72 68 69 76 72 
R2020 91 89 85 78 92 90 77 90 
Mean 79.4 78.1 78.7 76.9 77.9 81.2 79.4 79.5 
SD 8.03 10.43 10.11 8.96 8.10 7.42 7.08 8.90 
SE 1.79 2.33 2.26 2.00 1.81 1.66 1.58 1.99 
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 TABLE 8B. (CONTINUED) HOURLY DIASTOLIC BLOOD PRESSURE FOLLOWING A CONTINUOUS PHYISCAL 
ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure (mm Hg) Following a 
Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 88 82 82 60 
R2001 49 58 60 41 
R2002 86 89 83 85 
R2003 90 90 81 59 
R2004 69 63 70 64 
R2005 78 84 62 56 
R2006 79 77 87 72 
R2007 77 80 81 91 
R2008 66 68 77 80 
R2009 93 95 83 87 
R2010 89 86 77 78 
R2011 70 75 79 69 
R2012 76 80 73 59 
R2013 85 89 83 75 
R2014 88 78 77 76 
R2015 67 72 65 64 
R2017 59 61 58 62 
R2018 78 64 65 53 
R2019 77 69 72 60 
R2020 86 83 76 74 
Mean 77.3 77.1 74.5 68.2 
SD 11.49 10.50 8.58 12.70 
SE 2.57 2.35 1.92 2.84 
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 TABLE 9. AMBULATORY BLOOD PRESSURE MONITORING FOR REST PERIOD BETWEEN SHORT SESSIONS OF 
PHYSICAL ACTIVITY TREATMENT 
  Baseline  1st session 
ID 
Starting 
Time Sampled Used 
% 
Edited
Starting 
Time Sampled Used 
% 
Edited
R2000 8:35 3 3 100.0 9:08 6 6 100.0 
R2001 9:32 3 3 100.0 10:03 7 7 100.0 
R2002 9:21 3 3 100.0 9:48 7 7 100.0 
R2003 9:03 3 3 100.0 9:36 7 7 100.0 
R2004 8:57 3 3 100.0 9:42 6 6 100.0 
R2005 9:01 3 3 100.0 9:31 7 7 100.0 
R2007 8:56 3 3 100.0 9:25 7 7 100.0 
R2008 8:23 3 3 100.0 8:57 7 7 100.0 
R2009 8:48 3 3 100.0 9:15 7 7 100.0 
R2010 8:53 3 3 100.0 9:22 7 7 100.0 
R2011 8:57 3 3 100.0 9:37 7 7 100.0 
R2012 9:20 3 3 100.0 9:57 7 7 100.0 
R2013 8:50 3 3 100.0 9:17 7 7 100.0 
R2014 8:59 3 3 100.0 9:28 7 7 100.0 
R2015 8:52 3 3 100.0 9:18 6 6 100.0 
R2016 8:43 3 3 100.0 9:13 7 7 100.0 
R2017 9:18 3 3 100.0 9:47 7 7 100.0 
R2018 8:58 3 3 100.0 9:26 7 7 100.0 
R2019 9:19 3 3 100.0 9:51 7 7 100.0 
R2020 9:32 3 3 100.0 10:02 7 7 100.0 
Mean 9:00 3.0 3.0 100.0 9:32 6.9 6.9 100.0 
S.D. 0:17 0.00 0.00 0.00 0:18 0.37 0.37 0.00 
S.E. 0:03 0.00 0.00 0.00 0:04 0.08 0.08 0.00 
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 TABLE 9. (CONTINUED) AMBULATORY BLOOD PRESSURE MONITORING FOR AND REST PERIOD BETWEEN 
SHORT SESSIONS OF PHYSICAL ACTIVITY TREATMENT 
  2nd session  3rd session 
ID 
Starting 
Time Used 
% 
Edited
Starting 
Time Sampled Used 
% 
Edited Sampled
R2000 9:59 6 6 100.0 10:59 3 3 100.0 
R2001 11:06 7 7 100.0 12:07 5 5 100.0 
R2002 10:48 7 7 100.0 11:49 7 7 100.0 
R2003 10:37 5 5 100.0 11:39 7 7 100.0 
R2004 10:43 7 7 100.0 11:45 7 7 100.0 
R2005 10:31 7 7 100.0 11:31 6 6 100.0 
R2007 10:24 7 7 100.0 11:23 7 7 100.0 
R2008 9:57 7 7 100.0 10:59 7 7 100.0 
R2009 10:15 
171 7 7 100.0 11:15 7 7 100.0 
R2010 10:22 7 7 100.0 11:22 7 7 100.0 
R2011 10:37 7 7 100.0 11:37 7 7 100.0 
R2012 10:53 6 6 100.0 11:53 7 7 100.0 
R2013 10:19 7 7 100.0 11:19 7 7 100.0 
R2014 10:29 7 7 100.0 11:28 6 6 100.0 
R2015 10:19 7 7 100.0 11:19 7 7 100.0 
R2016 10:13 7 7 100.0 11:13 7 7 100.0 
R2017 10:47 7 7 100.0 11:47 7 7 100.0 
R2018 10:26 7 7 100.0 11:30 6 6 100.0 
R2019 10:51 7 7 100.0 11:52 7 7 100.0 
R2020 11:03 7 7 100.0 12:03 6 6 100.0 
Mean 10:31 6.80 6.80 100.0 11:32 6.50 6.50 100.0 
S.D. 0:18 0.52 0.52 0.00 0:18 1.00 1.00 0.00 
S.E. 0:04 0.12 0.12 0.00 0:04 0.22 0.22 0.00 
  
 TABLE 10A. SYSTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN SHORT SESSIONS 
OF PHYSICAL ACTIVITY TREATMENT 
 Baseline Systolic Blood Pressure (mm Hg)  
Systolic Blood Pressure Following the 1st Short Session (mm Hg) 
 
ID 5 min 
10 
min 
15 
min Mean  5 min 
10 
min 
15 
min 
20 
min 
30 
min 
40 
min 
50 
min Mean 
R2000 152 129 134 138.3  153 133 133 144 130 128  136.8 
R2001 136 122 119 125.6  126 118 124 129 126 124 121 124.0 
R2002 124 120 129 124.3  123 124 125 149 119 121 109 122.3 
R2003 127 129 126 127.3  127 124 123 123 121 118 120 124.3 
R2004 117 108 107 110.7  124 107 95 107 111 92  106.0 
R2005 149 137 145 143.6  144 144 139 136 140 131 128 137.4 
R2007 125 129 125 126.3  123 120 125 125 125 136 139 127.6 
R2008 115 114 124 117.6  132 135 118 118 117 113 120 121.9 
R2009 148 150 134 144.0  144 148 144 143 138 150 145 144.6 
R2010 130 128 128 128.6  135 128 136 136 126 134 140 133.6 
R2011 116 125 129 123.3  129 107 102 112 110 110 108 111.1 
R2012 120 121 108 116.3  117 104 117 122 118 112 115 115.0 
R2013 123 134 136 131.0  130 119 122 131 122 127 129 125.7 
R2014 128 121 122 123.7   122 124 128 122 122 124 123.7 
R2015 110 98 103 103.7  117 94 91 100 107 115 110 104.9 
R2016 134 132 132 132.7  136 136 129 139 137 136 128 134.4 
R2017 122 126 119 122.3  129 123 123 126 116 121 126 123.4 
R2018 121 133 120 124.7  129 123 125 125 110 117 121 121.4 
R2019 130 119 121 123.3  125 120 123 126 111 115 113 119.0 
R2020 147 146 139 144.0  149 144 143 139 140 141 130 140.9 
Mean 128.7 126.1 125.0 126.6  131.2 123.7 123.1 127.9 122.3 123.2 123.7 124.9 
SD 12.2 11.9 10.7 10.56  10.13 13.98 14.01 12.50 10.45 12.91 10.70 10.83 
SE    2.36         2.42 
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 TABLE 10A. (CONTINUED) SYSTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN 
SHORT SESSONS OF PHYSICAL ACTIVITY TREATMENT 
 Systolic Blood Pressure Following the 2nd Short Session (mm Hg) 
ID 5 min 10 min 15 min 20 min 30 min 40 min 50 min Mean 
R2000 129 128 132 129 122 127  127.8 
R2001 118 122 127 121 121 119 119 121.0 
R2002 116 129 125 116 113 126 118 120.4 
R2003 125 124 118 122   118 121.4 
R2004 92 93 87 99 94 93 89 92.4 
R2005 150 154 145 131 130 131 131 138.9 
R2007 128 124 145 127 130 128 123 129.3 
R2008 119 137 129 135 128 117 117 126.0 
R2009 138 146 135 138 136 139 148 140.0 
R2010 135 132 136 130 127 117 122 128.4 
R2011  128 115 121 109 120 114 117.8 
R2012 124 132 115 121 109 122 128 121.6 
R2013 130 99 118 125 114 112 115 116.1 
R2014 113 123 117 125 125 122 127 121.7 
R2015 115 118 119 119 109 119 108 115.3 
R2016 143 139 125 120 126 126 125 129.1 
R2017 128 119 121 118 126 127 125 123.4 
R2018 125 130 126 120 126 122 120 124.1 
R2019 125 133 118 125 111 120 112 120.6 
R2020 144 130 146 147 137 141 143 141.1 
Mean 126.2 127.0 125.0 124.5 120.7 122.5 121.2 123.8 
SD 13.15 13.74 13.45 9.67 11.04 10.17 12.54 10.48 
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 TABLE 10A. (CONTINUED) SYSTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN 
SHORT SESSIONS OF PHYSICAL ACTIVITY TREATMENT 
 Systolic Blood Pressure Following the 3rd Short Session (mm Hg) 
ID 5 min 10 min 15 min 20 min 30 min 40 min 50 min Mean 
R2000 130 138 138     135.3 
R2001 122 124 115 125 117   120.6 
R2002 120 122 122 112 109 120 121 118.0 
R2003 120 130 109 98 119 109 113 114.0 
R2004 110 102 104 105 70 100 100 98.7 
R2005 137 126 137 127 126 122  129.2 
R2007 136 124 121 122 128 125 127 126.1 
R2008 122 112 120 125 129 123 128 122.7 
R2009 142 138 139 132 138 128 137 136.3 
R2010 130 117 123 121 122 129 116 122.6 
R2011 93 115 103 111 107 98 106 104.7 
R2012 117 126 122 120 127 118 125 122.1 
R2013 124 122 121 128 119 121  122.5 
R2014 126 120 120 125 121 128 130 124.3 
R2015 115 115 113 97 118 115 108 111.6 
R2016 138 129 135 132 122 133 125 130.6 
R2017 129 127 131 129 125 125 126 127.4 
R2018  128 130 120 120 127 122 124.5 
R2019 125 124 122 124 127  117 123.2 
R2020 140 140 149 138 143 146 142 142.6 
Mean 125.1 124.0 123.7 120.6 120.4 121.6 121.4 122.9 
SD 11.78 9.19 12.03 11.25 14.85 11.61 11.13 10.28 
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 TABLE 10B. DIASTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN SHORT SESSIONS 
OF PHYSICAL ACTIVITY TREATMENT 
 
Baseline Diastolic Blood 
Pressure 
Diastolic Blood Pressure Following the 1st Short Session 
ID 5 min 
10 
min 
15 
min Mean 5 min 10 min 15 min 20 min 30 min 40 min 50 min Mean 
R2000 99 88 93 93.3 97 95 96 91 89   93.6 
R2001 87 72 91 83.3 82 86 78 75  81 92 82.3 
R2002 98 97 92 95.7 95 91 88 94 91 85 95 91.3 
R2003 89 93 90 90.7 95 94 93 87 97 86 91 91.9 
R2004 65 67 69 67.0 63 50 51 44 59 45  52.0 
R2005 80 75 81 78.7 95 83 88 68 95 77 81 83.9 
R2007 85 93 90 89.3 93 90 86 87 86 95 97 90.6 
R2008 75 63 67 68.3 82 73 72 75 78 81 82 77.6 
R2009 92 92 88 90.7 99 100 104 101 93 100 98 99.3 
R2010 86 77 79 80.7 76 77 70 81 75 78 77 76.3 
R2011 78 83 72 77.7 72 70 68 74 70 68 73 70.7 
R2012 77 79 76 77.3 76 82 81 82 80 76 78 79.3 
R2013 76 84 85 81.7 87 78 81 83 90 89 83 84.4 
R2014 83 87 81 83.7  87 87 87 86 82 91 86.7 
R2015 66 72 70 69.3 79 68 67 64 72 75 70 70.7 
R2016 76 75 69 73.3 70 70 78 75 71 85 76 75.0 
R2017 81 81 81 81.0 78 84 84 83 79 84 78 81.4 
R2018 69 72 72 71.0 75 78 78 76 78 81 74 77.1 
R2019 84 80 76 80.0 84 69 86 82 67 79 76 77.6 
R2020 84 86 89 86.3 88 88 90 96 89 92 85 89.7 
Mean 81.5 80.8 80.55 81.0 83.5 80.7 81.3 80.3 81.3 81.0 83.2 81.6 
SD 9.26 9.30 8.80 8.42 10.32 11.79 11.84 12.59 10.53 11.46 8.80 10.47 
SE    1.88        2.34 
175
  
 TABLE 10B. (CONTINUED) DIASTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN 
SHORT SESSIONS OF PHYSICAL ACTIVITY TREATMENT 
 Diastolic Blood Pressure Following the 2nd Short Session 
ID 5 min 10 min 15 min 20 min 30 min 40 min 50 min Mean 
R2000 87 90 86 94 88 102 87 90.6 
R2001 79 78 83 76 76 84 77 79.0 
R2002 84 96 92 77 87 87 88 87.3 
R2003 90 84 89 93   86 88.4 
R2004 51 55 50 54 64 58 63 56.4 
R2005 95 94 85 84 75 85 80 85.4 
R2007 93 97 99 87 91 85 90 91.7 
R2008 85 89 91 90 78 83 80 85.1 
R2009 94 93 83 98 102 94 98 94.6 
R2010 75 85 84 92 82 73 79 81.4 
R2011  80 64 76 71 75 74 73.3 
R2012 84 88 79 80 82 87 88 84.0 
R2013 87 74 80 92 82 76 78 81.3 
R2014 80 85 82 81 82 87 85 83.1 
R2015 74 79 80 72 74 68 65 73.1 
R2016 73 96 74 76 82 70 70 77.3 
R2017 75 77 77 87 77 78 81 78.9 
R2018 82 82 80 76 85 80 81 80.9 
R2019 86 80 87 84 74 78 77 80.9 
R2020 92 94 92 92 96 85 95 92.3 
Mean 82.4 84.0 81.9 83.1 81.5 80.8 81.1 82.3 
SD 10.26 9.98 10.59 10.21 8.95 9.84 9.00 8.52 
SE        1.90 
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TABLE 10B. (CONTINUED) DIASTOLIC BLOOD PRESSURES FOR BASELINE AND REST PERIOD BETWEEN 
SHORT SESSIONS OF PHSYCIAL ACTIVITY TREATMENT 
 Diastolic Blood Pressure Following the 3rd Short Session 
ID 5 min 10 min 15 min 20 min 30 min 40 min 50 min Mean 
R2000 92 93 88     91.0 
R2001 78 75 82 78 73 88 94 81.1 
R2002 84 89 83 86 83 84 84 84.7 
R2003 90 89 79 80 89 82 92 85.9 
R2004 41 68 63 58 62 58 67 59.6 
R2005 86 75 82 81  91 84 83.2 
R2007 92 89 91 90 97 92 91 91.7 
R2008 72 81 73 77 82 77 75 76.7 
R2009 92 96 92 88 100 93 104 95.0 
R2010 77 81 86 78 87 88 80 82.4 
R2011 73 68 67 76 71 58 74 69.6 
R2012 81 83 82 81 84 83 84 82.6 
R2013 76 84 81 82 85 92 84 83.4 
R2014 85 83 82 82 84 85 86 83.9 
R2015 70 74 77 70 79 71 71 73.1 
R2016 80 74 71 78 78 85 75 77.3 
R2017 76 78 79 78 82 79 82 79.1 
R2018  77 84 84 77 76 73 78.5 
R2019 82 82 78 78 79  70 78.2 
R2020 92 93 92 88 92 84 96 91.0 
Mean 80.0 81.6 80.6 79.6 82.4 81.4 82.4 81.4 
SD 11.87 8.11 7.77 7.14 9.07 10.40 9.92 8.17 
SE 1.83         
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 TABLE 11. BLOOD PRESSURES FOR BASELINE AND REST PERIOD 
BETWEEN SHORT SESSIONS OF PHYSICAL ACTIVITY TREATMENT  
 Systolic Blood Pressure (mm Hg) 
ID Baseline 1st 2nd 3rd 
R2000 138 134 128 138 
R2001 126 124 122 120 
R2002 127 122 121 113 
R2003 124 125 121 118 
R2004 111 102 93 97 
R2005 144 136 137 128 
R2007 126 128 130 125 
R2008 118 120 127 123 
R2009 144 145 140 135 
R2010 129 133 127 121 
R2011 123 108 118 107 
R2012 116 115 121 123 
R2013 131 125 114 122 
R2014 124 124 123 124 
R2015 104 103 115 111 
R2016 133 134 127 129 
R2017 122 123 123 127 
R2018 125 120 124 125 
R2019 123 118 120 123 
R2020 144 140 141 143 
Mean 126.6 123.9 123.5 122.6 
SD 10.56 11.35 10.37 10.49 
SE 2.36 2.54 2.32 2.35 
 
Values of blood pressure were average for 15-minute baseline and the last 40 
minutes of rest period following successive short sessions of exercise treatment.  
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TABLE 11. (CONTINUED) BLOOD PRESSURES FOR BASELINE AND REST 
PERIOD BETWEEN SHORT SESSIONS OF PHYSICAL ACTIVITY 
TREATMENT  
 Diastolic Blood Pressure (mm Hg) 
ID Baseline 1st 2nd 3rd 
R2000 93 93 91 91 
R2001 83 82 79 82 
R2002 91 91 88 85 
R2003 96 91 88 85 
R2004 67 50 57 63 
R2005 79 82 84 83 
R2007 89 90 92 92 
R2008 68 77 85 78 
R2009 91 99 95 96 
R2010 81 76 83 83 
R2011 78 71 73 69 
R2012 77 80 84 83 
R2013 82 84 80 85 
R2014 84 87 84 84 
R2015 69 69 73 74 
R2016 73 76 78 77 
R2017 81 82 80 80 
R2018 71 78 81 79 
R2019 80 77 80 77 
R2020 86 90 92 91 
Mean 93 81.19 82.29 81.6 
SD 8.42 10.77 8.38 7.79 
SE 1.88 2.41 1.87 1.74 
 
Values of blood pressure were average for 15-minute baseline and the last 40 
minutes of rest period following successive short sessions of exercise treatment.  
 TABLE 12A. CUMULATIVE SUM OF SYSTOLIC BLOOD PRESSURE REDUCTION FOLLOWING THE 
ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 Hourly Mean Blood Pressure Reduction (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 17 9 18 1 2 -14 -10 9 
R2001 5 14 22 8 2 6 10 4 
R2002 18 15 -7 11 12 24 18 15 
R2003 0 17 -9 5 7 17 6 -3 
R2004 27 17 -3 8 5 3 -10 -1 
R2005 25 18 24 21 46 20 23 28 
R2006 8 3 13 20 1 6 4 -8 
R2007 1 -6 -12 1 -6 -7 -13 -7 
R2008 -21 19 0 9 -9 0 -12 -20 
R2009 -3 3 -11 7 9 -3 -3 -11 
R2010 10 -2 7 2 1 19 9 -4 
R2011 16 1 -23 9 -13 0 3 -18 
R2012 21 22 32 13 6 31 23 20 
R2013 4 4 23 -7 20 9 -1 13 
R2014 24 27 -3 6 4 0 14 23 
R2015 13 18 22 13 28 3 -1 -17 
R2017 11 5 2 -14 0 -3 2 6 
R2018 -2 -2 -5 -10 1 6 8 2 
R2019 8 -8 3 -2 -18 0 2 -4 
R2020 14 1 1 -2 5 -2 1 5 
Mean 9.8 8.7 4.8 4.9 5.1 5.7 3.7 1.7 
Sum 9.8 18.6 23.4 28.3 33.4 39.1 42.8 44.4 
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 TABLE 12A. (CONTINUED) CUMULATIVE SUM OF SYSTOLIC BLOOD PRESSURE REDUCTION FOLLOWING THE 
ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure Reduction (mm Hg) 
Following a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 26 4 -4 -27 
R2001 13 32 9 19 
R2002 24 14 6 -3 
R2003 -3 27 10 6 
R2004 18 15 7 19 
R2005 0 12 -19  
R2006 17 1 3 -5 
R2007     
R2008 -16 -23 0 -5 
R2009 4 4 12 1 
R2010 -4 -19 0 8 
R2011 0 -13 -19 -5 
R2012 2 23 8 -7 
R2013 23 5 17 11 
R2014 5    
R2015 -13 15 3 8 
R2017 12 22 33 9 
R2018 -12 4 2 -28 
R2019 8 -7 -16 4 
R2020 5 -3 -5 -14 
Mean 5.7 6.2 2.5 -0.5 
Sum 50.2 56.4 58.9 58.4 
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 TABLE 12B. CUMULATIVE SUM OF DIASTOLIC BLOOD PRESSURE REDUCTION FOLLOWING THE 
ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 Hourly Mean Blood Pressure Reduction (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 10 10 11 23 21 21 19 15 
R2001 4 1 23 5 -12 -8 13 -3 
R2002 2 19 -7 5 7 10 6 17 
R2003 0 -16 -7 5 12 0 3 -4 
R2004 5 8 4 1 7 -1 -1 -4 
R2005 4 6 8 10 37 23 30 16 
R2006 -5 -11 -7 4 5 -8 3 -5 
R2007 0 -4 -5 -6 -13 -7 -4 -2 
R2008 -7 9 -4 -6 -16 -10 -12 -2 
R2009 -6 -1 -11 1 5 -7 2 -10 
R2010 4 8 17 3 10 10 0 -4 
R2011 4 8 9 3 16 16 3 2 
R2012 4 8 3 3 -6 6 16 13 
R2013 12 2 4 2 17 8 0 13 
R2014 12 1 -2 0 1 -2 10 1 
R2015 -3 9 11 3 5 0 6 -8 
R2017 5 3 1 12 4 7 -4 1 
R2018 -8 12 8 0 9 4 1 4 
R2019 5 4 8 -11 -6 -12 -2 -1 
R2020 4 7 1 -4 1 -3 4 -2 
Mean 2.4 4.1 3.3 2.7 5.2 2.5 4.6 1.7 
Sum 2.4 6.5 9.8 12.5 17.7 20.2 24.8 26.6 
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 TABLE 12B. (CONTINUED) CUMULATIVE SUM OF DIASTOLIC BLOOD PRESSURE REDUCTION FOLLOWING THE 
ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure Reduction (mm Hg) 
Following a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 23 13 -17 -17 
R2001 7 24 2 10 
R2002 18 10 7 -1 
R2003 1 2 7 -5 
R2004 15 10 16 16 
R2005 -3 6 -10  
R2006 11 -5 -3 -1 
R2007     
R2008 -7 -15 3 -6 
R2009 2 2 4 1 
R2010 1 -19 6 15 
R2011 14 11 -9 6 
R2012 -8 11 2 -14 
R2013 18 5 -2 6 
R2014 -13    
R2015 -6 3 -5 18 
R2017 6 31 21 17 
R2018 -4 12 5 -10 
R2019 -10 -8 -16 2 
R2020 -3 -6 -16 -13 
Mean 3.3 4.9 -0.2 1.3 
Sum 29.8 34.7 34.5 35.8 
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 TABLE 13A. CUMULATIVE SUM OF SYSTOLIC BLOOD PRESSURE REDUCTION FOLLOWING A CONTINUOUS 
PHYSICAL ACTIVITY TREATMENT 
 Hourly Mean Blood Pressure Reduction (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 8 13 19 12 -6 -22 -8 -5 
R2001 -10 7 3 -7 12 9 12 -5 
R2002 15 11 4 7 8 6 13 -1 
R2003 1 1 -11 3 15 21 9 4 
R2004 13 8 -11 -6 -11 -9 4 -17 
R2005 28 25 37 28 21 -3 -9 -3 
R2006 4 2 2 9 -3 3 -9 -10 
R2007 26 7 3 3 18 10 1 12 
R2008 -10 10 7 16 -17 -14 -20 -12 
R2009 8 7 5 -2 3 -2 -3 -13 
R2010 13 14 0 -6 11 30 4 -7 
R2011 1 17 -10 7 -3 -7 -3 -1 
R2012 11 29 33 29 11 14 8 13 
R2013 2 0 19 -5 7 -11 -1 -1 
R2014 18 27 0 0 -13 7 19 15 
R2015 22 36 27 15 27 5 11 19 
R2017 9 -15 -1 5 0 5 5 16 
R2018 19 -4 -8 0 6 6 -5 -8 
R2019 9 4 7 11 -6 7 -10 -1 
R2020 16 -4 7 -4 -5 -13 -4 2 
Mean 10.3 9.7 6.6 5.8 3.7 2.1 0.8 -0.1 
Sum 10.3 20.0 26.6 32.4 36.1 38.2 39.1 39.0 
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 TABLE 13A. (CONTINUED) CUMULATIVE SUM OF SYSTOLIC BLOOD PRESSURE REDUCTION FOLLOWING A 
CONTINUOUS PHYSICAL TREATMENT 
 
Hourly Mean Blood Pressure Reduction (mm Hg) 
Following a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 23 3 12 10 
R2001 18 13 -2 21 
R2002 -5 -13 -8 -13 
R2003 -18 -2 -1 26 
R2004 -24 -11 -24 -2 
R2005 -22 -21 -39 -12 
R2006 -6 -3 -20 -11 
R2007     
R2008 -14 -15 -21 -24 
R2009 0 8 18 -3 
R2010 -3 -12 -7 -15 
R2011 5 -15 -10 -1 
R2012 13 12 -3 1 
R2013 14 -6 3 1 
R2014 3 20 25 22 
R2015 16 14 17 -6 
R2017 26 22 27 2 
R2018 10 18 17 -12 
R2019 -3 -7 -17 -4 
R2020 3 4 -8 1 
Mean 1.9 0.5 -2.1 -1.0 
Sum 40.9 41.4 39.3 38.3 
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 TABLE 13B. CUMULATIVE SUM OF DIASTOLIC BLOOD PRESSURE REDUCTION FOLLOWING A CONTINUOUS 
PHYSICAL ACTIVITY TREATMENT 
 Hourly Mean Blood Pressure Reduction (mm Hg) Following a Treatment 
ID 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 7 hour 8 hour 
R2000 -1 -2 11 22 19 20 15 -1 
R2001 15 24 19 5 6 -8 9 3 
R2002 9 14 4 4 9 10 4 6 
R2003 -3 -14 -14 -2 15 -3 2 -3 
R2004 -2 17 3 -2 -4 -8 9 -4 
R2005 6 13 22 17 8 2 3 2 
R2006 -8 -7 -4 4 4 -3 -11 -9 
R2007 8 7 7 -6 11 8 2 5 
R2008 -5 2 -8 0 -11 -17 -12 -2 
R2009 2 0 4 -6 7 6 11 -1 
R2010 6 5 7 13 10 6 -2 -5 
R2011 10 -2 -1 13 21 16 0 7 
R2012 -1 6 5 8 2 -1 6 8 
R2013 5 -10 -1 -3 -1 -5 4 -7 
R2014 14 8 0 2 -13 0 9 1 
R2015 6 15 20 4 7 1 9 4 
R2017 -7 -7 -11 0 2 -3 0 6 
R2018 3 1 -5 -1 11 0 -3 6 
R2019 7 7 12 -1 1 -3 0 1 
R2020 -6 -7 -8 6 -14 -13 17 -2 
Mean 2.9 3.5 3.1 3.7 4.5 0.3 3.6 0.7 
Sum 2.9 6.3 9.4 13.1 17.7 18.0 21.5 22.2 
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TABLE 13B. (CONTINUED) CUMULATIVE SUM OF DIASTOLIC BLOOD PRESSURE REDUCTION FOLLOWING A 
CONTINUOUS PHYSICAL ACTIVITY TREATMENT 
 
Hourly Mean Blood Pressure Reduction (mm Hg) 
Following a Treatment 
ID 9 hour 10 hour 11 hour 12 hour 
R2000 15 18 -9 12 
R2001 26 10 1 21 
R2002 -1 -10 -6 -11 
R2003 -5 -13 -3 19 
R2004 0 0 -6 -5 
R2005 -20 -26 -21 -9 
R2006 -3 -3 -16 -2 
R2007     
R2008 -3 -5 -10 -17 
R2009 4 4 14 0 
R2010 -9 -19 4 1 
R2011 18 7 -18 3 
R2012 -3 -4 -12 -9 
R2013 4 -9 -6 -7 
R2014 -14 -4 -5 -2 
R2015 5 7 6 2 
R2017 24 29 29 10 
R2018 -3 11 8 3 
R2019 -10 -3 -17 -4 
R2020 -3 -6 -11 -4 
Mean 1.2 -0.8 -3.9 0.1 
Sum 23.5 22.7 18.8 18.9 
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 TABLE 14. MAGNITUDE OF BLOOD PRESSURE REDUCTION FOR THE 
ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 Systolic Blood Pressure (mm Hg) 
ID CONTROL ACCUMULATION DIFFERENCE 
R2000 144.2 139.1 5.1 
R2001 131.5 120.2 11.3 
R2002 132.1 118.5 13.6 
R2003 128.0 121.2 6.8 
R2004 111.0 103.1 7.8 
R2005 137.4 119.5 17.9 
R2006 123.6 117.5 6.1 
R2007 129.9 136.7 -6.8 
R2008 122.0 128.6 -6.7 
R2009 148.3 147.5 0.8 
R2010 132.4 130.8 1.6 
R2011 127.7 132.8 -5.2 
R2012 138.2 119.9 18.3 
R2013 133.7 123.7 10.1 
R2014 136.5 122.9 13.7 
R2015 137.5 129.7 7.8 
R2017 138.2 131.3 6.9 
R2018 133.3 134.1 -0.8 
R2019 123.8 126.9 -3.2 
R2020 137.0 135.1 1.9 
Mean 132.1 126.5 5.5 
SD 8.33 9.73 7.60 
SE 1.86 2.18 1.70 
 
Systolic blood pressures represent 11-hour average values. 
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 TABLE 14. (CONTINUED) MAGNITUDE OF BLOOD PRESSURE REDUCTION 
FOR THE ACCUMULATION OF PHYSICAL ACTIVITY TREATMENT 
 Diastolic Blood Pressure (mm Hg) 
ID CONTROL ACCUMULATION DIFFERENCE 
R2000 98.1 81.5 16.56 
R2001 80.9 75.5 5.46 
R2002 87.7 79.2 8.54 
R2003 84.7 85.1 -0.41 
R2004 63.4 58.9 4.52 
R2005 76.6 62.9 13.64 
R2006 71.6 73.3 -1.69 
R2007 87.1 91.5 -4.39 
R2008 69.4 76.4 -6.95 
R2009 94.1 96.4 -2.33 
R2010 82.1 79.1 2.99 
R2011 87.2 78.8 8.45 
R2012 83.2 78.1 5.11 
R2013 83.5 75.3 8.15 
R2014 80.3 79.9 0.42 
R2015 75.7 73.7 1.99 
R2017 75.6 71.7 3.86 
R2018 71.7 75.1 -3.38 
R2019 82.4 82.6 -0.24 
R2020 82.8 76.0 6.82 
Mean 80.80 77.63 3.17 
SD 8.31 8.30 6.00 
SE 1.86 1.86 1.34 
 
Diastolic blood pressures represent 10-hour average values. 
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 TABLE 15. MAGNITUDE OF BLOOD PRESSURE REDUCTION FOR A 
CONTINUOUS PHYSICAL ACTIVITY TREATMENT 
 Systolic Blood Pressure (mm Hg) 
ID CONTROL CONTINUOUS DIFFERENCE 
R2000 139.7 137.5 2.3 
R2001 135.8 132.3 3.6 
R2002 136.5 127.5 9.0 
R2003 129.3 123.5 5.7 
R2004 111.3 112.9 -1.6 
R2005 153.0 134.8 18.2 
R2006 126.3 124.9 1.4 
R2007 129.4 119.6 9.8 
R2008 128.3 132.4 -4.1 
R2009 147.5 145.3 2.2 
R2010 135.7 126.3 9.3 
R2011 131.5 131.1 0.3 
R2012 144.6 125.2 19.4 
R2013 132.6 130.8 1.8 
R2014 130.8 122.4 8.4 
R2015 139.3 118.9 20.4 
R2017 137.2 136.0 1.3 
R2018 130.5 128.4 2.1 
R2019 124.8 121.7 3.1 
R2020 139.0 140.0 -0.9 
Mean 133.9 128.0 5.9 
SD 8.33 9.73 7.60 
SE 1.86 2.18 1.70 
 
Systolic blood pressures represent 7-hour average values. 
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 TABLE 15. (CONTINUED) MAGNITUDE OF BLOOD PRESSURE REDUCTION 
FOR A CONTINUOUS PHYSICAL ACTIVITY TREATMENT 
 Diastolic Blood Pressure (mm Hg) 
ID CONTROL CONTINUOUS DIFFERENCE 
R2000 98.1 86.3 11.9 
R2001 85.0 75.1 9.9 
R2002 89.6 81.9 7.7 
R2003 85.8 88.3 -2.5 
R2004 62.8 60.9 1.9 
R2005 82.0 72.1 9.8 
R2006 71.1 74.8 -3.7 
R2007 86.5 81.4 5.1 
R2008 71.3 78.6 -7.3 
R2009 93.8 90.3 3.5 
R2010 84.9 78.5 6.4 
R2011 88.9 80.8 8.1 
R2012 85.1 81.6 3.5 
R2013 82.8 84.2 -1.4 
R2014 81.2 78.3 2.9 
R2015 76.7 67.9 8.8 
R2017 74.9 74.0 0.9 
R2018 73.1 69.8 3.2 
R2019 82.4 85.8 -3.5 
R2020 82.0 85.6 -3.6 
Mean 81.9 78.5 3.4 
SD 8.36 7.43 5.44 
SE 1.87 1.66 1.22 
 
Diastolic blood pressures represent 7-hour average values. 
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 TABLE 16. AREAS OF BLOOD PRESSURE REDUCTION FOLLOWING 
PHYSICAL ACTIVITY TREATMENTS 
 
Area of SBP Reduction 
(mm Hg⋅hour) 
Area of DBP Reduction 
(mm Hg⋅hour) 
ID ACCUMULATION CONTINUOUS ACCUMULATION CONTINUOUS
C2000 35.4 3.5 155.7 73.5 
C2001 119.8 14.4 51.3 59.2 
C2002 146.8 64.7 85.8 57.9 
C2003 61.7 19.3 -0.2 -14.0 
C2004 75.2 -14.5 48.1 16.8 
C2005 203.7 127.2 137.3 71.4 
C2006 61.2 5.5 -14.5 -25.1 
C2007 95.2 69.4 -31.1 39.0 
C2008 -77.4 -21.8 -78.5 -53.3 
C2009 -8.2 11.9 -26.0 19.6 
C2010 28.7 62.5 41.7 41.8 
C2011 -0.3 -30.8 90.4 40.1 
C2012 173.2 139.9 19.4 25.9 
C2013 95.3 4.2 78.7 -10.5 
C2014 455.4 50.8 123.1 15.9 
C2015 78.3 128.2 20.3 56.1 
C2017 73.3 4.2 65.1 -30.1 
C2018 0.3 10.7 43.3 6.4 
C2019 -38.5 13.6 -35.0 18.8 
C2020 19.3 -6.1 -2.1 -29.2 
Mean 79.91 32.83 38.63 19.00 
SD 112.36 50.72 61.97 36.75 
SE 25.12 11.34 13.86 8.22 
 
SBP = systolic blood pressure, DBP = diastolic blood pressure 
Areas of systolic blood pressure reduction for the accumulation of short bouts 
and a long bout of exercise treatments were 11-hour and 7 hour averages, 
respectively.  Areas of diastolic blood pressure reduction for the accumulation of 
short bouts and a long bout of exercise treatments were 10-hour and 7 hour 
averages, respectively.   
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TABLE 17. ENERGY EXPENDITURE FOLLOWING PHYSICAL ACTIVITY 
TREATMENTS 
 Energy Expenditure for 12 hours (kcal) 
ID CONTROL ACCUMULATION CONTINUOUS 
R2000 355.6   264.7 
R2001 320.4 340.3 416.8 
R2002 391.6 228.2 182.7 
R2003       
R2004 110.5 130.8 182.4 
R2005 328.7 343.1 263.6 
R2006 483.0 317.6 332.7 
R2007 730.3 301.3 546.4 
R2008 344.9 194.6 243.4 
R2009 255.6 290.4 324.4 
R2010 517.9 365.3 312.1 
R2011 450.0 460.6 208.1 
R2012 163.8 248.5 325.1 
R2013 260.5 315.9 210.2 
R2014 226.2 438.5 222.6 
R2015 153.3 231.0 319.2 
R2017 307.3 561.3 570.8 
R2018 517.8 569.7 716.4 
R2019       
R2020 407.6 587.9 320.4 
Mean 351.39 348.51 331.22 
SD 153.37 134.53 146.06 
SE 34.29 30.08 32.66 
 
 TABLE 18. AVERAGE HEART RATE VARIABILITY FOLLOWING A CONTROL TREATMENT 
  
Normalized Low Frequency 
Power (%) 
Normalized High Frequency 
Power (%) 
Low to High Frequency Power 
Ratio 
ID 7 hour 10 hour 11 hour 7 hour 10 hour 11 hour 7 hour 10 hour 11 hour 
R2000 86.67 84.89 83.73 12.23 13.90 14.91 7.57 6.67 6.33 
R2001 84.76 83.96 84.27 13.84 14.04 13.83 6.52 6.39 6.48 
R2002 73.39 68.75 65.46 21.24 26.79 30.35 3.64 3.10 2.87 
R2003 81.87 82.28 82.63 16.54 16.25 15.95 6.00 5.95 6.01 
R2004 53.79 63.15 63.61 38.45 31.15 31.04 2.20 3.50 3.39 
R2005 73.45 69.03 66.23 22.58 26.27 28.53 4.15 3.51 3.26 
R2006 66.90 68.73 69.29 28.43 27.06 26.64 2.46 2.69 2.74 
R2007 69.15 71.08 71.92 23.55 23.03 22.60 3.69 3.65 3.72 
R2008 72.88 65.12 65.12 23.52 31.75 31.84 3.30 2.60 2.55 
R2009                   
R2010 67.14 66.32 65.54 29.50 30.87 31.71 2.70 2.50 2.40 
R2011 85.97 81.81 81.39 10.78 14.38 14.81 8.48 7.03 6.76 
R2012 69.51 65.06 62.58 26.86 31.13 33.59 3.31 2.90 2.70 
R2013                   
R2014 80.41 79.63 79.96 18.05 18.86 18.61 5.27 4.87 4.90 
R2015 68.20 69.16 67.50 27.56 26.60 28.23 2.56 2.68 2.54 
R2017 87.09 86.65 86.65 12.05 12.44 12.45 7.38 7.14 7.11 
R2018 76.74 76.24 76.56 20.69 21.21 20.93 4.13 3.94 3.98 
R2019 83.36 81.21 78.02 14.45 16.50 19.65 6.05 5.32 4.92 
R2020 79.91 77.88 77.51 18.29 20.45 20.89 4.51 4.27 4.15 
Mean 75.62 74.50 73.78 21.03 22.37 23.14 4.66 4.37 4.27 
SD 8.95 7.87 8.22 7.34 6.78 7.16 1.93 1.65 1.64 
SE 2.11 1.86 1.94 1.73 1.60 1.69 0.46 0.39 0.39 
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 TABLE 19. AVERAGE HEART RATE VARIABILITY FOLLOWING THE ACCUMULATION OF PHYSICAL ACTIVITY 
TREATMENT 
  
Normalized Low Frequency 
Power (%) 
Normalized High Frequency 
Power (%) 
Low to High Frequency 
Power Ratio 
ID 10 hour 11 hour 10 hour 11 hour 10 hour 11 hour 
R2000 76.89 75.84 18.70 19.74 4.57 4.35 
R2001 84.09 83.24 13.93 14.82 6.34 6.05 
R2002 62.03 59.74 34.97 37.39 2.50 2.33 
R2003 88.06 88.11 10.86 10.86 8.90 8.84 
R2004 69.71 70.38 28.13 27.33 3.11 3.20 
R2005 40.43 41.75 47.75 46.81 0.95 1.00 
R2006 74.52 73.48 22.03 22.88 3.49 3.35 
R2007 81.76 79.13 14.65 17.40 7.28 6.73 
R2008 73.72 73.44 23.15 23.39 3.58 3.50 
R2009             
R2010 72.85 73.08 24.28 24.08 3.44 3.44 
R2011 82.50 81.23 13.54 14.74 6.55 6.18 
R2012 63.80 63.20 30.05 30.85 2.84 2.71 
R2013             
R2014 83.44 82.34 14.68 15.81 7.54 7.09 
R2015 69.08 69.03 27.31 27.44 2.63 2.60 
R2017 88.20 87.44 10.76 11.50 8.86 8.44 
R2018 76.16 75.49 21.60 22.25 3.93 3.79 
R2019 84.83 83.53 13.85 14.97 6.30 5.97 
R2020 75.92 75.35 22.76 23.35 4.67 4.47 
Mean 74.89 74.21 21.83 22.53 4.86 4.67 
SD 11.53 11.14 9.52 9.22 2.33 2.20 
SE 2.72 2.63 2.24 2.17 0.55 0.52 
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Normalized Low Frequency 
Power (%) 
Normalized High Frequency 
Power (%) 
Low to High Frequency 
Power Ratio 
ID 7 hour 7 hour 7 hour 
R2000 82.37 15.12 5.87 
R2001 80.55 17.75 4.81 
R2002 76.21 21.10 3.85 
R2003 89.83 9.01 11.07 
R2004 78.14 19.37 4.84 
R2005 43.95 43.29 1.17 
R2006 74.25 21.65 3.61 
R2007 71.23 21.22 3.78 
R2008 70.17 26.46 2.95 
R2009    
R2010 72.32 25.85 3.07 
R2011 83.53 11.80 7.71 
R2012 76.80 18.64 4.35 
R2013    
R2014 81.86 16.04 5.51 
R2015 64.37 28.89 2.30 
R2017 89.27 9.99 9.30 
R2018 86.22 11.78 7.95 
R2019 81.93 16.15 5.32 
R2020 77.32 21.02 3.84 
Mean 76.68 19.73 5.07 
SD 10.55 8.12 2.53 
SE 2.49 1.91 0.60 
TABLE 20. AVERAGE HEART RATE VARIABILITY FOLLOWING A CONTINUOUS PHYSICAL ACTIVITY 
TREATMENT 
 TABLE 21A. NORMALIZED LOW FREQUENCY POWER OF HEART RATE 
VARIABILITY FOR BASELINE AND FOLLOWING SUCCESSIVE SHORT 
SESSIONS OF EXERCISE TREATMENT 
 Normalized Low Frequency Power (%) 
ID Baseline  1st  2nd  3rd 
R2000 78.037  88.995  88.165  88.594 
R2001 82.552  84.691  86.38  87.586 
R2002 82.765  83.687  84.093  91.038 
R2003 75.153  76.92  94.401  86.913 
R2004 68.838  68.028  69.752  52.44 
R2005 74.563  69.109  61.476  47.089 
R2007 68.459  76.644  73.454  88.655 
R2008 83.197  80.589  80.161  48.063 
R2009 79.787  86.263  91.143  92.224 
R2010 80.814  53.402  78.119  79.008 
R2011 81.525  87.198  83.001  87.132 
R2012 85.073  62.215  48.283  62.852 
R2013 85.377  81.368  87.072  83.65 
R2014 90.812  88.632  88.848  88.61 
R2015 71.533  76.459  79.341  80.13 
R2016 76.844  79.782  64.463  60.132 
R2017 87.179  87.407  85.092  83.47 
R2018 81.247  93.228  89.857  93.641 
R2019 83.323  90.667  87.63  85.544 
R2020 82.188  85.96  81.431  84.842 
Mean 79.96  80.06  80.11  78.58 
SD 5.91  10.21  11.51  15.27 
SE 1.32  2.28  2.57  3.41 
 
Values of heart rate variability were average for 15-minute baseline and the last 
40 minutes of rest period following successive short sessions of exercise 
treatment.
 197
 Table 21b. NORMALIZED HIGH FREQUENCY POWER OF HEART RATE 
VARIABILITY FOR BASELINE AND FOLLOWING SUCCESSIVE SHORT 
SESSIONS OF EXERCISE TREATMENT
 Normalized High Frequency Power (%) 
ID Baseline  1st  2nd  3rd 
R2000 20.694    11.148  10.785 
R2001 15.985  14.044  12.262  11.047 
R2002 15.676  14.721  13.71  7.633 
R2003 22.601  20.861  5.196  12.02 
R2004 28.634  28.964  25.804  44.781 
R2005 20.364  24.498  30.959  43.432 
R2006        
R2007 27.135  20.274  21.755  8.365 
R2008 15.447  17.496  18.212  45.507 
R2009 16.828  11.069  7.029  6.247 
R2010 17.634  44.764  20.693  19.763 
R2011 16.342  11.566  14.429  10.883 
R2012 13.019  29.947  47.356  32.981 
R2013 13.599  17.534  12.452  14.385 
R2014 8.632  8.867  9.635  9.452 
R2015 24.037  22.01  18.963  18.269 
R2016 22.045  19.265  34.356  38.559 
R2017 11.936  11.822  14.24  15.646 
R2018 17.168  5.656  9.176  5.349 
R2019 15.077  8.392  11.375  13.516 
R2020 15.876  12.985  17.227  14.173 
Mean 17.94  18.14  17.80  19.14 
S.D. 5.06  9.31  10.29  13.68 
S.E. 1.13  2.08  2.30  3.06 
 
Values of heart rate variability were average for 15-minute baseline and the last 
40 minutes of rest period following successive short sessions of exercise 
treatment.
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 Table 21c. LOW TO HIGH FREQUENCY POWER OF HEART RATE 
VARIABILITY FOR BASELINE AND FOLLOWING SUCCESSIVE SHORT 
SESSIONS OF EXERCISE TREATMENTT
 Normalized High Frequency Power (%) 
ID Baseline  1st  2nd  3rd 
R2000 3.771  8.575  7.908  8.214 
R2001 5.164  6.03  7.045  7.929 
R2002 5.28  5.685  6.134  11.927 
R2003 3.325  3.687  18.167  7.231 
R2004 2.404  2.349  2.703  1.171 
R2005 3.662  2.821  1.986  1.084 
R2006        
R2007 2.523  3.78  3.376  10.599 
R2008 5.386  4.606  4.402  1.056 
R2009 4.741  7.793  12.968  14.764 
R2010 4.583  1.193  3.775  3.998 
R2011 4.989  7.539  5.752  8.006 
R2012 6.534  2.078  1.02  1.906 
R2013 6.278  4.641  6.992  5.815 
R2014 10.521  9.996  9.221  9.374 
R2015 2.976  3.474  4.184  4.386 
R2016 3.486  4.141  1.876  1.559 
R2017 7.304  7.394  5.976  5.335 
R2018 4.732  16.484  9.793  17.505 
R2019 5.527  10.805  7.704  6.329 
R2020 5.177  6.62  4.727  5.986 
Mean 4.92  5.98  6.29  6.71 
S.D. 1.86  3.62  4.08  4.57 
S.E. 0.42  0.81  0.91  1.02 
 
Values of heart rate variability were average for 15-minute baseline and the last 
40 minutes of rest period following successive short sessions of exercise 
treatment. 
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APPENDIX D - STATISTICAL SUMMARIES 
 
 TABLE 1. DEMOGRAPHICS OF SUBJECTS  
 
Descriptive Statistics
20 25.00 66.00 47.1500 2.92113 13.06371
20 156.00 186.70 176.3150 1.70575 7.62836
20 46.40 138.10 84.4730 4.38527 19.61152
20 19.07 40.44 26.9965 1.16848 5.22559
20 24.85 48.70 34.4763 1.63559 7.31458
20 123.00 139.70 131.8450 1.05440 4.71543
20 68.70 89.00 82.4500 1.41937 6.34761
20
Age
Ht
Wt
BMI
VO2
SBP
DBP
Valid N (listwise)
Statistic Statistic Statistic Statistic Std. Error Statistic
N Minimum Maximum Mean Std.
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Age (years), Ht = height (cm), Wt = weight (kg), BMI = body mass index (kg/m2), VO2 = peak oxygen uptake (kg/ml/min), 
SBP = screening systolic blood pressure (mm Hg), DBP = screening diastolic blood pressure (mm Hg) 
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TABLE 2. CORRELATIONS BETWEEN SYSTOLIC BLOOD PRESSURE REDUCTION AND CONFOUNDING 
VARIABLES 
 Descriptive Statistics 
  Mean Std. Deviation N 
SBP 5.3555 7.58854 20 
AGE 47.1500 13.06371 20 
BMI 26.9965 5.22559 20 
energy expenditure 342.9967 114.13919 18 
 
 Correlations 
  SBP AGE BMI energy expenditure 
SBP Pearson Correlation 1 -.215 .405 -.399 
  Sig. (2-tailed)   .362 .077 .101 
  N 20 20 20 18 
AGE Pearson Correlation -.215 1 -.592(**) -.263 
  Sig. (2-tailed) .362   .006 .292 
  N 20 20 20 18 
BMI Pearson Correlation .405 -.592(**) 1 .396 
  Sig. (2-tailed) .077 .006   .104 
  N 20 20 20 18 
energy 
expenditure 
Pearson Correlation -.399 -.263 .396 1 
  Sig. (2-tailed) .101 .292 .104   
  N 18 18 18 18 
 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
SBP = systolic blood pressure reduction (mm Hg), age (years), BMI = body mass index (kg/m2), energy expenditure (kcal)
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Table 3. MAGNITUDE OF BLOOD PRESSURE REDUCTION
 
 Paired Samples Statistics 
  Mean N Std. Deviation 
Std. Error 
Mean 
11 hr SBP 132.3070 20 8.32604 1.86176 Pair 1 
11 hr SBP 126.9525 20 9.72810 2.17527 
7hr SBP 134.1485 20 8.97254 2.00632 Pair 2 
7hr SBP 128.5670 20 7.88483 1.76310 
10 hr DBP 80.9045 20 8.30844 1.85782 Pair 3 
10hr DBP 77.5480 20 8.30038 1.85602 
7hr DBP 81.8835 20 8.35694 1.86867 Pair 4 
7hr DBP 78.8055 20 7.42662 1.66064 
 
SBP = systolic blood pressure (mm Hg), DBP = diastolic blood pressure (mm Hg) 
Pair 1 = 11-hour mean systolic blood pressures from a control and the 
accumulation of short bouts of exercise treatments 
Pair 2 = 7-hour mean systolic blood pressures from a control and a long bout of 
exercise treatments 
Pair 3 = 10-hour mean diastolic blood pressures from a control and the 
accumulation of short bouts of exercise treatments 
Pair 4 = 7-hour mean diastolic blood pressures from a control and a long bout of 
exercise treatments 
 TABLE 3. (CONTINUED) MAGNITUDE OF BLOOD PRESSURE REDUCTION 
 
Paired Samples Test 
Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 
1 
11 hr SBP - 11 hr 
SBP 5.35450 7.59062 1.69731 1.80198 8.90702 3.155 19 .005 
Pair 
2 
7hr SBP - 7hr 
SBP 5.58150 6.99658 1.56448 2.30700 8.85600 3.568 19 .002 
Pair 
3 
10 hr DBP - 10hr 
DBP 3.35650 6.00063 1.34178 .54812 6.16488 2.502 19 .022 
Pair 
4 
7hr DBP - 7hr 
DBP 3.07800 5.44185 1.21683 .53114 5.62486 2.530 19 .020 
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SBP = systolic blood pressure (mm Hg), DBP = diastolic blood pressure (mm Hg) 
Pair 1 = 11-hour mean systolic blood pressures from a control and the accumulation of short bouts of exercise treatments 
Pair 2 = 7-hour mean systolic blood pressures from a control and a long bout of exercise treatments 
Pair 3 = 10-hour mean diastolic blood pressures from a control and the accumulation of short bouts of exercise treatments 
Pair 4 = 7-hour mean diastolic blood pressures from a control and a long bout of exercise treatments 
 
TABLE 4. AREAS OF BLOOD PRESSURE REDUCTION  
Paired Samples Statistics 
  Mean N 
Std. 
Deviation 
Std. Error 
Mean 
SBP area - 11hr 79.9090 20 112.35628 25.12363 Pair 1 
SBP area - 7hr 32.8340 20 50.71918 11.34115 
DBP area - 
10hr 38.6295 20 61.96703 13.85625 
Pair 2 
DBP area - 7hr 19.0005 20 36.75081 8.21773 
 
 Paired Samples Test 
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Paired Differences 
95% Confidence 
Interval of the 
Difference 
  Mean 
Std. 
Deviation 
Std. 
Error 
Mean Lower Upper t df 
Sig. (2-
tailed) 
Pair 
1 
SBP area - 
11hr - SBP 
area - 7hr 
47.0750
0 98.23932 
21.9669
8 1.09758 
93.0524
2 2.143 19 .045 
Pair 
2 
DBP area - 
10hr - DBP 
area - 7hr 
19.6290
0 51.55373 
11.5277
7 -4.49889
43.7568
9 1.703 19 .105 
 
SBP area = area of systolic blood pressure reduction (mm Hg•hr), DBP area = area of diastolic blood pressure reduction 
(mm Hg•hr)
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TABLE 5. AMBULATORY BLOOD PRESSURE MONITORING  
 
 
 
 Within-Subjects Factors 
 
Measure: MEASURE_1  
 
Factor1 Dependent Variable 
1 Control 
2 Accumulation 
3 Long 
 
  
 
 
 
 Descriptive Statistics 
 
  Mean Std. Deviation N 
Control 93.8300 7.04722 20 
Accumulation 92.1300 10.48071 20 
Long 91.5350 8.05705 20 
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TABLE 5. (CONTINUED) AMBULATORY BLOOD PRESSURE MONITORING 
 
 Tests of Within-Subjects Effects 
 
Measure: MEASURE_1  
Source   
Type III Sum 
of Squares df Mean Square F Sig. 
factor1 Sphericity Assumed 56.740 2 28.370 .903 .414 
  Greenhouse-Geisser 56.740 1.605 35.348 .903 .396 
  Huynh-Feldt 56.740 1.731 32.786 .903 .402 
  Lower-bound 56.740 1.000 56.740 .903 .354 
Error(factor1) Sphericity Assumed 1193.906 38 31.419     
  Greenhouse-Geisser 1193.906 30.498 39.146     
  Huynh-Feldt 1193.906 32.882 36.309     
  Lower-bound 1193.906 19.000 62.837     
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TABLE 6. ENERGY EXPENDITURE 
 
 
 
 Within-Subjects Factors 
 
Measure: MEASURE_1  
 
factor1 Dependent Variable 
1 Control 
2 Accumulation 
3 Long 
 
 
 
  
 
 Descriptive Statistics 
 
  Mean 
Std. 
Deviation N 
kcal 351.1476 158.08324 17 
kcal 348.5127 134.52595 17 
kcal 335.1320 149.57411 17 
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TABLE 6. (CONTINUED) ENERGY EXPENDITURE 
 
 
 
 Tests of Within-Subjects Effects 
 
Measure: MEASURE_1  
Source   
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Partial 
Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power(a) 
factor1 Sphericity 
Assumed 2507.407 2 1253.704 .104 .902 .006 .208 .065 
  Greenhouse-
Geisser 2507.407 1.915 1309.688 .104 .894 .006 .199 .064 
  Huynh-Feldt 2507.407 2.000 1253.704 .104 .902 .006 .208 .065 
  Lower-bound 2507.407 1.000 2507.407 .104 .751 .006 .104 .061 
Error 
(factor1) 
Sphericity 
Assumed 386376.679 32 12074.271           
  Greenhouse-
Geisser 386376.679 30.632 12613.454           
  Huynh-Feldt 386376.679 32.000 12074.271           
  Lower-bound 386376.679 16.000 24148.542           
 
a  Computed using alpha = .05 
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TABLE 7. ASSOCIATION BETWEEN CHANGES IN SYMPATHETIC 
MODULATION AND BLOOD PRESSURE REDUCTION 
 
Correlation between systolic blood pressure reduction and changes in 
sympathetic modulation for the accumulation of short bouts of exercise treatment 
 
 Descriptive Statistics 
  Mean Std. Deviation N 
accumulation-SBP 5.3472 7.86441 18 
LF-accum -.4367 7.70056 18 
HF-accum .6083 6.22529 18 
ratio-accum -.4017 1.41884 18 
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Accumulation-SBP = systolic blood pressure reduction (mm Hg) following the accumulation of short bouts of exercise, LF-
accum = changes in normalized low frequency power (%) following the accumulation of short bouts of exercise, HF-accum 
= changes in normalized high frequency power (%) following the accumulation of short bouts of exercise, ratio-accum = 
changes in ratio of low to high frequency power (%) following the accumulation of short bouts of exercise 
TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN SYMPATHETIC MODULATION AND BLOOD 
PRESSURE REDUCTION 
 Correlations 
  accumulation-SBP LF-accum HF-accum ratio-accum 
accumulation-SBP Pearson Correlation 1 .517(*) -.503(*) .381 
  Sig. (2-tailed)   .028 .033 .119 
  N 18 18 18 18 
LF-accum Pearson Correlation .517(*) 1 -.981(**) .739(**) 
  Sig. (2-tailed) .028   .000 .000 
  N 18 18 18 18 
HF-accum Pearson Correlation -.503(*) -.981(**) 1 -.734(**) 
  Sig. (2-tailed) .033 .000   .001 
  N 18 18 18 18 
ratio-accum Pearson Correlation .381 .739(**) -.734(**) 1 
  Sig. (2-tailed) .119 .000 .001   
  N 18 18 18 18 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
*  Correlation is significant at the 0.05 level (2-tailed). 
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TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN 
SYMPATHETIC MODULATION AND BLOOD PRESSURE REDUCTION 
 
Correlation between diastolic blood pressure reduction and changes in 
sympathetic modulation for the accumulation of short bouts of exercise treatment 
 
 Descriptive Statistics 
  Mean Std. Deviation N 
Accumulation-DBP 3.4056 6.08170 18 
LF-DBP-10hr accum -.3911 8.74618 18 
HF-DBP .5383 6.99793 18 
ratio-DBP -.4867 1.59268 18 
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TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN SYMPATHETIC MODULATION AND BLOOD 
PRESSURE REDUCTION 
 Correlations 
  Accumulation-DBP LF-DBP-10hr accum HF-DBP ratio-DBP 
Accumulation-DBP Pearson Correlation 1 .745(**) -.738(**) .756(**) 
  Sig. (2-tailed)   .000 .000 .000 
  N 18 18 18 18 
LF-DBP-10hr accum Pearson Correlation .745(**) 1 -.983(**) .754(**) 
  Sig. (2-tailed) .000   .000 .000 
  N 18 18 18 18 
HF-DBP Pearson Correlation -.738(**) -.983(**) 1 -.763(**) 
  Sig. (2-tailed) .000 .000   .000 
  N 18 18 18 18 
ratio-DBP Pearson Correlation .756(**) .754(**) -.763(**) 1 
  Sig. (2-tailed) .000 .000 .000   
  N 18 18 18 18 
Accumulation-DBP = diastolic blood pressure reduction (mm Hg) following the accumulation of short bouts of exercise, 
LF-DBP-10hr accum = changes in normalized low frequency power (%) following the accumulation of short bouts of 
exercise, HF-DBP = changes in normalized high frequency power (%) following the accumulation of short bouts of 
exercise, ratio-DBP = changes in ratio of low to high frequency power (%) following the accumulation of short bouts of 
exercise
 
**  Correlation is significant at the 0.01 level (2-tailed). 
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TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN 
SYMPATHETIC MODULATION AND BLOOD PRESSURE REDUCTION 
 
Correlation between systolic blood pressure reduction and changes in 
sympathetic modulation for a long bout of exercise treatment 
 
 Descriptive Statistics 
  Mean Std. Deviation N 
Long-SBP 5.9756 7.28566 18 
LF-long -1.0617 10.35496 18 
HF-long 1.3050 7.98753 18 
ratio-long -.4083 1.98504 18 
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Long-SBP = systolic blood pressure reduction (mm Hg) following a long bout of exercise, LF-long = changes in 
normalized low frequency power (%) following a long bout of exercise, HF-long = changes in normalized high frequency 
power (%) following a long bout of exercise, ratio-long = changes in ratio of low to high frequency power (%) following a 
long bout of exercise 
TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN SYMPATHETIC MODULATION AND BLOOD 
PRESSURE REDUCTION 
 Correlations 
  Long-SBP LF-long HF-long ratio-long 
Pearson Correlation 1 .374 -.303 .236 
Sig. (2-tailed)   .126 .222 .345 
Long-SBP 
N 18 18 18 18 
Pearson Correlation .374 1 -.989(**) .759(**) 
Sig. (2-tailed) .126   .000 .000 
LF-long 
N 18 18 18 18 
Pearson Correlation -.303 -.989(**) 1 -.793(**) 
Sig. (2-tailed) .222 .000   .000 
HF-long 
N 18 18 18 18 
Pearson Correlation .236 .759(**) -.793(**) 1 
Sig. (2-tailed) .345 .000 .000   
ratio-long 
N 18 18 18 18 
 
**  Correlation is significant at the 0.01 level (2-tailed). 
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TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN 
SYMPATHETIC MODULATION AND BLOOD PRESSURE REDUCTION 
 
Correlation between diastolic blood pressure reduction and changes in 
sympathetic modulation for a long bout of exercise treatment 
 
  Descriptive Statistics 
 
  Mean Std. Deviation N 
Long-DBP 3.3078 5.64307 18 
LF-long -1.0617 10.35496 18 
HF-long 1.3050 7.98753 18 
ratio-long -.4083 1.98504 18 
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Long-DBP = diastolic blood pressure reduction (mm Hg) following a long bout of exercise, LF-long = changes in 
normalized low frequency power (%) following a long bout of exercise, HF-long = changes in normalized high frequency 
power (%) following a long bout of exercise, ratio-long = changes in ratio of low to high frequency power (%) following a 
long bout of exercise 
TABLE 7. (CONTINUED) ASSOCIATION BETWEEN CHANGES IN SYMPATHETIC MODULATION AND BLOOD 
PRESSURE REDUCTION 
 Correlations 
  Long-DBP LF-long HF-long ratio-long 
Pearson Correlation 1 .382 -.371 .543(*) 
Sig. (2-tailed)   .118 .130 .020 
Long-DBP 
N 18 18 18 18 
Pearson Correlation .382 1 -.989(**) .759(**) 
Sig. (2-tailed) .118   .000 .000 
LF-long 
N 18 18 18 18 
Pearson Correlation -.371 -.989(**) 1 -.793(**) 
Sig. (2-tailed) .130 .000   .000 
HF-long 
N 18 18 18 18 
Pearson Correlation .543(*) .759(**) -.793(**) 1 
Sig. (2-tailed) .020 .000 .000   
ratio-long 
N 18 18 18 18 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
*  Correlation is significant at the 0.05 level (2-tailed). 
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TABLE 8. BLOOD PRESSURE FOLLOWING SUCCESSIVE SHORT 
SESSIONS OF EXERCISE TREATMENT 
 
Systolic blood pressure 
 
 
 Within-Subjects Factors 
 
Measure: MEASURE_1  
factor1 Dependent Variable 
1 baseline 
2 first 
3 second 
4 third 
 
 
 
 Descriptive Statistics 
 
  Mean Std. Deviation N 
baseline 126.5787 10.55943 20 
first 124.8961 10.82745 20 
second 123.8289 10.48500 20 
third 122.8502 10.28020 20 
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TABLE 8. (CONTINUED) BLOOD PRESSURE FOLLOWING SUCCESSIVE SHORT SESSIONS OF EXERCISE 
TREATMENT 
Systolic blood pressure 
Tests of Within-Subjects Effects
Measure: MEASURE_1
179.762 3 59.921 2.979 .039 .136 8.936 .675
179.762 2.352 76.426 2.979 .053 .136 7.006 .595
179.762 2.706 66.441 2.979 .045 .136 8.059 .640
179.762 1.000 179.762 2.979 .101 .136 2.979 .374
1146.618 57 20.116
1146.618 44.690 25.657
1146.618 51.406 22.305
1146.618 19.000 60.348
Sphericity Assume
Greenhouse-Geiss
Huynh-Feldt
Lower-bound
Sphericity Assume
Greenhouse-Geiss
Huynh-Feldt
Lower-bound
Source
factor1
Error(factor1
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Powera
Computed using alpha = .05a. 
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TABLE 8. (CONTINUED) BLOOD PRESSURE FOLLOWING SUCCESSIVE 
SHORT SESSIONS OF EXERCISE TREATMENT 
 
Diastolic blood pressure 
 
 
 Within-Subjects Factors 
 
Measure: MEASURE_1  
factor1 Dependent Variable 
1 baselineDBP 
2 firstDBP 
3 secondDBP 
4 thirdDBP 
 
 
 
 Descriptive Statistics 
 
  Mean Std. Deviation N 
DBP-15 min 80.9545 8.42645 20 
firstDBP 81.1885 10.76894 20 
secondDBP 82.2915 8.38196 20 
thirdDBP 81.6255 7.78639 20 
 
 
 
 
 TABLE 8. (CONTINUED) BLOOD PRESSURE FOLLOWING SUCCESSIVE SHORT SESSIONS OF EXERCISE 
TREATMENT 
 
Diastolic blood pressure 
Tests of Within-Subjects Effects
Measure: MEASURE_1
20.718 3 6.906 .580 .630 .030 1.741 .163
20.718 2.123 9.759 .580 .574 .030 1.232 .142
20.718 2.397 8.643 .580 .594 .030 1.391 .149
20.718 1.000 20.718 .580 .456 .030 .580 .112
678.502 57 11.904
678.502 40.336 16.821
678.502 45.548 14.896
678.502 19.000 35.711
Sphericity Assumed
Greenhouse-Geisse
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisse
Huynh-Feldt
Lower-bound
Source
factor1
Error(factor1
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Powera
Computed using alpha = .05a. 
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 TABLE 9. HEART RATE VARIABILITY FOLLOWING SUCCESSIVE SHORT SESSIONS OF EXERCISE TREATMENT 
Normalized low frequency power (%) 
 
 Descriptive Statistics 
  Mean Std. Deviation N 
LF0 79.9633 5.91251 20 
LF1 80.0622 10.21451 20 
LF2 80.1081 11.51311 20 
LF3 78.5807 15.26631 20 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
32.363 3 10.788 .160 .923 .008 .479 .078
32.363 2.319 13.958 .160 .881 .008 .370 .075
32.363 2.660 12.167 .160 .905 .008 .425 .076
32.363 1.000 32.363 .160 .694 .008 .160 .067
3851.746 57 67.574
3851.746 44.053 87.435
3851.746 50.538 76.214
3851.746 19.000 202.723
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
factor1
Error(factor1)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Powera
Computed using alpha = .05a. 
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LF = normalized low frequency power (%), 0 = baseline, 1= rest period following the 1st short session of exercise, 2 = rest 
period following the 2nd short session of exercise, 3 = rest period following the 3rd session of exercise 
 
 TABLE 9. (CONTINUED) BLOOD PRESSURE FOLLOWING SUCCESSIVE SHORT SESSIONS OF EXERCISE 
TREATMENT 
Normalized high frequency power (%) 
 
 Descriptive Statistics 
  Mean Std. Deviation N 
HF0 17.9365 5.05739 20 
HF1 17.7557 9.22561 20 
HF2 17.7989 10.29109 20 
HF3 19.1397 13.68188 20 
 
Tests of Within-Subjects Effects
Measure: MEASURE_1
26.071 3 8.690 .153 .927 .008 .459 .077
26.071 2.384 10.936 .153 .891 .008 .365 .074
26.071 2.749 9.484 .153 .914 .008 .421 .075
26.071 1.000 26.071 .153 .700 .008 .153 .066
3234.420 57 56.744
3234.420 45.294 71.409
3234.420 52.231 61.925
3234.420 19.000 170.233
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
factor1
Error(factor1)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Powera
Computed using alpha = .05a. 
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HF = normalized high frequency power (%), 0 = baseline, 1= rest period following the 1st short session of exercise, 2 = 
rest period following the 2nd short session of exercise, 3 = rest period following the 3rd session of exercise 
 
 TABLE 9. (CONTINUED) BLOOD PRESSURE FOLLOWING SUCCESSIVE SHORT SESSIONS OF EXERCISE 
TREATMENT 
Ratio of low to high frequency power 
 
 Descriptive Statistics 
 
  Mean Std. Deviation N 
ratio0 4.9182 1.86221 20 
ratio1 5.9845 3.62330 20 
ratio2 6.2855 4.08153 20 
ratio3 6.7087 4.56857 20 
  
Tests of Within-Subjects Effects
Measure: MEASURE_1
35.034 3 11.678 1.477 .230 .072 4.431 .370
35.034 2.544 13.772 1.477 .236 .072 3.757 .337
35.034 2.970 11.795 1.477 .231 .072 4.387 .368
35.034 1.000 35.034 1.477 .239 .072 1.477 .211
450.670 57 7.906
450.670 48.334 9.324
450.670 56.434 7.986
450.670 19.000 23.719
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Sphericity Assumed
Greenhouse-Geisser
Huynh-Feldt
Lower-bound
Source
factor1
Error(factor1)
Type III Sum
of Squares df Mean Square F Sig.
Partial Eta
Squared
Noncent.
Parameter
Observed
Power a
Computed using alpha = .05a. 
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ratio = ratio of low to high frequency power, 0 = baseline, 1= rest period following the 1st short session of exercise, 2 = 
rest period following the 2nd short session of exercise, 3 = rest period following the 3rd session of exercise 
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TABLE 10. CORRELATION BETWEEN SYSTOLIC BLOOD PRESSURE REDUCTION DURING THE REST PERIOD 
FOLLOWING SHORT SESSIONS AND SYSTOLIC BLOOD PRESSURE REDUCTION FOLLOWING THE 
ACCUMULATION OF SHORT BOUTS OF EXERCISE  
 
 Descriptive Statistics 
  Mean Std. Deviation N 
accumulation reduction 5.3555 7.58854 20 
ave reduction 3.2810 5.60654 20 
 
 Correlations 
  
accumulation 
reduction ave reduction 
Pearson Correlation 1 .135 
Sig. (2-tailed)   .581 
accumulation reduction 
N 20 19 
Pearson Correlation .135 1 
Sig. (2-tailed) .581   
ave reduction 
N 19 20 
 
 
Accumulation reduction = average systolic blood pressure reduction following the accumulation of short bouts of exercise 
(mm Hg), ave reduction = average systolic blood pressure reduction during rest periods following three short sessions
  
 
 
 
APPENDIX E - REVIEW AND APPROVAL OF RESEARCH PROJECT 
UTILIZING HUMAN SUBJECTS 
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 NOTICE OF APPROVAL  – FULL COMMITTEE REVIEW 
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 DOCUMENTATION OF REVIEW AND APPROVAL 
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 BLOOMINGTON CAMPUS COMMITTEE for the PROTECTION OF HUMAN SUBJECTS 
 
EXPEDITED/FULL REVIEW CHECKLIST 
DIRECTIONS: This form is to be completed and submitted to the Committee 
when the investigator plans a research project which, in the investigator's 
judgment, requires expedited or full Committee review.  Items 1-7 are the 
categories which may qualify for expedited review.  If "yes" is the response to 
any of items 10-13, the study will most likely require full Committee review.   
 
STUDIES INVOLVING minors, pregnant women, fetuses, prisoners, persons with 
mental disabilities and economically or educationally disadvantaged persons 
MAY, IN THE DISCRETION OF THE CHAIR, REQUIRE FULL COMMITTEE 
REVIEW. 
 
APPLICABILITY: 
 
(A) Research activities that (1) present no more than minimal risk to human 
subjects, and (2) involve ONLY procedures listed in one or more of the following 
categories, may be reviewed by HSC through the expedited review procedures 
authorized by 45 CFR 46.110 and 21 CFR 56.110.  The activities listed should 
not be deemed to be of minimal risk simply because they are included on this list.  
Inclusion on this list merely means that the activity is eligible for review through 
the expedited review procedures when the specific circumstances of the 
proposed research involve no more than minimal risk to human subjects. 
 
(B) The categories in this list apply regardless of the age of subjects, except as 
noted. 
 
(C) The expedited review procedure may not be used where identification of the 
subjects and/or their responses would reasonably place them at risk of criminal 
or civil liability or be damaging to the subjects’ financial standing, employability, 
insurability, reputation, or be stigmatizing, unless reasonable and appropriate 
protections will be implemented so that risks related to invasion of privacy and 
breach of confidentiality are no greater than minimal. 
 
(D) The expedited review procedure may not be used for classified research 
involving human subjects. 
 
(E) The standard requirements for informed consent (or its waiver, alteration, or 
exception) apply regardless of the type of review. 
 
CIRCLE THE APPROPRIATE CATEGORY NUMBERS THAT APPLY TO 
YOUR RESEARCH PROJECT AND UNDERLINE, OR HIGHLIGHT, THE 
SPECIFIC SECTION WITHIN EACH CATEGORY. 
 
1. Clinical studies of drugs and medical devices only when condition (a) OR 
(b) is met. 
 
(a) Research on drugs for which an investigational new drug application 
(21 CFR Part 312) is not required.  (Note: Research on marketed drugs 
that significantly increases the risks or decreases the acceptability of the 
risks associated with the use of the product is not eligible for expedited 
review.) 
 
(b) Research on medical devices for which (i) an investigational device 
exemption application (21 CFR Part 812) is not required; or (ii) the 
medical device is cleared/approved for marketing and the medical device 
is being used in accordance with its cleared/approved labeling. 
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2. Collection of blood samples by finger stick, heel stick, ear stick, or 
venipuncture as follows: 
 
(a) from healthy, nonpregnant adults who weigh at least 110 pounds.  
For these subjects, the amounts drawn may not exceed 550ml in an 8 
week period and collection may not occur more frequently than 2 times 
per week; OR  
 
(b) from other adults and children* considering the age, weight, and 
health of the subjects, the collection procedure, the amount of blood to 
be collected, and the frequency with which it will be collected.  For these 
subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml 
per kg in an 8 week period and collection may not occur more frequently 
than 2 times per week. 
  A 20-45ml sample of venous blood for hypertensive adults will be 
drawn by a certified technician via sterile techniques for analysis of 
cholesterol, triglycerides, glucose, and various electrolytes and enzymes.  
This blood draw will take place at the Indiana University Health Center.  
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EXPEDITED/FULL REVIEW CHECKLIST continued 
 
                           
3. Prospective collection of biological specimens for research purposes by 
noninvasive means. 
 
Examples of biological specimens: (a) Hair and nail clippings in a 
nondisfiguring manner; (b) deciduous teeth at time of exfoliation or it 
routine patient care indicates a need for extraction; (c) permanent teeth if 
routine patient care indicates a need for extraction; (d) excreta and 
external secretions (including sweat); (e) uncannulated (not by a tube 
inserted into the mouth) saliva collected either in an unstimulated fashion 
or stimulated by chewing gumbase or wax or by applying a dilute citric 
solution to the tongue; (f) placenta removed at delivery; (g) amniotic fluid 
obtained at the time of rupture of the membrane prior to or during labor; 
(h) supra- and subgingival dental plaque and calculus, provided the 
collection procedure is not more invasive than routine prophylactic 
scaling of the teeth and the process is accomplished in accordance with 
accepted prophylactic techniques; (i) mucosal and skin cells collected by 
buccal scraping or swab, skin swab, or mouth washings; (j) sputum 
collected after saline mist nebulization. 
 
4. Collection of data through noninvasive procedures (not involving general 
anesthesia or sedation) routinely employed in clinical practice, excluding 
procedures involving x-rays or microwaves.  Where medical devices are 
employed, they must be cleared/approved for marketing.  (Studies 
intended to evaluate the safety and effectiveness of the medical device 
are not generally eligible for expedited review, including studies of 
cleared medical devices for new indications.) 
 
Examples of procedures: (a) Physical sensors that are applied either to 
the surface of the body or at a distance and do not involve input of 
significant amounts of energy into the subject or an invasion of the 
subject’s privacy; (b) weighing or testing sensory acuity; (c) magnetic 
resonance imaging; (d) electrocardiography, electroencephalography, 
thermography, detection of naturally occurring radioactivity, 
electroretinography, ultrasound, diagnostic infrared imaging, doppler 
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 blood flow, and echocardiography; (e) moderate exercise, muscular 
strength testing, body composition assessment, and flexibility testing 
where appropriate given the age, weight, and health of the individual. 
 
5. Research involving materials (data, documents, records, or specimens) 
that have been collected or will be collected solely for nonresearch 
purposes (such as medical treatment or diagnosis).  (Note: Some 
research in this category may be exempt from the HHS regulations for 
the protection of human subjects.  45 CFR 46.101(b)(4).  This listing 
refers only to research that is not exempt.) 
 
6. Collection of data from voice, video, digital, or image recordings made for 
research purposes. 
 
7. Research on individual or group characteristics or behavior (including, 
but not limited to, research on perception, cognition, motivation, identity, 
language, communication, cultural beliefs or practices, and social 
behavior) or research employing survey, interview, oral history, focus 
group, program evaluation, human factors evaluation, or quality 
assurance methodologies.  (Note: Some research in this category may 
be exempt from the HHS regulations for the protection of human subjects 
45 CFR 46.101 (b)(3).  This listing refers only to research that is not 
exempt.) 
 
8. Use of minors under age 18, or economically or educationally 
disadvantaged persons. 
 
9. Use of deception.  (See item 14 on page 11.) 
 
10. Use of prisoners, pregnant women, fetuses, the seriously ill, or 
persons with mental disabilities, or incompetent individuals. 
 
11. Collection of information or recording of behavior which, if known outside of the 
research, could reasonably place the subject at risk of civil or criminal liability or 
damage the subject’s financial standing, employability, insurability, reputation, or 
be stigmatizing. 
 
12. Collection of information regarding sensitive aspects of the 
subject's behavior such as: drug and alcohol use, illegal conduct, 
or sexual behavior. 
 
13. This project includes procedures that present more than minimal 
risk to the subject. 
 
14. This project includes procedures not listed above. 
 
* Children are defined in the HHS regulations as “persons who have not attained 
the legal age for consent to treatments or procedures involved in the research, 
under the applicable law of the jurisdiction in which the research will be 
conducted.”  45 CFR 46.402(a). 
2/00;www;msw   
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 BLOOMINGTON CAMPUS COMMITTEE for the PROTECTION OF HUMAN SUBJECTS 
 
SUMMARY SAFEGUARD STATEMENT                           
Project Title (if you wish to use a different title in the consent statement than is 
listed on page 3, explain here): 
 
Accumulation of three short bouts of brisk walking on blood pressure reduction in 
hypertension 
 
 
IF ADDITIONAL SPACE FOR RESPONSES IS DESIRED, THIS DOCUMENT 
MAY BE 
RETYPED ONTO PLAIN PAPER MAINTAINING THE IDENTICAL ORDER AND 
EXACT 
QUESTION WORDING WHILE ADDING EXTRA SPACE WHERE NEEDED. 
 
 Do not type on the reverse side of any form.   
Use type size no smaller than ARIAL 11 or TIMES NEW ROMAN 12 point. 
 
 
A. Briefly describe, in lay terms, the general nature and purpose of the 
proposed research, and where the study will take place.  If student 
research, indicate whether for a course, thesis, dissertation, or 
independent research.  If the study is only for a course, please review the 
Student Research Policy to ascertain if this project requires HSC review. 
 
 More than 50 millions of Americans have high blood pressure.  Exercise is one 
of the most promising lifestyle modifications for treatment of high blood pressure.  
A single exercise treatment significantly decreases 5-8 mmHg of systolic blood 
pressure for 11 to 13 hours and 6-8mmHg of diastolic blood pressure for 4 to 9 
hours.  However, trends toward participation of exercise appear to be stabilizing 
or reversing.  One of the primary barriers to exercise is the lack of time and 
amount of time consumed at exercise.  For many individuals short bouts of 
exercise may fit better into a busy schedule than a single long bout of exercise.  
Accumulating short bouts of exercise has been found to improve fitness.  Thus, 
accumulating exercise in daily life has been widely recommended by Surgeon 
General, American Heart Association, and American College of Sports and 
Medicine to improve fitness or decrease the risk of heart disease.  Accumulating 
short bouts of exercise is also recommended as a treatment for high blood 
pressure.  However, there is no study to support the effects of accumulating 
exercise as a treatment for high blood pressure.      
  
The purpose of the study is (1) to describe the magnitude and duration of 
blood pressure reduction following each successive short bout (15 minutes) of 
brisk walking, (2) to compare the magnitude and duration of the blood pressure 
reduction following the accumulation of short bouts of brisk walking to the 
magnitude and duration of the blood pressure reduction following a single long 
bout of brisk walking, (3) to investigate the possible mechanism (sympathetic 
modulation analyzed by ambulatory electrocardiogram, EKG monitor) of the 
blood pressure reduction following each successive short bouts of brisk walking, 
and (4) to compare the possible mechanism of the blood pressure reduction 
following the accumulation of short bouts of brisk walking to the possible 
mechanism of the blood pressure reductions following a single long bout of brisk 
walking in hypertensive adults.  It is hypothesized that the blood pressure 
reduction following the accumulation of three short bouts of brisk walking will be 
more effective than a single long bout of brisk walking in hypertension.  It is also 
hypothesized that the possible mechanism of blood pressure reduction following 
exercise will be changes in the nervous control of blood pressure regulation (or 
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 changes in the sympathetic modulation using heart rate variability measured by 
ambulatory EKG monitor).   
 
This study will be conducted in the Clinical Exercise Physiology of the 
Human Performance Laboratories in the Department of Kinesiology, School of 
HPER.   
  
This study is student research for doctoral dissertation.   
 
B. Describe the process by which subjects will be recruited (see item F on 
page 2), how many (or estimate) subjects will be involved in the research, 
and how much time will be required of them.  List specific eligibility 
requirements for subjects (or describe screening procedures), including 
those criteria that would exclude otherwise acceptable subjects.  If your 
study uses only male or female subjects, explain why.  For NIH-funded 
research only, address the inclusion of women, minorities and children in 
the research.  Disclose any relationship between researcher and subjects - 
such as, teacher/student; superintendent/principal/teacher; 
employer/employee (see Students as Subjects section in the Policy 
Manual). 
 
 
 The recruitment process will start with letters to local physicians (attached).  
These letters will inform the primary physicians of the study, define their roles, 
and ask for assistance in recruiting subjects.  Public service announcements 
(attached) on local radio stations and press releases in the local newspaper will 
serve as additional means for subject recruitment.  Information will be given at 
local health fairs and some subjects will be recruited from the Indiana University 
Adult Fitness Program.   
 
Approximately 18 hypertensive adults will be involved in this study.   
 
 The total required time for each subject will be 7-8 hours over 21 to 30 day 
period. 
(1) Blood pressure screening (15 minutes) 
(2) First day of laboratory testing (1-1.5 hours)  
a. Resting blood pressure measurements 
b. Resting 12-lead electrocardiogram (EKG) 
c. Pulmonary function tests (for smokers only)  
d. Fasting venous blood draw at IU Health Center 
(3) Second day of laboratory testing (2 hours)   
a. Resting blood pressure measurements 
b. Second resting 12-lead EKG 
c. Maximal graded exercise test 
(4) 24-hour ambulatory blood pressure and EKG monitoring trials (3 
hours) 
a. On a day following three short bouts (15 minutes) of exercise  
b. On a day following a long bout (45 minutes) of exercise  
c. On a day of the control without exercise (20 minutes)   
 
 Subjects will be hypertensive adults (18 years or older).  Hypertensive adults 
will be defined by one of the following: 1) having had a previous diagnosis of 
hypertension by a primary physician; 2) having a mean systolic blood pressure ≥140 mmHg and/or a mean diastolic blood pressure ≥90 mmHg taken from at 
least two readings on two separate days, three days apart, or 3) exhibiting a 
mean daytime ambulatory blood pressure of ≥135/85 mmHg.  Subject exclusion 
will include 1) significant cardiovascular disease, 2) significant dysrhythmia, 3) 
brachial artery bruits, 4) cardiac or renal transplant patients, 5) treatment with 
antihypertnesive medications, and 6) sleep apnea.  A physician clearance by the 
subject’s primary physician will be required for every subject prior to participation 
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 in the study (form attached).  Hypertensive subjects who are taking 
antihypertensive medications will be taken off medications with approval of their 
primary physician.  Blood pressure screening for subjects going off anti-
hypertensive medications will be continued on a daily basis for the first week of 
withdrawal to every other day thereafter.  Subjects will be referred back to their 
primary physician to resume medications and withdraw from the study if the 
screening blood pressures exceed the criterion blood pressure measurement (>3 
days in a row) determined by the primary physician.     
   
The relationship between subjects and investigators is researcher-subject.   
 
C. Check appropriate box for type of vulnerable subject population involved 
when investigation specifically studies: N/A 
[_] minors (under age 18), [_] fetuses, [_] pregnant women, [_] persons 
with mental disabilities, 
[_] prisoners, [_] persons with physical disabilities, [_] economically or 
educationally disadvantaged, 
[_] other vulnerable population. 
 
If any of the above are used, state the necessity for doing so.  Please 
indicate the approximate age range of the minors to be involved. 
 
 
 
D. List all procedures to be used on human subjects or describe what subjects  
will do.  If done during regular class time, explain what non-participants will 
do.  If you are taping, explain that here (see item 13 on page 11).  Asterisk 
those you consider experimental.  For those asterisked procedures, 
describe the usual method(s), if any, that were considered and why they 
were not used.  (See item F on page 2 for more information.) 
 
Subjects will be asked to complete a blood pressure screening following 
by two sets of laboratory testing.  Because this study is a within-subjects design, 
each subject will experience all three of 24-hour ambulatory blood pressure and 
EKG monitoring trials; one on a control day without exercise, and two on days 
with exercise (three short bouts (15 minutes) of brisk walking and a long bout (45 
minutes) of brisk walking).   
 
Procedures include  
1) Blood pressure screening 
Subject will be seated at least 5 minutes in a chair with his/her back 
supported and arms bared and supported heart level prior to a blood pressure 
screening.  A blood pressure screening will consist of three blood pressure 
measurements on two separate days, at least three days apart (a total of six 
measurements).  On the first day of screening, blood pressure will be taken on 
both arms.  The arm with the higher blood pressure will be used for the screening 
on the second day and for the calculation of the average of the six screening 
pressures. 
Blood pressure screening for subjects going off anti-hypertensive 
medications will be continued on a daily basis for the first week of withdrawal to 
every other day thereafter.  Subjects will be referred back to their primary 
physician to resume medications and withdraw from the study if the screening 
blood pressures exceed the criterion blood pressure measurement (>3 days in a 
row) determined by the primary physician.     
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 2) First day of laboratory testing:  
a. Resting 12-lead EKG 
  Subject will lie on a cot and have electrodes attached to his/her 
arms, legs, and chest to observe the electrical activity of the heart.  
Subject will also be asked to breathe deeply for 20 seconds to observe 
how deep breathing affects his/her EKG. 
b. Pulmonary function tests (for smokers only)  
Subject will breathe in and out as hard and fast as he/she can with 
room air through hoses attached to the computer to determine the 
capacity of his/her lung.  This will be done for smokers to assure that lung 
function will not limit the ability to do exercise. 
c. Fasting venous blood draw at IU Health Center 
Subject will be asked to be fasting at least for 12 hours prior to 
blood draw.  All blood sampling will take place at IU Health Center.  All 
samples will be collected by laboratory technologists certified in 
phlebotomy.  The amount of whole blood drawn is minute, 20-45 ml.  The 
efficacy of cardiovascular or hemodynamic mechanisms and arterial 
pressure are not compromised with these volumes of blood draw.   
 
 
3) Second day of laboratory testing:  
a. Second resting 12-lead EKG 
  Before a maximal graded exercise test, subject will lie on a cot and 
have electrodes attached to his/her shoulder, hip, and chest to observe 
the electrical activity of the heart in a lying position.  Then, subject will be 
asked to stand up to record EKG in an upright position.  This second EKG 
will be compared to the previous EKG to see any recent significant 
changes occurred. 
b. Maximal graded exercise test 
This test is designed to measure subject’s fitness and cardiovascular 
response to exercise.  Subject will walk on a motor-driven treadmill with 
the grade or slope increasing progressively until fatigue, breathlessness, 
chest discomfort, and/or any other symptoms which indicate to a medical 
doctor, technicians or subject him/herself that he/she should stop 
exercise.  Heart rate, EKG and blood pressure will be monitored through 
the test.  Subject’s expired gases will be also collected through 
mouthpiece either throughout the test or at the end of the test.  A medical 
doctor will be present and supervising the entire test. 
 
4) Measurements of 24-hour ambulatory blood pressure and EKG 
monitoring trials:  
a. Following three short bouts of Exercise treatment 
b. Following a long bout of exercise treatment  
c. Following a control treatment (without exercise)  
Exercise Treatments 
The long bout (45 minutes) of exercise treatment will be 
administered between 6am and 8am.  The first session of an accumulating 
three short bouts (15 minutes) of exercise treatment will be administered 
between 6am and 8am, the second between 11am and 1pm and the third 
between 4pm and 6pm.  Each exercise treatment will be 45 minutes.  
Each exercise treatment will consist of walking on a motor driven treadmill 
at 50% of maximal oxygen uptake (VO2max), which will be obtained by the 
maximal exercise test.  That is, the speed and grade form the stage of the 
test that is elicited 50 % of VO2max will be used for the exercise stimulus.  
VO2 will be measured during the 4th through the 6th minutes to confirm the 
exercise stimulus.  The work rate will be adjusted if it is not within ±10% of 
the target oxygen uptake.  VO2 will then be measured during the 10th 
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 through the 12th minutes of the work to confirm the new exercise intensity.  
Heart rate (via ECG) will be measured every minute during the exercise 
session; blood pressure (via auscultation) will be measured every 2 to 5 
minutes.   
24-hour Ambulatory Blood Pressure and EKG Monitoring 
Ambulatory 24-hour blood pressure and EKG (Holter) will be taken, 
starting in the morning following both the exercise and control treatments.  
The order of presentation of the three short bouts and a long bout of 
exercise treatments as well as a control treatment will be randomized.  
The two exercise treatments will be greater than 7 days apart to avoid 
training effect. 
The Accutracker II will be used for ambulatory 24-hour blood 
pressure measurements.  The sampling interval will be randomized to take 
a reading on the average of every 15 ± 5 minutes for daytime hours (6 am 
to 10 pm) and on the average of every 30 ± 5 minutes for nighttime hours 
(10 pm to 6 am).  One repeat measurement will be taken if the first 
measurement is unsuccessful during the daytime hours and two repeat 
measurements will be taken during the nighttime hours.  The cuff inflation 
cuff for each measurement will be 30 mmHg greater than the previous 
reading.  The cuff deflation will be set at 3 mmHg/second.   The blood 
pressure cuff will be worn on the non-dominant arm.  Four EKG electrodes 
will be placed in the chest.  Electrode wires and blood pressure tubing will 
be taped securely to the chest.  The subject will be given the option to 
secure a small box, recording unit with a belt or the shoulder strap 
provided.  A roll of micropore tape and new electrodes will be given to 
each subject to re-tape areas or to replace electrodes if needed.   
The DigiCorder will be used for 24-hour electrocardiogram or EKG 
recording.  Subject will get seven electrodes attached to his/her chest and 
will carry a small box on a belt or shoulder strap.  Electrode wires will be 
taped securely to the chest.  A roll of micropore tape and new electrodes 
will be given to each subject to re-tape areas or to replace electrodes 
(picture will be given) if needed.  When the data from DigiCorder is 
downloaded, the changes in the nervous control of blood pressure 
regulation using heart rate variability software (Del Mar Medical systems, 
LLC) will be obtained.  This measurement will be performed to investigate 
the mechanism of blood pressure reductions resulted from different 
exercise treatments. 
Subjects will be asked to document 1) time of sleep, 2) time at 
work, 3) time of meals, 4) time at leisure activities, and 5) any physical 
activities or exercise.  Subjects will be instructed 1) not to get the monitor 
wet, 2) not to exercise, 3) not to take a shower, 4) not to use electric 
blanket, 5) not to operate a lawn mower, a vacuum cleaner or any 
equipment which would cause vibration, and 6) to relax and straighten out 
the arm during the blood pressure recording for the entire 24-hour period. 
   
 All of the laboratory testing protocols listed below have been previously 
approved for use in the Adult Fitness Program (97-21) and Blood Pressure Clinic 
as well as other studies involving hypertensive adults (97-1962, and Bogle, P.G. 
(2001) Hemodynamic determinants of post exercise hypotension: An ambulatory 
study).  Saejong Park, P.I. has been performing the research (01-4483, Effects of 
morning and evening exercise treatments on the diurnal variation of blood 
pressure effects of exercise on hypertension) with similar procedures.  
 
 
 
E. State the potential risks - for example, physical, psychological, financial, 
social, legal or other - connected with the proposed procedures. 
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 Briefly describe how risks to subjects are reasonable in relation to anticipated 
benefits.  Describe procedures for protecting against, or minimizing, potential 
risks.  Assess their likely effectiveness.  If you are using an electrical device 
that is attached directly to subjects explain how the subjects will be protected 
from shock. 
 
1) Blood pressure screening 
 There are no major risks associated with a blood pressure screening.  The risk 
associated with temporary discontinuation of antihypertensive medication is 
the return of blood pressure to pre-medication pressures.  The temporary 
discontinuation of antihypertensive medication must be approved by the 
subject’s primary physician (form included).  During the discontinuation of 
medications the blood pressure will be monitored and recorded daily for the first 
week, and every other day thereafter by lab technicians.  The primary physician 
will indicate the threshold blood pressure for resuming medication.  If the subject 
reaches this threshold, the subject will be referred back to their primary care 
physician, encouraged to resume to taking antihypertensive medication and will 
be discontinued from the study. 
 
2) First day of laboratory testing:  
a. Resting 12-lead EKG 
b. Pulmonary function tests (for smokers only)  
c. Fasting venous blood draw at IU Health Center 
There are no major risks associated with resting 12-lead EKG and 
pulmonary function tests.  Light headiness is experienced by some people 
undergoing pulmonary tests.  Subjects will be seated during pulmonary 
function tests to prevent episodes.  To minimize the risk, trained 
staff/student personnel will give instructions and demonstrations in testing.  
Testing will be under the supervision of Janet P. Wallace, Ph.D.  Each 
room of the Clinical Exercise Physiology Laboratory has two emergency 
buttons.  The yellow light is for assistance and the red light is for 
emergencies.  The physician’s office, reception area, and the office of the 
Human performance Director have a panel that indicates which room and 
light is activated.  Notification of emergency, action of personnel, and 
protocol can be communicated over the lab public address system. 
The risks associated with venous draw are minimal: bruising, 
infection or soreness at the puncture site, and falls due to fainting.  These 
risks will be minimized by having the blood drawn by a trained technician 
at the IU health center while subjects are seated.  The amount of whole 
blood drawn is minute, 20-45 ml.  The efficacy of cardiovascular or 
hemodynamic mechanisms and arterial pressure are not compromised 
with these volumes of draw or finger prick.  Infectious waste are collected 
separately and stored in hazardous bags until disposal.  Methods of 
disposal by incineration are performed by IU Health Center.  There is a 
greater risk of contracting HIV virus for the technician than for the subject.   
 
3) Second day of laboratory testing:  
a. Second resting 12-lead EKG 
b. Maximal graded exercise test 
There are no major risks associated with resting 12-lead EKG.  The 
discomforts associated with exercise treatment can include episodes of 
transient light headaches, occasional irregular heart beats, chest 
discomfort, abnormal blood pressure responses, musculoskeletal injury 
and sore muscles.  Risks inherent in maximal graded exercise test range 
from traumatic events from falling on the treadmill to sudden death.  The 
risk of cardiac event is 1 to 3 in 10,000 tests and the risk of death is 1 in 
10, 000 tests for a high risk population.   
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   Procedures for protecting against or minimizing, potential risks are 
described:  
Trained staff/student personnel will give instructions and demonstrations 
in the testing.  Standard procedures will be used for preparation, test 
administration, and test termination to minimize risk for maximal graded 
exercise test.  Established criteria for the maximal graded test include: a 
physician approved clearance for participation, risk factor identification, 
resting 12 lead electrocardiogram (EKG), and instruction and practice to 
accustom the subject to the treadmill.  Risk will be minimized during 
exercise testing with continuous monitoring of the EKG, heart rate, blood 
pressure and monitoring the signs and symptoms as well as maintaining 
constant communication with the subject (both visually and verbally).  
Prior physician approval serves as a preliminary screening for medical 
conditions and medical histories contraindicated for exercise testing.  Risk 
factor identifications including family history, blood lipids, blood pressure, 
blood glucose, body composition, physical activity habits, age and sex 
determine the pre-test likelihood for coronary heart disease.  This 
identification dictates physician supervision of testing, modification of the 
test protocol, and the frequency of monitoring variables during testing.  
The resting EKG screens prior silent infarcts and EKG changes from 
previous testing.  Both are absolute and/or relative EKG contraindications 
for exercise testing.  Treadmill instruction and practice will help the subject 
comfort walking or jogging.  Continuous monitoring of variables during 
testing help detect early test termination points.  This detection will help 
prevent potential cardiac events.  Constant visual and verbal 
communication with the subject assures early detection and evaluation of 
symptoms which may develop during the testing such as chest discomfort, 
lightheadedness, and musculoskeletal problems.   
Physician supervision is warranted for all hypertensive subjects 
during exercise testing.  In other words, a physician will be present and 
supervising maximal graded exercise test for all the subjects.  Criterion for 
physician supervision will be in accordance with ACSM Guidelines for 
Exercise Testing and Prescription.  Individual risk status will be 
determined for each subject prior to the exercise test.  This risk status will 
be based on subject responses on the Medical History/Health Habits 
Questionnaire, results of the physician examination, resting blood 
pressure, body composition analysis and fasting blood chemistry 
measurements.  Classifications of risk status for adults include low, 
moderate and high risk.  Subjects who present with any absolute 
contraindications to exercise will not be allowed to participate in this study.  
Subjects who present with relative contraindications can be tested 
provided the Medical Director or primary physician approves.  Test 
termination for exercise testing will adhere to the ACSM Guidelines. 
The exercise testing will also be under the supervision of the 
Medical Director, Larry Rink, M.D.  All technicians have practiced the 
emergency protocol and participated in CPR classes three times a year.  
All technicians are certified (American Heart Association) in the use of an 
automatic external defibrillator (AED).  In addition, a practice run will be 
coordinated with the ambulance service of Bloomington Hospital once a 
year.   
Each room of the Clinical Exercise Physiology Laboratory has two 
emergency buttons.  The yellow light is for assistance and the red light is 
for emergencies.  The physician’s office, reception area, and the office of 
the Human performance Director have a panel that indicates which room 
and light is activated.  Notification of emergency, action of personnel, and 
protocol can be communicated over the lab public address system.   
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 4) Measurements of 24-hour ambulatory blood pressure and Holter 
monitoring trials:  
a. Following three short bouts of physical activity treatment 
b. Following a long bout of physical activity treatments  
c. The corresponding morning of the non-exercise control treatment.   
There are no major risks for 24-hour ambulatory blood pressure 
monitoring.  Discomforts include minor skin irritation from adhesive, 
possible sleep disturbances, minor discomfort of the arm during cuff 
inflation, possible disturbance of daily tasks, and rare events that include 
petechiae (tiny little broken capillary blood vessels), thrombophlebitis 
(formation of a blood clot inside an inflamed vein), edema, abrasions, and 
eccymoses (larger bruises).  The risks will be minimized by inflating blood 
pressure cuff just little above (30 mmHg) the previous subject’s blood 
pressure.  Phone numbers of the investigators will be provided to the 
subjects if they have any problems with the device during the course of 
the monitoring.   
There are no major risks for 24-hour ambulatory EKG monitoring.  
Discomforts include minor skin irritation from adhesive, possible sleep 
disturbances, and/or possible disturbance of daily tasks.  Phone numbers 
of the investigators will be provided to the subjects if they have any 
problems with the device during the course of the monitoring.  
The discomforts associated with exercise treatment (50% of 
amount of exercise from graded maximal exercise test) can include 
episodes of transient light headaches, occasional irregular heart beats, 
chest discomfort, abnormal blood pressure responses, musculoskeletal 
injury and sore muscles.  The risk of heart attack, although small (1 to 3 in 
10,000), does exist.  Reasonable effort will be made to minimize risk 
through the use of proper warm-up, exercise, and cool-down techniques.  
Blood pressure and EKG will be monitored during exercise treatments by 
technicians.  All technicians have practiced the emergency protocol and 
participated in CPR classes three times a year.  All technicians are 
certified (American Heart Association) in the use of an automatic external 
defibrillator (AED).  In addition, a practice run will be coordinated with the 
ambulance service of Bloomington Hospital once a year.  Clinical Exercise 
Physiology Laboratory has two emergency buttons.  The yellow light is for 
assistance and the red light is for emergencies.  The physician’s office, 
reception area, and the office of the Human performance Director have a 
panel that indicates which room and light is activated.  Notification of 
emergency, action of personnel, and protocol can be communicated over 
the lab public address system.       
 
  
 
F. Describe methods for preserving confidentiality.  How will data be recorded 
and stored, with or without identifiers?  If identifiers are used describe the 
type: names, job titles, number code, etc.  How long are identifiers kept?  If 
coding system is used, is there a link back to the subject’s ID?  If yes, 
where is the code list stored in relation to data and when is the code list 
destroyed?  How will reports will be written, in aggregate terms, or will 
individual responses be described?  Will subjects be identified in reports 
(see item 5 on page 10)? Describe disposition of tapes/films at the end of 
the study.  If tapes are to be kept, indicate for how long and describe future 
uses of tapes. 
 
Confidentiality will be preserved.  All subjects will be given a laboratory 
identification number.  There is a file that cross-lists names and ID numbers.  The 
files will be integrated into the filing system of the Adult Fitness Program and will 
be kept as long as that program exists.  All data will be logged and identified by 
identification numbers.  No subject will be referred to by name in any publication 
or summary of this work.  All data will be kept in locked PI's laboratory, the 
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 Clinical Exercise Physiology of the Human Performance Laboratories in the 
Department of Kinesiology, School of HPER, and will be available to the 
investigators. 
 
 
 
G. What, if any, benefit is to be gained by the subject?  In the event of 
monetary gain, include all payment arrangements (amount of payment and 
the proposed method of disbursement), including reimbursement of 
expenses.  If class credit will be given, list the amount and the value as it 
relates to the total points needed for an A.  List alternative ways to earn the 
same amount of credit.  If merchandise or a service is given, indicate the 
value.  Explain the amount of partial payment/class credit if the subject 
withdraws prior to completion of the study.  (See policy at 
http://www.indiana.edu/~resrisk/compensation.html) 
 
 
 The subject will receive a free evaluation of general health/fitness and exercise 
tolerance, including ECG, heart rate, and blood pressure responses.  The same 
procedures perform independently at the IU Adult Fitness Program, which would 
result in costs of $200.  If performed in clinical settings, reimbursement estimates 
are between $325.49 and $831.70.  For participation in this study, a gift 
certificate ($20 worth) will be offered to each subject.  After the completion of the 
whole study, $130 will be provided to subjects.  The subject is free to withdraw 
prior to completion of the study.  The results of all the testing will be sent to the 
subject and/or to the subject’s primary physician if the subject wants.  Patient 
evaluation and management by the primary physician may be enhanced with the 
use of 24-hour ambulatory blood pressure measurements.  If desired, exercise 
counseling will be also provided. 
 
 
 
H. What information may accrue to science or society in general as a result of 
this work? 
 
 The use of life style modifications or non-pharmacological treatments has been 
recommended for the treatment of hypertension due to economics, drug side 
effects, and low adherence to antihypertnesive medication.  Exercise has been 
recognized as the most effective non-pharmacological treatments.  Exercise 
reduces systolic blood pressure 6.2 to 9.9 mmHg and diastolic blood pressure 
6.8 to 7.6 mmHg.  However, not all hypertnesive adults participate in exercise 
program.  The accumulation of short bouts of exercise may fit to the busy days, 
and promote prevention and treatment of hypertension.   
 
 
 
I. Coinvestigators, Cooperating Departments, Cooperating Institutions.  If 
there are multiple investigators, please indicate only one person on the 
Documentation of Review and Approval (page 3) as the principal 
investigator; others should be designated as coinvestigators here.  
Coinvestigators, not signing on page 3, should sign here, pledging to 
conform to the sentences on page 3.  If you anticipate that another 
department or institution may be involved in this research, list that here.   If 
you are working with another institution, please include a letter of 
cooperation from that institution. 
 Please provide the person’s name and e-mail address. 
  
 NONE 
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 INDIANA UNIVERSITY 
BLOOMINGTON CAMPUS COMMITTEE FOR THE PROTECTION OF HUMAN SUBJECTS 
 
(((((((((((((((   STUDY AMENDMENT   ((((((((((((((( T
Study #   03-8515               of 
Research Project Utilizing Human Subjects 
NOTE TO INVESTIGATORS:  Study amendments may not be instituted until written 
approval from the IUB Campus Committee for the Protection of Human Subjects has been 
given.  Return this form to:  HSC, Caramichael Center L03, 530 E. Kirkwood Ave., IUB.  
Please complete in a legible manner!  This entire page MUST be on a single sheet of paper.  
Use this as a cover page and attach pages with the information requested in items 1 and 2. 
 
TITLE OF PROJECT A comparison of a single exercise treatment to a physical activity treatment 
in hypertension and prehypertension                                                                                                                            
PRIN. INVESTIGATOR   Saejong Park                                                SCHOOL/DEPARTMENT 
HPER/Kinesiology                                            
ADDRESS (campus or US)   HPER 070  E-MAIL  saejpark@indiana.edu TELEPHONE  812-855-
7556
FUNDING AGENCY:   American Heart Association_________________________________                                   
*************************************************************************************************************** 
 PLEASE USE THIS AS A COVER PAGE. 
ATTACH PAGES with the INFORMATION REQUESTED in items 1 and 2. 
1. Describe the proposed change(s) and rationale for the change(s).  Include any changes to 
project start and end dates.  If submitting a revised questionnaire or survey, please include a 
copy with changes highlighted. 
See attachment.  
2.    Describe how the amendment will affect the risk:benefit ratio for subjects. 
The risk: benefit ratio for subject will not be affected by the amendment. 
3.    Does the proposed amendment require changes in the Consent Statement/Information 
Sheet?  Yes 
       If the answer is yes, check the appropriate line and attach a copy of the revised Consent 
Statement/Information 
       Sheet, with changes highlighted.     
       ______ The new Consent Statement/Information Sheet is in addition to the current one    
       ___X__ The new Consent Statement/Information Sheet is to replace the current one. 
 
_Park, Saejong_______________________       _____________________________________   
________________                                                                                             
Principal Investigator (typed/printed name) (signature—must be PI’s own signature) (date) 
_Wallace, Janet P.___________________        _____________________________________    
________________                                                                                          
Faculty Advisor/Sponsor (typed/printed name) (signature—must be sponsor’s own signature) (date) 
***************************************************************************************************************
CAMPUS LEVEL REVIEW 
            The Amendment of this protocol for use of human subjects has been reviewed and approved by the IUB 
Campus Committee for the Protection of Human Subjects. 
 
            Exempt review ¶#                       Exempt review with documentation of consent ¶# _____          
  
            Expedited review ______ Full Committee review 
________________________________________    ______________ 
Chairperson/Agent IUB Committee                                                        Date 
 
logged in ts                          approval logged                         copy to PI  ______________  notice to SOE _____________  
rank code _________ 
test:  PI ________________  sponsor _______________  co-PI _________________ 
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  1.  Describe the proposed change(s) and rationale for the change(s).  
Include any changes to project start and end dates.  If submitting a revised 
questionnaire or survey, please include a copy with changes highlighted. 
 
   The proposed changes will be the duration of monitoring ambulatory EKG 
and physical acitiviy. 
   First, prehypertensive adults will be included in this study.  In 2003, 
prehypertension is newly classified to promote lifestyle modifications to prevent 
cardiovascular disease.  Prehypertension is defined as a systolic blood pressure 
of 120-139 mm Hg or a diastolic blood pressure of 80-89 mm Hg.  The rational 
for this new classification is that prehypertensvie adults are at increased risk for 
progression to hypertension: those in the 130/80 to 139/89 mm Hg are at twice 
this risk to develop hypertension as those with lower values.   
   Second, subjects will be compensated according to the following scale: 
1st lab test = $15, 2nd lab test = $35, 1st 24 Hour blood pressure monitor = $20, 
2nd 24 Hour blood pressure monitor = $25, 3rd 24 Hour Blood Pressure monitor 
= $35.  If subjects do not finish a particular session, subjects will still be paid the 
amount of money:  If subjects complete the entire study, subjects will receive an 
additional $20 for a total of $150.  This compensation has been approved by 
Human Subject Committee for original application.    
   Changes in the project start and end dates are 07/01/2004 and 
06/30/2005. 
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 Study # 03-8515        
 
INDIANA UNIVERSITY – BLOOMINGTON 
INFORMED CONSENT STATEMENT 
A comparison of a single exercise treatment to a physical activity treatment in 
hypertension and prehypertension 
 You are invited to participate in a research study.  This study will be conducted 
by a doctoral student under an authorized research program with the supervision of 
Janet P. Wallace, Ph.D. FASCM, and Larry Rink, M.D. at Indiana University.  The 
purpose of this study is (1) to study how effective the accumulation of short bouts of 
brisk walking compared to one long bout of brisk walking is to reduce blood pressures 
(2) to observe the nature of the blood pressure reduction following each successive 
short bout of exercise, and (3) to investigate the role of nervous system as a possible 
mechanism for the blood pressure reduction following the brisk walking in adults with 
pre-high and high blood pressure. 
 
INFORMATION 
Design:  You will be asked to have a physical examination at your expense and 
to have clearance from your primary physician to participate this study.  You will be 
asked to report to the Clinical Exercise Physiology of the Human Performance 
Laboratories in the Department of Kinesiology, School of HPER for all the procedures in 
the study.  You will complete two days of blood pressure screening.  If your primary 
physician gives you permission to discontinue your medications for this study, your will 
have more blood pressure screenings after you stop taking your medications.  You will 
complete two days of laboratory testing.  Then, there will be two exercise and one 
control (without exercise) sessions.  Each session will begin in the morning.  The control 
session will be a day without exercise.  On one of the exercise sessions you will walk on 
the treadmill for 40 minutes.  On the other exercise day you will walk on the treadmill for 
four 10 minute sessions spread throughout the morning.  On a control day and on days 
following exercise sessions, you will wear the ambulatory blood pressure and heartbeat 
(or EKG) monitor for 24 hours.  The two exercise sessions will be greater than 7 days 
apart to avoid training effect.  The order of the control and exercise treatments will be 
randomized.  The total required time will be 10 to 11 hours over 21 to 30 day period.  
Approximately 20 hypertensive and 20 prehypertensive adults will be recruited for this 
study.   
 
Blood Pressure Screening 
 Your blood pressure will be taken at least three times on two separate days.  A 
blood pressure cuff will be attached to your upper arm, inflated, and released.  This test 
will be repeated 3 times, and an average blood pressure be will be calculated.  You will 
be classified to pre-high blood pressure or high blood pressure based on the screening 
blood pressure if your doctor did not confirm you have high blood pressure. 
 If you discontinue your blood pressure medication with your doctor’s approval for 
this study, you will have more blood pressure screenings: every day for the first week 
and every other day for the rest of the study.  You will be referred back to your primary 
physician to resume your medication and withdraw from the study if the screening blood 
pressures exceed the criterion blood pressure measurement (>3 days in a row) 
determined by your primary physician. 
                                                                                                                   Subject’s Initials 
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 Laboratory Testing 
 
1. First Day of Testing: Quiet Testing (1-1.5 hours) 
_____  Fasting venous blood draw:  You must be fasting for at least 12 hours prior to 
this test.  A 20-45ml sample of venous blood will be drawn by a certified technician 
via sterile techniques for analysis of cholesterol, triglycerides, glucose, and various 
electrolytes and enzymes.  This blood draw will take place at the University Health 
Center. 
_____  12-Lead Electrocardiogram (EKG):  You will lie on a cot and have electrodes 
attached to your arms, legs, and chest to observe the electrical activity of your heart.  
You will also be asked to breathe deeply for 20 seconds to observe how deep 
breathing affects your EKG. 
_____  Pulmonary Function Testing (For smokers only):  You will breathe in and out 
as hard and fast as you can with room air through hoses attached to the computer to 
determine the capacity of your lung.  This will be done for smokers to assure that 
lung function will not limit the ability to do exercise. 
 
 Risks   
  The risks associated with EKG and pulmonary function test are minimal.  The 
risks associated with the venous blood draw may include soreness, bruising, fainting, 
and/or swelling at the puncture site.  These risks are minimized by having the blood 
drawn by a trained technician at the Health Center while you are seated. 
 
2. Second Day of Testing: Exercise Testing (2 hours) 
_____  12-Lead Electrocardiogram (EKG):  Before the exercise test, you will lie on a 
cot and have electrodes attached to your shoulders, hips, and chest to observe the 
electrical activity of your heart.  You will be also asked to stand up after recording an 
EKG in the lying position.  Another EKG will be recorded in the upright position. 
_____  Maximal Graded Exercise Test:  This test is designed to measure your fitness 
and cardiovascular response to exercise.  You will walk on a motor-driven treadmill 
with the grade increasing progressively until fatigue, breathlessness, chest 
discomfort, and/or any other symptoms which indicate to the technicians or yourself 
that you should stop exercise.  Heart rate, EKG and blood pressure will be monitored 
through the test.  Your expired gases will be also collected through mouthpiece 
either throughout the test or at the end of the test.   
   
 Risks
   The discomforts involved with maximal graded exercise testing can include 
episodes of transient light headaches, chest discomfort, leg cramps, occasional 
irregular heart beats and abnormal blood pressure responses.  The risk of heart 
attack, although rare (approximately 1 to 3 in 10,000), does exist.   
 
 Reasonable effort will be made to conduct the test in such a way as to minimize 
discomfort and risk.  In the unlikely event of a heart related emergency we will call 
Bloomington Hospital Ambulance Service.  The laboratory is equipped to respond to 
such situations and its personnel are trained to administer emergency care in the 
form of Basic Life Support.  Advanced Cardiac Life Support will be provided by 
Bloomington Hospital 
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 Ambulance Service.  There is a one hour recovery period following maximal exercise 
testing during which you should not subject yourself to additional stress such as a 
very hot or very cold shower, smoking, heavy food intake, or other exercise. 
  
Exercise Treatments (40 minutes each)
 Exercise treatments will be the accumulation of four short bouts (10 minutes 
each separated by at least 50 minutes) and one long bout (40 minutes) of brisk walking.  
The first session of short bouts of exercise will be administered between 9am and 
9:30am, the second session between 10am and 10:30am, and the third session between 
11am and 11:30am and the last session between 12pm and 12:30pm.  One long bout of 
exercise will be between 12pm and 1pm.  Each exercise session you will walk on a 
motor driven treadmill at 50% of your exercise capacity, which will be estimated from 
your maximal graded exercise test.  Expired gases will be measured during the 3th 
through the 4th minutes to confirm your exercise intensity.  The work rate will be adjusted 
if it is not within ±10% of your target exercise intensity.  Expired gases will then be 
measured during the 6th through the 7th minutes to confirm the new exercise intensity.  
Heart rate (every minute) and blood pressure (every 2 to 5 minutes) will be measured 
during the exercise session.   
Risks
 The discomforts involved with exercise sessions can include episodes of 
transient light headaches, chest discomfort, leg cramps, occasional irregular heart beats 
and abnormal blood pressure responses.  The risk of heart attack, although rare, is 
significantly reduced from exercise testing because of the sub-maximal intensity 
(approximately 1/300,000 man hours of exercise). 
 Reasonable effort will be made to minimize risk through the use of proper warm-
up, exercise and cool-down technique.  Mouth piece will be sanitized with proper 
detergents.  In the unlikely event of a heart related emergency we will call the 
Bloomington Hospital Ambulance Service.  The laboratory is equipped to respond to 
such situations and its personnel are trained to administer emergency care in the form of 
Basic Life Support.  Advanced Cardiac Life Support will be provided by Bloomington 
Hospital Ambulance Service. 
 
Ambulatory Blood Pressure, Heartbeat (or EKG) and Activity Monitoring 
 1. On one day for successive short bout of exercise (4 to 5 hours) 
  You will be asked to report the laboratory at between 8am and 8:30am 
and to stay at the lab until 12:30pm on one day for the accumulation of short 
bouts of exercise.  Ambulatory blood pressure, heartbeat (or EKG) and activity 
monitors will be set up.  Ambulatory blood pressure, EKG and activity monitors 
will be started following a 10-minute seated resting period.  The Accutracker II 
will be used for all ambulatory blood pressure measurements.  The sampling 
interval will be 5 minutes for 15 minutes prior to short bout of exercise.  The cuff 
inflation for each measurement will be 30 mmHg greater than the previous 
reading.  The cuff deflation will be set at 3 mmHg/second.  The blood pressure 
monitor will be worn on the non-dominant arm.  The Aria digital recorder will be 
used to record your heartbeat or EKG.  Total seven (three from ambulatory blood 
pressure monitor and four from EKG monitor) EKG electrodes will be placed in 
chest.  Electrode wires will be taped securely to the chest.  The RT3 monitor 
(beeper size) will be attached to a belt at the hip of your dominant leg to monitor 
your activity.  
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   During the short bout of exercise (10 minutes) and resting period you will 
wear ambulatory blood pressure, EKG monitors and activity monitor.  During the 
long bout of exercise you only wear activity monitor.  After the long bout of 
exercise, you will be attached to the ambulatory blood pressure and EKG 
monitors.  The sampling interval of ambulatory blood pressure monitor will be 5 
minutes for a 15 minutes and 15 minutes for a 50-minute supine resting period 
for the successive short bouts of exercise.   
 2. On three days following the control and two exercise sessions (20 mins) 
  Ambulatory blood pressure and heartbeat monitoring will be taken 
following the control and two exercise sessions.  The sampling interval of the 
Accutracker II, will be randomized to take a reading on the average of every 15+5 
minutes for a 12-hour collection period following two exercise and one control 
(without exercise) sessions.  The monitor will be programmed to take no readings 
following the 12-hour collection period.  You can take all the monitors off when 
you are awake.  One repeat measurement will be taken if the first measurement 
was unsuccessful.  The cuff inflation for each measurement will be 30 mmHg 
greater than the previous reading.  The cuff deflation will be set at 3 
mmHg/second.  The blood pressure monitor will be worn on the non-dominant 
arm.  EKG electrodes will be placed in chest.  Electrode wires and blood 
pressure tubing will be taped securely to the chest.  You will be given the option 
to secure the recording unit with a belt or the shoulder strap provided.  A roll of 
micropore tape and extra electrodes will be given to re-tape areas or to replace 
electrodes if needed.   
  The Aria digital recorder will be used for 12-hour EKG recording.  This is 
a device which records your heartbeat or EKG.  Four EKG electrodes will be 
placed in chest.  Electrode wires will be taped securely to the chest.  You will be 
given the option to secure the recording unit with a belt or the shoulder strap 
provided.  Extra electrodes will be given to replace electrodes when they become 
loosened.  Instructions will be given on how to replace electrodes.   
  The RT3 monitor will be used for 12-hour activity recording.  The RT3 is a 
size of beeper.  The RT3 monitor will be firmly attached to a belt at the hip of 
your dominant leg. 
  You will be encouraged to participate in normal daily activities.  You will 
be asked to document 1) time of sleep, 2) time at work, 3) time of meals, and 4) 
time at leisure activities.  You will be instructed 1) not to get the monitor wet, 2) 
not to exercise, 3) not to take a shower, 4) not to use electric blanket, 5) not to 
operate a lawn mower, a vacuum cleaner or any equipment which would cause 
vibration, and 6) to relax and straighten out the arm during the blood pressure 
recording for the entire 12-hour period.   
Risks 
 The discomforts involved with ambulatory blood pressure monitoring can include 
minor disturbance of daily tasks, tightness of blood pressure cuff, and skin irritation from 
the tape and/or sleep interruption.  There are rare events which include cases of minute 
spots of bruising and slight discoloration of skin, irritation to the veins, swelling, and 
abrasions.  The discomforts associated with the heartbeat or EKG monitoring are 
minimal.  Redness and/or itchiness at the electrode sites may occur.   
 Reasonable effort will be made to minimize discomforts.  Blood pressure cuff will 
be inflated just little above your previous blood pressure.  Phone numbers of the 
investigators will be provided to you if they have any problems with the device during the 
course of the monitoring. 
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 EMERGENCY MEDICAL TREATMENT  
 In the unlikely event of physical injury resulting from your participation in this 
research, emergency medical treatment will be provided at no cost to you.  Be certain 
that you immediately notify the researcher if you are injured.  If you require additional 
medical treatment you will be responsible for the cost.  No other compensation will be 
provided if you are injured in this research.  Be certain that you immediately notify the 
researcher if you are injured. 
 
BENEFITS 
 You will receive a free evaluation of general health/fitness and exercise 
tolerance, including EKG, heart rate, and blood pressure responses as well as 
information regarding the effectiveness of exercise to reduce your blood pressure.  The 
same procedures are performed independently at the IU Adult Fitness Program (cost is 
$250).  If performed in clinical settings, reimbursement estimate is $325.49-$831.70.  
Your physician will also receive this information which may aid in management of your 
health/disease if you want.  Exercise prescription and counseling will also be provided 
on your request. 
 
CONFIDENTIALITY 
 Data or answers to questions will remain confidential with regard to your 
identity.  You will be given an identification number.  All data will be logged and identified 
by identification numbers.  All data will be kept in the locked investigators’ laboratory, the 
Clinical Exercise Physiology and will be only available to persons conducting the 
research.  Results will be made available to your physician.  No subject will be referred 
to by name in any publication or summary of this work.   
 
COMPENSATION  
 You will be compensated according to the following scale: 1st lab test = $15, 2nd lab 
test = $35, 1st 24 Hour blood pressure monitor = $20, 2nd 24 Hour blood pressure 
monitor = $25, 3rd 24 Hour Blood Pressure monitor = $35.  If you do not finish a 
particular session you will still be paid the amount of money:  If you complete the entire 
study you will receive an additional $20 for a total of $150.    
 
CONTACT  
If you have questions at any time about the study or the procedures (or you 
experience adverse effects as a result of participating in this study) you may contact  
 
Saejong Park HPER 070 Indiana University, Bloomington, IN 47405  855-
7556 
Dr. Wallace HPER 112-G Indiana University, Bloomington, IN 47405  855-
6384 
Dr. Rink HPER 070 Indiana University, Bloomington, IN 47405  855-
7556 
 
If you feel you have not been treated according to the descriptions in this form, or 
your rights as a participant in research have been violated during the course of this 
project, you may contact the office for the Human Subjects Committee, Indiana 
University, Carmichael Center L03, 530 E. Kirkwood Ave., Bloomington, IN 47408, 
812/855-3067, by e-mail at iub_hsc@indiana.edu. 
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 PUBLIC SERVICE ANOUNCEMENT 
 
Indiana University Clinical Exercise Physiology Lab Seeks  
Volunteers for Exercise and Blood Pressure Study 
 
The Indiana University Clinical Exercise Physiology laboratory is currently 
seeking volunteers over 18 years old who have prehypertension (a systolic blood 
pressure of 120-140 mm Hg or a diastolic blood pressure of 80-89 mmHg).  The 
purpose of the study is to see if the accumulation of four short brisk walking 
sessions (10-min) is as effective in lowering your blood pressure as one single 
long brisk walkingsession (40-min) is. 
 
After the completion of this study, you will receive $150.  Prior physician approval 
is required to participate. 
 
For more information on this study contact Saejong Park (saejpark@indiana.edu) 
or Janet P. Wallace, Ph.D. (wallacej@indiana.edu) at the Clinical Exercise 
Physiology Laboratory, 812-855-7556. 
 253
 TELEPHONE SCRIPT 
 
Accumulation of four short bouts of brisk walking  
on blood pressure reduction in prehypertension 
 
Saejong Park, M.S. 
 
Thank you for your interest in this study.  Our purpose is to see if the 
accumulation of four short bouts of brisk walking is as effective as one long bout 
of brisk walking in order to lower your blood pressure. 
 
Are you interested? 
 
If the answer is no:  “Thank you. If you know of anyone who might be interested, 
please give them our phone number” 
 
If the answer is yes: 
 
Do you know your blood pressure?  What is your blood pressure?  Is your blood 
pressure between 120 and 140 for the top number or between 80-89 for the 
bottom number?   
 
If the answer is no: “Thank you for your interest, but you do not qualify for the 
study.  If you know of anyone who might be interested, please give them our 
phone number” 
 
If the answer is no:  “Your blood pressure will be screened on two separate days 
in the laboratory and you might not be qualified for the study based on the 
screening blood pressure.” 
 
If the answer is yes: 
 
This requires walking on a treadmill three times in one day, 10 minuets each time 
spread throughout the morning.  The blood pressure reduction will then be 
compared to walking on the treadmill for one 40 minute walk.  We will also have 
a day that you do not do any exercise.  For each of these three days, you will 
wear a blood pressure monitor that measures your blood pressure every 15 
minutes for 12 hours.  We will also measure your heartbeat or EKG during that 
time.  
 
Are you still interested? 
 
If the answer is no: “Thank you for your interest.  If you know of anyone who 
might be interested, please give them our phone number” 
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 If the answer is yes: 
To be eligible for the study you must 
 
have clearance from your primary physician  
complete a health history form  
complete some laboratory testing so that we can find out how much exercise is 
safe for you.   
 
Are you still interested in the study? 
 
If the answer is no: “Thank you for your interest.  If you know of anyone who 
might be interested, please give them our phone number” 
 
If the answer is yes: 
 
Once your physician gives permission, you will be scheduled for laboratory 
testing.  This testing includes blood draw at IU health center, resting EKG, stress 
test, and lung function test (only for smokers).  On the day of your stress test, 
you will walk on the treadmill until you cannot walk any longer.  Your blood 
pressure, heart rhythm, signs and symptoms will be monitored by a physician 
and lab technicians. 
 
After your treadmill test, you will be scheduled to return to the lab within a week 
to perform a 40-minute brisk walking and four 10-minute brisk walking on 
treadmill.  The order of these will be randomized.   
 
After each brisk walking on treadmill session you will wear 12-hour ambulatory 
blood pressure and heartbeat or EKG monitors (70 minutes).  You will be asked 
to report to the lab and to wear 12-hour ambulatory blood pressure and EKG 
monitors on a day without exercise (20 minutes). 
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 PHYSICIAN LETTER 
February 16, 2004 
 
 
Dear Physician, 
 
 A doctoral student in the Indiana University Clinical Exercise Physiology is 
currently conducting a research study to compare the blood pressure reduction 
following the accumulating four short bouts (10-minute) of brisk walking to the 
blood pressure reduction following one single long bout (40-minute) of brisk 
walking in prehypertensive adults.  In 2003, prehypertension (defined as systolic 
120-139 mm Hg or diastolic blood pressure 80-89mm Hg) is newly classified by 
the Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure to prevent cardiovascular diseases through 
health-promoting lifestyle modifications.  Changes in autonomic nerve modulation 
measured by heart rate variability using the Holter monitor will be investigated as 
possible mechanisms of the blood pressure reduction following exercise 
interventions in hypertension. 
 
 Your assistance will be needed if any of your patients want to participate 
in the study.  Before entering the study, each participant must consult his/her 
physician for a physical examination. 
 
 A recruitment flyer on the study has also been enclosed if you would like 
to post it for your patients to read.  Reports of the exercise testing and 
ambulatory blood pressure monitoring, and other reports requested on your 
patient will be sent to you. 
 
 Your assistance in the study is greatly appreciated.  It is hoped that 
participating in this study will provide each participant a greater awareness of 
his/her personal fitness, health behaviors, and hypertensive disease.  It is also 
hoped that the results of this study will promote a better understanding of how 
exercise intervention may assist in the management of prehypertension.  If you 
have any questions, concerns, or comments, please contact the program at 855-
7556.   
 
Sincerely, 
 
Saejong Park   Janet P. Wallace, Ph.D.         Larry Rink, MD 
Doctoral Student    Research Director             Medical Director 
Clinical Exercise Physiology Adult Fitness Program           Adult Fitness 
Program 
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 PHYSICAL EXAMINATION AND MEDICAL HISTORY 
Name of Patient_________________________________ DOB__________ 
Medical History 
Does the above patient have or ever had the 
following conditions? (Please check the 
appropriate column). 
 
No 
Yes Comments 
Acute myocardial infarction    
Angina (please comment)    
Angina (please comment)    
Manifest circulatory insufficiency (CHF)    
Cardiomyopathy (IHSS) or Valvular heart disease 
(specify)    
Suspected or known aneurysm    
Embolism or thrombophlebitis    
ECG abnormalities (specify type)    
Active or suspected myocarditis or pericarditis    
Serious systemic disorder (ie: Mononucleosis, 
Hepatitis)    
Pulmonary disorders (ie: COPD, asthma, hypertension)    
Diabetes (specify type and severity)    
Uncontrolled metabolic disease (ie: Myxedema, 
Thyrotoxicosis)    
Electrolyte abnormalities (specify type)    
Prescribed medications (specify type)    
Neuromuscular, musculoskeletal, or rheumatoid 
disorders 
which would make exercise difficult 
   
Significant emotional distress    
Physical Examination 
Blood Pressure______________mmHg 
Heart Sounds (please check if present): 
Lifts_____ Heaves_____ Clicks_____ Thrills_____ Murmurs_____(location and 
grade) 
Lung Sounds (please describe auscultation): 
Clear_____ Wheezes_____ Rales_____ 
Quality of peripheral pulses (please check): 
Absent_____ 1/4_____ 2/4_____ 3/4_____ 4/4_____ 
Edema (please quantify if present):_____________ 
Edema (please quantify if present):_____________ 
Is this person capable of performing a maximal_____or moderate_____graded 
treadmill/bicycle exercise test? 
     *If no, please 
comment.___________________________________________________________ 
Yes No 
This individual is capable of participating in a maximal_____or moderate_____exercise program 
under the guidance of a certified exercise specialist. 
 
Date of Health Examination________________________ (must be valid within the past six month) 
 
Signed___________________________________ M.D._________________________________
 Date_______________ 
 (signature of physician)    (printed na e of physician) m
Indiana University Adult Fitness Program (812) 855-7556 
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 ADULT FITNESS PROGRAM 
 
EXERCISE TEST DATA SHEET 
         Time______ a.m. 
 
I.D.#_________ Name_____________________Date______________   Age___      Sex____ 
   Last First            Day    Month     Year 
DOB __________     Weight  ______ lb.   ________ kg.   Physician ______________________ 
Fasting:  Yes______   No______      Do you smoke:  Yes_____   No_____ 
Rest BP (mm Hg) #1_____/_____-_____  #2 _____/_____-_____   #3_____/_______-_______ 
Height _________in. ___________ cm.  Rest HR  _________ b/min.  Time of Day __________   
 
Recent illness, Chest Discomfort, or Arrhythmias, etc. 
____________________________________________________________________________ 
____________________________________________________________________________ 
 
Current Medications 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
 
Rest EKG___________________________________   Axis__________*  P-R __________ sec. 
 
MD comments/Conclusions_______________________________________________________ 
____________________________________________________________X________________ 
 
Previous test : 
Date Speed Final grade Time Peak HR Peak VO2 EKG 
       
 
Time 
(min) 
Grade 
(%) 
Load 
(rpm) 
Rate 
(mph) 
(kpm/min) 
Work 
Rate 
(kpm/min)   
Heart 
Rate 
(beats/min)   
Ectopy 
       
Blood 
Pressure 
mmHg 
Phase: 1/4-5 
 
RPE 
 
Comments 
baseline                 /              
0-1                  /            
1-2                 /              
2-3                 /              
3-4                 /              
4-5                 /              
5-6                 /              
6-7                 /              
                 /              
                 /              
                 /              
                 /              
                 /              
peak                 /              
                 /              
                 /              
                 /              
                 /              
                 /              
                  /             
 
Reason for termination___________________________________________________________ 
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 Clinical Exercise Physiology 
Indiana University 
 
 
BLOOD PRESSURE SCREENING 
 
Name: __________________________   Subject ID: ____________ 
  
 
 
 
DATE: ____________________ 
Right Arm 
 Systolic blood pressure Diastolic blood pressure 
1st trial   
2nd trial   
3rd trial   
   
 
DATE: ____________________ 
Left Arm 
 Systolic blood pressure Diastolic blood pressure 
1st trial   
2nd trial   
3rd trial   
 
 
DATE: ____________________ 
Right / Left Arm 
 Systolic blood pressure Diastolic blood pressure 
1st trial   
2nd trial   
3rd trial   
 
 
 
 
*AVERAGE BLOOD PRESSUE: _____________________________ mm Hg  
 
* average blood pressure is calculated based on blood pressures of both visits using Right / Left 
arm. 
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 GXT RESULT LETTER 
Subject Name 
Address 
 
Dear Subject, 
 
This is a summary of the laboratory evaluation for you conducted on Month Year 
by the Clinical Exercise Physiology Program.   
 
RESTING VARIABLES: 
 The resting heart rate was 79 beats per minute.  Resting blood pressure, 
using first and fourth sounds of Korotkoff, was xxx / xx mm Hg (a mean of six 
measurements over two days).  Resting electrocardiogram demonstrated -
_______.  Fasting blood chemistries measured on Month Year, demonstrated a 
serum glucose of xx mg/dL, a total cholesterol of xxx mg/dL, and a HDL of xx 
mg/dL, and a LDL of xxx mg/dL as well as a serum triglycerides of xxx mg/dL.   
 
EXERCISE TESTING: 
 A graded exercise test was performed on a motor driven treadmill.  The 
workrate began at x mph and x % grade.  Incremental work was performed until 
a maximal workrate was achieved at xx:xx minutes.  The maximal voluntary effort 
was reached at x mph and x % grade.  The test was terminated due to -
_________.  The highest heart rate achieved was 181 beats per minute.  Heart 
rate response to exercise and recovery was _____.  ECG showed ______ at rest 
and during submaximal exercise.  Blood pressure response to exercise was 
________ although blood pressure response during recovery was normal.  
Expired gases were collected during this test.  Measured peak oxygen uptake 
(VO2peak) for this test was xx ml·kg-1·min-1.  Your predicted VO2max was xx ml·kg-
1·min-1.  The conclusion of Dr. Hipskind, physician in attendance, 
______________. 
 
RECOMMENDATIONS 
 The exercise prescription based on the goal of your blood pressure 
reduction includes 3-7 days/week of walking for 30-60minutes at the exercise 
intensity of 40-70 %.   
 If you have any further questions about this test or our program please call 
855-7556.  Office hours are Tuesday and Thursday morning 8:00 am to 12:00 
noon.   
 
 Thank you very much for your participation. 
 
Sincerely, 
 
Saejong Park 
Clinical Exercise Physiology 
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 INFORMATION FORM 
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 6. Relax your arm while the blood pressure cuff is 
pumping up. 
7. The blood pressure monitor is programmed to 
take a blood pressure about every 15 minutes 
from 12pm to 2am.  It will not take your blood 
pressure exactly every 15 minutes. 
8. The blood pressure monitor is also programmed 
to inflate the cuff just a little above the last 
reading.  The cuff should not pump up as high 
the first time each reading.  
9. Please, record the following information. 
 
Time on Blood 
Pressure Monitor 
Predominant Activity Duration 
 Sleep  
 Work  
 Meals  
 Leisure  
   
   
 
Call us any time of day or night if the blood 
pressure monitor pumps up as high as it can go 
and/or if it pumps up every 5 to 7 minutes for an 
hour.  We may come out and adjust it or we may 
ask you to turn it off. 
 
AFP Office   855-7556    
Saejong Park  333-8249 
Dr. Wallace   334-8217 
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 Clinical Exercise Physiology 
Indiana University 
 
 
SHORT BOUTS OF EXERCISE TREATMENTS 
 
 
Name: ___________________ Subject ID: ______   Date: ___________ 
 
Age: _________ Sex: _____ Height (cm): _________   Weight (kg):______ 
 
 
 
 
VO2peak (ml/kg/min): _____        HRpeak (bpm): ______      
Treadmill Speed (mph): _______       Treadmill Grade (%): ______ 
  
 
Target VO2peak by graph: ______________ HR: ____________  
Treadmill Speed (mph): _______   Treadmill Grade (%): _______ 
  
 
 
Time at End of Exercise Treatment:  ___________  
Time @ 24hr BP Monitor:    ___________  
Test Operator:     _________     
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Stage Time (min) 
Time at 
BP 
Monitor 
Speed 
(mph) 
Grade 
(%) 
 
HR (bpm) BP  (mm Hg) 
VO2 
(ml/kg/
min) 
R
P
E
0-5        
5-10        
Rest 
10-15        
0-2         
2-4         
4-6         
6-8         
1 
8-10         
5        
10        
15        
20        
30        
40        
Recovery 
50        
0-2         
2-4         
4-6         
6-8         
2 
8-10         
Recovery 5        
 10        
 15        
 20        
 30        
 40        
 50        
0-2         
2-4         
4-6         
6-8         
3 
8-10         
Recovery 5        
 10        
 15        
 20        
 30        
 40        
 50        
0-2         
2-4         
4-6         
6-8         
4 
8-10         
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 Clinical Exercise Physiology 
Indiana University 
 
 
LONG BOUT OF EXERCISE TREATMENTS 
 
 
 
Name: ___________________ Subject ID: ______   Date: ___________ 
 
Age: _________ Sex: _____ Height (cm): _________   Weight (kg):______ 
 
 
VO2peak (ml/kg/min): _____        HRpeak (bpm): ______      
Treadmill Speed (mph): _______       Treadmill Grade (%): ______ 
  
 
Target VO2peak by graph: ______________ HR: ____________  
Treadmill Speed (mph): _______   Treadmill Grade (%): _______ 
  
 
 
Stage Time (min) 
Speed 
(mph) 
Grade 
(%) 
 
HR (bpm) BP  (mm Hg) 
VO2 
(ml/kg/
min) 
R
P
E 
0-2        
2-4        
4-6        
6-8        
1 
8-10        
0-2        
2-4        
4-6        
6-8        
2 
8-10        
0-2        
2-4        
4-6        
6-8        
3 
8-10        
0-2        
2-4        
4-6        
6-8        
4 
8-10        
 
Time at the End of Exercise Treatment:  ___________  
Time @ 24hr BP Monitor:    ___________  
Test Operator:    ____________     
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 BLOOD PRESSURE RESULT LETTER 
Clinical Exercise Physiology 
Indiana University 
 
Blood Pressure and Exercise Study 
 
You, ______, participated in a research study entitled a comparison of a 
single exercise treatment to a physical activity treatment in prehypertension at 
the Indiana University Clinical Exercise Physiology Program.  The purpose of this 
research is to study how effective the accumulation of short bouts of brisk 
walking compared to one long bout of brisk walking is to reduce blood pressure, 
and to observe the nature of the blood pressure reduction following each 
successive short bout of exercise in prehypertension.  
 
Ambulatory Blood Pressure Results 
Here are the results of the 12-hour blood pressure monitoring for the exercise 
sessions (one long & four short bouts of brisk walking) and the control day 
(without exercise).  The average blood pressure for the entire 12-hour period 
following exercise sessions is calculated (Mean 12-hr).   
 
Table 1.  12-hour average blood pressure following exercise sessions and control 
session 
 Mean 
12-hr SBP (mmHg) 
Mean 
12-hr DBP 
(mmHg) 
Mean difference 
in 12-hr SBP/DBP 
(mmHg) 
Control (without 
exercise) 
   
40-min Exercise    
Accumulation of four 
10-min Exercise 
   
SBP: systolic blood pressure/DBP: diastolic blood pressure (mmHg) 
 
Table 2.  50-minute average blood pressure following each 10-minute of exercise 
 Mean 
50-min SBP (mmHg) 
Mean 
50-min DBP 
(mmHg) 
Mean difference 
in 50-min BP/DBP 
(mmHg) 
Baseline    
1st     
2nd    
3rd    
 
Saejong Park 
Blood Pressure Study/Adult Fitness Program 
HPER 070 
Indiana University Bloomington, IN 47405 
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APPENDIX G - PAST RELEVANT PUBLICATION 
 
 
TIME OF DAY FOR EXERCISE ON BLOOD PRESSURE REDUCTION IN 
DIPPING AND NONDIPPING HYPERTENSION 
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 APPENDIX H - DISSERTATION PROPOSAL 
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 PROBLEM 
High blood pressure, or hypertension, is a major risk factor for many 
cardiovascular diseases including stroke (35), coronary artery disease (35), 
congestive heart failure (64), and end-stage renal disease (26).  The prevalence 
of hypertension increases with advancing age.  According to the Framingham 
Heart Study (63), 90% of  individuals with normal blood pressure at 55 to 65 
years of age will develop hypertension, defined as blood pressure of 140/90 mm 
Hg or greater or use of antihypertensive medications, over the course of their 
lifetime.  The mortality from both ischemic heart disease and stroke increases 
two-fold for each 20 mm Hg increase in systolic or 10 mm Hg increase in 
diastolic blood pressure above 115 mm Hg of systolic and 75 mm Hg of diastolic 
blood pressure (29).  In addition, there is a two-fold increase in relative risk from 
cardiovascular disease with systolic blood pressure of 130 to 139 mm Hg and 
with diastolic blood pressure of 85 to 89 mm Hg compared with a blood pressure 
of below 120/80 mm Hg (63).   
In 2003 the new classification of blood pressure, prehypertension, was 
introduced by the Joint National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure 1) to identify individuals who are at high 
risk of developing hypertension, 2) to decrease the rate of progression of 
hypertension or 3) to prevent hypertension and its related cardiovascular disease 
for those individuals (7).  Prehypertension is defined as systolic blood of 120 to 
139 mm Hg and/or diastolic blood pressure of 80 to 89 mm Hg.  Approximately 
45 million Americans have prehypertension (6).  Early intervention by adopting 
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 healthy lifestyles has been proposed for individuals with prehypertension to lower 
blood pressure and to delay or to prevent hypertension entirely.  The new 
exercise prescription, the accumulation of moderate physical activity on most if 
not all days of the week, has been advocated as a lifestyle modification for the 
prevention of hypertension (3, 7) by several health organizations, including the 
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (6), the American Heart Association (16), and the American 
College of Sports Medicine (2).  There are limited studies, however, supporting 
the daily accumulation of physical activity as a means to treat prehypertnesion 
and to prevent progression to hypertension.  This recommendation has been 
formulated based on the epidemiological evidence (5, 42) and a few clinical 
studies (10, 38) compared to the literature supporting traditional exercise 
recommendation (20 to 60 minutes of moderate aerobic exercise at 40 to 70% of 
maximal oxygen consumption, VO2max) (4, 12, 13, 18, 31, 66, 67, 69).  Thus, 
studies are warranted to investigate the effectiveness of the daily accumulation of 
physical activity on the treatment for prehypertension and the prevention of 
hypertension.   
There are only a few studies to investigate the effects of physical activity 
on blood pressure reduction in prehypertension.  Dunn et al. (10) compared the 
24-month intervention effects of a lifestyle physical activity (accumulation of 30-
minutes of any type of activity) with traditional structured exercise (50-85% of 
VO2peak at 20-60 minutes) on cardiorespiratory fitness and cardiovascular 
disease risk factors.  They reported significant reductions in systolic (3.63 mm Hg 
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 and 3.26 mm Hg) and diastolic (5.38 mm Hg and 5.14 mm Hg) blood pressure 
with physical activity and structured exercise, respectively.  Moreau et al. (38) 
also found a reduction in systolic blood pressure following 12 weeks (6 mm Hg) 
and 24 weeks (additional 5 mm Hg) of a walking program (3 km/day) in 24 post-
menopausal women with prehypertension and stage 1 hypertension.  In both 
studies it was unclear the physical activities were performed all at once and they 
were accumulated throughout the day.  Furthermore, the duration and magnitude 
of blood pressure reduction were not investigated.  Thus, the effect of 
accumulated several short bouts compared to one long continuous bout of 
physical activity on blood pressure reduction could not be determined from these 
studies.   
The effects of the accumulation of physical activity on health outcomes 
have been investigated with fractionated exercise (1, 9, 17, 24, 40).  
Fractionation of exercise is the term used to investigate  different patterns (one 
continuous long versus several short bouts of exercise) and/or intensity of 
exercise (moderate/hard versus low intensity of exercise) (20).  Long versus 
several short bouts of exercise has been studied on variables of health and 
fitness, such as VO2max (1, 24), blood lipids (17, 40), glucose/insulin dynamics 
(17), bone mass (51), and exercise adherence (53).  While it appears that 
several short bouts of exercise improves functional capacity (VO2max) (20), and 
blood lipids (17, 40), there is little information on the effects of fractionated 
exercise on blood pressure.   
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 There are only one study to date has demonstrated the effects of one long 
versus several short bouts or fractionated exercise on blood pressure by Murphy 
and Hardman (39) as a secondary outcome.  They investigated training effects of 
short and long bouts of brisk walking in sedentary women.  Women were 
randomly assigned to three 10-minute walks (n=12), one 30-minute walk (n=12) 
at 70 to 80 % of maximal heart rate for 10 weeks or control group (no walk, 
n=10).  The short bouts of exercise group reduced systolic blood pressure by 
7.4+7.3 mm Hg and the long bout exercise group reduced systolic blood 
pressure by 4.6+5.9 mm Hg.  Yet, the blood pressure reduction was not 
statistically significant.  It might be possibly due to lack of statistical power in the 
study (n=12).  Thus, more investigation is warranted to explore the effects of one 
long versus the accumulation of several short bouts of exercise on blood 
pressure reduction as a primary outcome. 
  A sustained reduction in resting blood pressure following a single bout of 
aerobic exercise has been defined as post exercise hypotension (25).  Post 
exercise hypotension resulted from traditional exercise prescription is sustained 
for a prolonged period of time under free-living conditions up to 11 to 12 hours for 
systolic blood pressures (5-8 mm Hg) and/or up to 6 to 8 hours for diastolic blood 
pressure (6-8 mm Hg) (25, 34, 47, 65, 67) in hypertensive individuals.  The 
duration and magnitude of post exercise hypotension resulting from the 
accumulation of physical activity are unknown.   
The mechanisms of post exercise hypotension are not fully understood at 
this time, however, sympathetic modulation has recently received more focus as 
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 one of the possible mechanisms of post exercise hypotension (19, 31).  
Sympathetic modulation describes changes in the balance between sympathetic 
and parasympathetic influences (50).  Power spectral analysis of the RR interval 
of the electrocardiogram has emerged as a method to measure sympathetic 
modulation in hypertension (43, 45, 50, 57).  A decreased sympathetic activity 
and/or an increased parasympathetic activity would be considered as an 
improvement of sympathetic modulation.  Exercise training has been found to 
improve sympathetic modulation measured by power spectral analysis of heart 
rate variability in various populations (21-23, 36, 37, 54, 55, 61, 62) including 
hypertensive individuals (44, 58).  Sympathetic modulation measured by power 
spectral analysis of heart rate variability has not been studies extensively during 
post exercise hypotension (27, 33).  MacDonald et al. showed increased 
parasympathetic activity after acute exercise (70% of VO2peak for 30 minutes) 
using short-term heart rate variability (33) while Legramante et al. failed to see 
the changes in sympathetic modulation after maximal exercise test (27).  Studies 
using long-term heart rate variability, however, would be of interest in post 
exercise hypotension studies because post exercise hypotension persists up to 
11 to 12 hours under free-living conditions (25, 34, 47, 65, 67).  Furthermore, a 
single bout of submaximal exercise improved sympathetic modulation measured 
by heart rate variability at hour six after cessation of exercise in healthy subjects 
(49).  No study has been attempted to explore the autonomic mechanisms of 
post exercise hypotension during free-living conditions. 
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 PURPOSE OF THE STUDY 
The purpose of this study is (1) to compare the blood pressure reduction 
following the accumulation of short bouts of exercise and one long bout of 
exercise in adults with prehypertension, and (2) to compare the blood pressure 
reduction following each successive short bout of exercise in adults with 
prehypertension.  In addition, sympathetic modulation will be investigated as a 
possible mechanism for the blood pressure reduction following exercise in adults 
with prehypertension. 
 
HYPOTHESES 
The Accumulation of Short Bouts versus One Long Bout of Exercise  
1. The blood pressure reduction following the accumulation of four short 
bouts of exercise will not be different from the reduction following one long 
bout of exercise in adults with prehypertension.   
a. The duration of blood pressure reduction from control following the 
accumulation of four short bouts of exercise will not be different 
from the duration of the reduction from control following one long 
bout of exercise in adults with prehypertension.   
b. The magnitude of blood pressure reduction from control following 
the accumulation of four short bouts of exercise will not be different 
from the magnitude of the reduction from control following one long 
bout of exercise in adults with prehypertension.   
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 2. The sympathetic modulation, measured by power spectral analysis of the 
RR interval of the electrocardiogram, will be associated with the blood 
pressure reduction following the accumulation of short bouts of exercise 
and one long bout of exercise in adults with prehypertension.   
a. The magnitude of blood pressure reduction will be negatively 
associated with the change in low frequency component of the 
power spectral analysis of the RR interval in adults with 
prehypertension.   
b. The magnitude of blood pressure reduction will be positively 
associated with the change in high frequency component of the 
power spectral analysis of the RR interval in adults with 
prehypertension.   
c. The magnitude of blood pressure reduction will be negatively 
associated with the change in low to high frequency ratio of the 
power spectral analysis of the RR interval in adults with 
prehypertension.   
3. The association between blood pressure reduction and sympathetic 
modulation following the accumulation of four short bouts of exercise will 
not be different from the association following one long bout of exercise in 
adults with prehypertension. 
a. The association between the magnitude of blood pressure 
reduction and the change in sympathetic modulation (measured by 
low and high frequency component as well as the low to high 
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 frequency ratio of the power spectral analysis of the RR interval) 
following the accumulation of four short bouts of exercise will not be 
different from the association between the magnitude of blood 
pressure reduction and the change in sympathetic modulation 
following one single long bout of exercise.   
 
Successive Short Bouts of Exercise 
1. The magnitude of blood pressure reduction following each successive 
short bout of exercise will be different in adults with prehypertension.   
a. The magnitude of blood pressure reduction from baseline following 
each successive short bout of exercise will be greater for each 
successive short bout of exercise in adults with prehypertension.   
2. The sympathetic modulation, measured by power spectral analysis of the 
RR interval of the electrocardiogram, will be different following each 
successive short bout of exercise in adults with prehypertension.   
a. The low frequency component of the power spectral analysis of the 
RR interval following each short bout of exercise will be lower each 
successive short bout of exercise in adults with prehypertension.   
b. The high frequency component of the power spectral analysis of 
the RR interval following each short bout of exercise will be higher 
each successive short bout of exercise in adults with 
prehypertension.  
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 c. The low to high frequency ratio of the power spectral analysis of the 
RR interval following each short bout of exercise will be lower each 
successive short bout of exercise in adults with prehypertension. 
 
STUDY DESIGN   
The study will be a within-subjects design.  Each prehypertensive subject 
will receive all of the treatment conditions in a randomized order.  The treatment 
conditions will be composed of (a) the accumulation of four short bouts of 
exercise treatment (four 10-minute treadmill walk at 50% of VO2peak at least 50-
minute apart), (b) one long bout of exercise treatment (40-minute treadmill walk 
at 50% of VO2peak), and (c) a control treatment.  The two exercise treatments 
will be separated by at least seven days to avoid a training effect.  Following 
each treatment blood pressure will be measured for 12 hours during activities of 
daily living using ambulatory blood pressure monitoring.  Changes in sympathetic 
modulation, measured by power spectral analysis of the RR interval of the 
electrocardiogram, will be investigated as a possible mechanism of blood 
pressure reduction following exercise treatments.  The amount of physical 
activities in each treatment will be assessed using an accelerometer to 
statistically control physical activity as a confounding factor for the blood 
pressure reduction seen in the study.   
Although the timing of the exercise treatments in this study may not 
appear to be applicable to daily living, this study design is based on diurnal 
variations in blood pressure and the nature of blood pressure reduction through 
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 exercise treatments.  Greater blood pressure reductions can be found for higher 
blood pressures (18).  Blood pressure is highest in the afternoon/evening hours 
and lowest in the nighttime (7).  This design, by completing the treatments by 
1:00 p.m., optimizes the ability to detect blood pressure changes, i.e. the 
afternoon/evening elevations, which is the highest point of the diurnal rhythm.  
The chances of detecting blood pressure reductions may be compromised by the 
low, near normal nocturnal pressures (28, 46, 68) if the stimulus would end in the 
evening.  Therefore, both treatments will end prior to this time, allowing for the 
most optimal approach to find a treatment effect.  
 
SUBJECTS   
At least 20 adults with prehypertension will be recruited for this study.  The 
number of subjects has been estimated based on power analysis (46) performed 
on previous study for blood pressure with a similar study design (41) using 
physical activity treatment in perhypertensive adults (power:>0.80; effect size 
using partial eta squared:>0.41).  Inclusion criteria for adults with 
prehypertension will be a mean systolic screening blood pressure 120 to 139 
mmHg and/or a mean diastolic blood pressure 80 to 89 mmHg taken from at 
least two readings on two separate days, three days apart.  Subject exclusion 
criteria will include: 1) significant cardiovascular disease; 2) significant 
dysrhythmia (66, 67); 3) brachial artery bruits (66, 67); 4) cardiac or renal 
transplant patients (66, 67); or 5) medications such as anti-arrhythmic drugs or 
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 low dose muscarinic receptor blockers including atropine and scopolamine that 
affect the heart rate variability (57). 
Clearance by the subjects’ primary physician will be required prior to 
participation in the study.  The study is approved by the Bloomington Campus 
Committee for the Protection of Human Subjects at Indiana University.  Each 
subject will be given informed consent prior to participation in the study.  The 
study will be carried out in the Clinical Exercise Physiology Laboratory in the 
Department of Kinesiology at Indiana University. 
 
PROCEDURE   
 Procedures include: (1) blood pressure screening; (2) maximal graded 
exercise test; and (3) measurements of ambulatory blood pressure, ambulatory 
electrocardiogram (EKG) and accelerometer: (a) following the accumulation of 
four short bouts of exercise treatment (four 10-minute treadmill walks at 50% 
VO2peak, at least 50-minute apart), (b) following one long bout of exercise 
treatment (40-minute treadmill walk at 50% VO2peak), (c) following each 
separate short bout of exercise for 50 minutes in a seated position, and (d) 
following corresponding time of the non-exercise control treatment.  Ambulatory 
blood pressure and ambulatory EKG monitors will be taken off during the 
exercise sessions and will be restarted after the exercise treatments.  An 
accelerometer will be worn during the exercise treatments.  The order of all three 
treatments will be randomized.  The two exercise days will be separated by at 
least  seven days (48). 
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 METHODOLOGY 
Blood Pressure Screening 
 For all subjects three blood pressures will be taken in the seated position 
on two separate days, three days apart (a total of six measurements) using a 
mercury sphygmomanometer.  Subjects will be seated for at least five minutes in 
a chair, with feet on the floor, and arm supported at heart level (7).  Subjects will 
be asked to avoid caffeine, exercise and smoking for at least 30 minutes prior to 
measurement (7).  An appropriate sized cuff (cuff bladder encircling at least 80% 
of the arm) will be used to ensure accuracy (7).  On the first day blood pressure 
will be taken in both arms to detect possible differences due to peripheral 
vascular disease (70, 71).  The arm with highest blood pressure will be used for 
the screening (70).   
 
Maximal Graded Exercise Test 
 The purpose of maximal graded exercise test is to measure physical work 
capacity to ensure the exercise intensity for the treatments.  A fasting blood draw 
and a standard resting 12 lead electrocardiogram (EKG) will precede the 
maximal graded exercise test to establish risk for exercise (2).  Body weight (kg) 
and height (cm) will be determined to the nearest value of 0.1.  The graded 
exercise test will be performed on a treadmill with a speed between 2.5 and 4.0 
mph at 0% grade.  The speed will remain constant throughout the test while the 
grade increase 2.0% every minute until a maximal voluntary effort is achieved.  
Blood pressure (by auscultation) and heart rate (by EKG) will be measured every 
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 minute.  The EKG will be monitored continuously.  Expired gases will be 
measured on-line breath-by-breath using a Sensor Medics 2900 Metabolic Cart.  
Peak oxygen uptake (VO2peak) will be obtained during the symptom-limited 
maximal exercise test.  VO2peak is defined as the highest VO2 obtained from the 
symptom-limited maximal exercise test.   
 
Treatments 
 The treatments include 1) one long continuous bout of exercise; 2) four 
short bouts of exercise; and 3) one control.  The mode of exercise will be walking 
on a motorized treadmill and the intensity of each exercise bout will be at 50% 
VO2peak.  Oxygen uptake (VO2) will be measured during the 4th through the 6th 
minutes of each walk to confirm the intensity of exercise.  The work rate will be 
adjusted if it is not within ±10% of the target VO2.  Then, VO2 will be measured 
during the 6th through the 8th minutes of the next work interval to confirm the 
new exercise intensity.  Heart rate (via EKG) and blood pressure (via 
auscultation) will be measured throughout the exercise treatments.   
One Long Bout of Exercise Treatment:  The duration of the one long bout of 
exercise will be 40-minutes.  The one long bout of exercise will begin between 
1200 and 1300 hrs.  
Four Short Bouts of Exercise Treatment:  The duration of each short bout of 
exercise stimulus will be 10-minute; the first between 0900 and 0930 hours, the 
second between 1000 and 1030 hours, the third between 1100 and 1130 hours, 
and the last between 1200 and 1230 hours to end the time as one long bout.   
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 Control Treatment:  For the control treatment the subject will report to the lab 
between 1200 and 1300 hours approximately 15 minutes before the time when 
the monitors would be activated for the exercise treatments.  Control data will be 
collected for the same time period as the other two treatments.  No sham rest 
period will be used for the control treatment to simulate the time of attention 
given to the subject during exercise treatments because rest if considered an 
intervention itself. 
 
24-hour Ambulatory Blood Pressure Monitoring 
 The Accutracker II (Suntech Medical Instruments, Inc., Raleigh, NC) will 
be used for all ambulatory measurements.  The Accutracker II has been 
validated in accordance to the standards of the British Hypertension Society and 
the American Association for Medical Instrumentation (59).  Two sampling 
intervals will be utilized.  First, the sampling interval will be 5-minutes for the 15-
minute following each successive short bout of exercise in seated position (32, 
34).  Repeat measurement will be taken during the 15-minute period if the first 
measurement is unsuccessful.  The second sampling interval will be 15±5 
minutes (60) for a 12-hour collection period following the all three treatments 
(1200 to 0000 hours).  One repeat measurement will be taken if the first 
measurement is unsuccessful.  The monitor will be programmed to take no 
readings following 12-hour collection period.  The cuff inflation for each 
measurement will be 30 mm Hg greater than the previous reading, and the cuff 
deflation will be set at 2 mm Hg·second-1 (7).   
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  Individual blood pressure measurements will be reviewed for missing and 
erroneous readings.  Reading will be purged if 1) data are missing, 2) systolic 
blood pressure is lower than diastolic pressure, or >240 mm Hg or <50 mm Hg, 
3) diastolic blood pressure is >140 mm Hg or < 40 mm Hg, or 4) heart rate is 
>150 or <40 beats/minute.  System tagged data will be eliminated if 1) systolic 
blood pressures deviate ±50 mm Hg, 2) diastolic blood pressures deviate ±20 
mm Hg, or 3) heart rate deviates ±30 beats from the surrounding values.  The 
number of recordings taken and the number of recordings will be reported.  
 Ambulatory blood pressure data will be analyzed for average systolic and 
diastolic blood pressure.  Blood pressures will be averaged for the 1) 15-minute 
following the first three short bout of exercise, 2) each hour following the fourth 
short bout of exercise as well as following one long bout of exercise and control, 
and 3) the duration of respective blood pressure reduction.  The duration of 
respective blood pressure reduction will be determined by the length of time the 
hourly blood pressure differs significantly from the control treatment.  The 
magnitude of respective blood pressure reduction will be the average blood 
pressure reduction for the duration of the blood pressure reduction. 
 
Power Spectral Analysis of the RR Interval of the Electrocardiogram 
 The Aria Digital Recorder (Del Mar Reynolds Medical, Inc., Irvine, CA) will 
be used to monitor heart rate variability.  Subjects will be requested to empty 
their bladder before beginning each exercise treatment to avoid any increase of 
sympathetic nerve activity through bladder distension (15).  The data from Aria 
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 Digital Recorder will be scanned on a computer-assisted Holter system 
(Impresario, Solo Holter analysis software, Del Mar Reynolds Medical, Inc., 
Irvine, CA) for the variables of heart rate variability.  Frequency-domain 
measures of heart rate variability will be assessed using the fast Fourier 
transform.  The manual editing of the R-R interval data will be performed to 
ensure correct identification and classification of every QRS complex (57).  
Artifact and ectopic beats will be removed for the R-R interval calculation.  The 
relative number and duration of R-R intervals which are omitted and interpolated 
will be reported.   
 The total power will be calculated by the standard deviation of the R-R 
interval (<0.1 Hz).  The spectral analysis of the total 12-hour record will be 
computed using the whole range of high frequency (0.15 to 0.04 Hz), low 
frequency (0.04 to 0.15 Hz), and very low frequency (0.003-0.04 Hz) 
components.  Spectral analysis in 12-hour period will be obtained from the 
average 5-minute segments.  The ratio of low frequency to high frequency will be 
determined.  Frequency components will be reported in absolute units (ms2) and 
normalized units (%).  Normalized units represent the relative value of each 
power component in proportion to the total power minus the very low frequency 
component (14, 57).  Absolute and normalized units will be used in analysis.  
 
Accelerometer 
The purpose of monitoring physical activity is to statistically control the 
differences of physical activity in each treatment.  The amount of physical activity 
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 will be used as a covariate if there is a significant difference found among the 
three conditions.  An RT3 (Stayhealthy, Inc., Monrovia, CA) will be used for a 12-
hour collection period following the all three treatments.  The RT3 has been 
validated for measuring physical activity (52).  The RT3 is a battery powered 
three-dimensional (tri-axial) accelerometer. The RT3 will be firmly attached to a 
belt on the hip at the anterior axillary line of the dominant leg. RT3 records data 
in three axis (X, Y, and Z) using three separate accelerometers positioned 
internally at 90 degrees to one another.  It measures motion as acceleration of 
the body.  Output from each accelerometer is reported along with a composite 
three-dimensional signal called the vector magnitude.  The vector magnitude will 
be used in analysis.  RT3 will be programmed to sample data every second and 
average over one minute (using Mode 3) period for 12-hour.   
 
Preparation of Subjects  
 The blood pressure monitor will be worn on the non-dominant arm.  Seven 
EKG electrodes (three from ambulatory blood pressure monitor and four from 
Holter monitor) will be placed on the chest.  Electrode wires and blood pressure 
tubing will be taped securely to the chest.  RT3 will be worn on the hip at the 
anterior axillary line of the dominant leg. Subjects will be asked to document the 
following: 1) time of sleep, 2) time at work, 3) time of meals, and 4) time and type 
of leisure physical activities.  Subjects will be asked to do the similar routines of 
the activities of daily living on all treatment days.  Subjects will be instructed 1) 
not to exercise, 2) not to take a shower, 3) not to use an electric blanket, 4) not to 
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 operate a lawn mower, a vacuum cleaner or any equipment which causes 
vibration, 5) replace electrodes with new electrodes when electrodes become 
loose, and 6) to relax and straighten out the arm during the recording interval for 
the entire 12-hour period.    
 
STATISTICAL METHODS 
 The SPSS software (SPSS 12.0) will be used for all statistical analyses.  
Values will be expressed as means ± standard deviations.  Statistical analyses 
will be performed by use of descriptive statistics, and analysis of variance 
(ANOVA) for repeated measures.  The Tukey test will be used for post hoc 
comparisons.  The significant level will be set at p<0.05.   
 Descriptive statistics will be performed to describe the characteristics of 
subjects.  The variables are sex, age, body mass index (kg/m2), screening 
systolic and diastolic blood pressures, and VO2peak.  One-way ANOVA with 
repeated measures will be used to test the differences in the amount of physical 
activity measured by vector magnitude on each treatment. 
 
The Accumulation of Short Bouts versus One Long Bout of Exercise  
1. The blood pressure reduction following the accumulation of four short 
bouts of exercise will not be different from the reduction following one long 
bout of exercise in adults with prehypertension.   
a. In order to determine the duration of blood pressure reduction, two-
way ANOVA with repeated measures (Treatments X Time) will be 
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 used.  The dependent variables to determine the duration of blood 
pressure reduction will be average hourly systolic and diastolic 
blood pressures.  In order to determine the difference in the 
duration of blood pressure reduction, paired T-test (Treatments) will 
be used.  The dependent variables for the difference in the duration 
of blood pressure reduction will be time (hour).   
b. In order to determine the difference in the magnitude of blood 
pressure reduction, paired T-test will be used.  The dependent 
variables for the difference in the magnitude of blood pressure 
reduction will be average systolic and diastolic blood pressure for 
the duration of the blood pressure reduction found in 1-a (mm Hg). 
2. The sympathetic modulation, measured by power spectral analysis of the 
RR interval of the electrocardiogram, will be associated with the blood 
pressure reduction following the accumulation of short bouts of exercise 
and one long bout of exercise in adults with prehypertension.   
a. In order to determine the association between the blood pressure 
reduction and sympathetic modulation, Pearson correlation will be 
used.  The dependent variables will be the magnitude of systolic 
and diastolic blood pressure reduction and the changes in 
sympathetic modulation (measured by low and high frequency 
component as well as the low to high frequency ratio of the power 
spectral analysis of the RR interval). 
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 3. The association between blood pressure reduction and sympathetic 
modulation following the accumulation of four short bouts of exercise will 
not be different from the association following one long bout of exercise in 
adults with prehypertension. 
a. In order to compare the associations between the magnitude of 
blood pressure reduction and the change in sympathetic 
modulation (measured by low and high frequency component as 
well as the low to high frequency ratio of the power spectral 
analysis of the RR interval) for each treatment, the test of 
significance will be performed for r.  The dependent variables will 
be Pearson correlation coefficients (r) between blood pressure 
reduction and sympathetic activities following both exercise 
treatments. 
 
Successive Short Bouts of Exercise 
1. The magnitude of blood pressure reduction following each successive 
short bout of exercise will be different in adults with prehypertension.   
a. In order to compare the magnitude of blood pressure reduction 
from baseline following each successive short bout of exercise, 
one-way ANOVA with repeated measures will be used.  The 
dependent variables will be the 15-minute average systolic and/or 
diastolic blood pressures following each short bout of exercise. 
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 2. The sympathetic modulation, measured by power spectral analysis of the 
RR interval of the electrocardiogram, will be different following each 
successive short bout of exercise in adults with prehypertension.   
a. In order to compare the changes in sympathetic modulation, one-
way ANOVA with repeated measures will be used.  The dependent 
variables will be the 15-minute average sympathetic modulation 
(measured by low and high frequency component as well as the 
low to high frequency ratio of the power spectral analysis of the RR 
interval) following each short bout of exercise. 
  
SIGNIFICANCE  
Hypertension has long been known to be a major modifiable risk factor for 
cardiovascular disease.  Exercise is one of lifestyle modification for the 
prevention of hypertension.  The magnitude and duration of blood pressure 
reduction from traditional exercise prescription, 20 to 60 minutes of moderate 
aerobic exercise, is clinically significant in hypertensive individuals.  Exercise, 
however, is one of the greatest barriers among other lifestyle modification to 
blood pressure control (8).  One of the primary barriers to exercise is the lack of 
time (11, 30, 56).  Short bouts of exercise may fit better into a busy schedule 
than a single long bout (9).  Thus, the new exercise prescription, the 
accumulation of moderate physical activity on most if not all days of the week, 
has been advocated as a lifestyle modification for the prevention of hypertension.  
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 More investigation is required to determine the magnitude and duration of the 
new exercise prescription in prehypertension.   
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Courses Taught as an Associate Instructor at the School of Health, Physical 
Education and Recreation 
       Applied Statistics: 
       T691 – Correlational Techniques 
       T693 - Experimental Design and Analysis 
 T591 – Interpretation of Data in HPER 
       T592 - Statistical Analysis of Behavioral Data 
 
 
Internships/ Clinical Rotation 
 
 Bloomington Hospital Cardiac/Pulmonary Rehabilitation (Spring, 2002) 
  Phase I and II 
Cardiovascular Testing  
 
 Internal Medicine Association (Summer II, 2001) 
  Cardiovascular Testing 
 
Bloomington Hospital Cardiac/Pulmonary Rehabilitation (Summer I, 2001)  
 RESEARCH AND CREATIVE ACTIVITY 
 
i)    FOCUS 
        My research interests focus on the exercise prescription for health 
and disease.  I have been investigating the role of the exercise in 
controlling blood pressure in adults with prehypertension and 
hypertension.  The long-term goal of these projects is to develop short- 
and long-term intervention programs to prevent and control the 
cardiovascular disease for these populations.  I also have studied force 
production using mouse skeletal muscle in vitro, and athletic performance.   
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Park, S., Rink, LD, and Wallace, JP (in press) The accumulation of 
physical activity leads to a greater blood pressure reduction than a single 
continuous session in prehypertension. Journal of Hypertension. 
 
Park, S., Rink, LD, and Wallace, JP (submitted) Accumulation of physical 
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Science in Sports Exercise: 37, 1264-1275. 
 
Lehmkuhl, L.A.A., Park, S., Zakutansky, D.W., Jastremski, C.A. and 
Wallace, J.P. (2005) Reproducibility of postexercise ambulatory blood 
pressure in stage I hypertension. Journal of Human Hypertension: 19, 
589-595. 
  
Wallace, J.P., Park, S., Zakutansky, D.W., Lehmkuhl, L.A.A. and 
Jastremski, C.A. (2005) Time of day to monitor ambulatory blood pressure 
affects outcome. Blood Pressure Monitoring: 10, 43-50. 
 
Nagahama, H., Hanna, J.D., Park, S., and Stager, J.M. (2004).  Reliability 
and validity of a field test for determination of onset of blood lactate 
accumulation in soccer players. Journal of Training Science for Exercise 
and Sports: 16, 227-235. 
 
 
 iii)   PUBLISHED ABSTRACTS AND RESEARCH PRESENTATIONS  
 
Park, S., Scherzinger, J. R., Bollinger, L. C., Nuseibeh, L. O., Rink, L. D., 
& Wallace, J. P. (in press). Blood Pressure Reduction in Prehypertension: 
Accumulation of Physical Activity vs. a Single Continuous Session. 
Medicine and Science in Sport and Exercise, 38(5 Supplement). 
 
Park, S., Collins, K. G., Roble, A. E., Rush, L. S., Zakutansky, D. W., 
Jastremski, C., et al. (2004). Blood Pressure Response to Exercise in 
Prehypertensive Adults. Medicine and Science in Sport and Exercise, 36(5 
Supplement), S251. 
 
 Harris, R., Padilla, J., Park, S., & Wallace, J. P. (2004). Blood pressure 
reduction following physical activity: a case study approach. Medicine and 
Science in Sport and Exercise, 36(5 supplement), S251. 
Padilla, J., Park, S., Harris, R., & Wallace, J. P. (2004). Ambulatory Blood 
Pressure Response Following Free-Living Physical Activity in Pre- and 
Hypertensive Adults. Medicine and Science in Sport and Exercise, 36(5 
supplement), S251. 
 
Wallace, J. P., Padilla, J. P., Park, S. J., & Harris, R. A. (2004). What is 
the adherence to free-living physical activity? Medicine and Science in 
Sport and Exercise, 36(5 Supplement), S64. 
 
Krasnoff, J. B., Wallace, J. P., Park, S., Wallace, J. P., Painter, P. L. & 
Vardaxis, V.G. (2004). Activation of the rectus abdominis during activities 
of daily living and therapeutic exercise. Medicine and Science in Sport and 
Exercise, 36(5 supplement), S35. 
 
Zakutansky, D. W., Kitano, K., Park, S., Koceja, D. M., & Wallace, J. P. 
(2004). Sensory and motor responses to acute ischemia in healthy 
individuals. Medicine and Science in Sport and Exercise, 36(5 
supplement), S165. 
 
Park, S. J., Black, K. N., Weaver, V. R., Hawkins, C., Jastremski, C. A., & 
Wallace, J. P. (2003). Is evening exercise more effective than evening 
exericse in reducing blood pressure in nocturnal non-dipping 
hypertension. Medicine and Science in Sports and Exercise: 35, S174. 
 
Wallace, J. P., Park, S.J., Lehmkuhl, L. A. A., & Jastremski, C. (2003). Do 
nocturnal dippers and non-dippers respond similarly to exercise treatment 
for hypertension? Medicine and Science in Sports and Exercise, 35, S174. 
 
 Krasnoff, J. B., Raglin, J., Zakutansky, D. W., Park, S., Wallace, J. P., & 
Painter, P. L. (2003). Predictors of adherence to a home-based exercise 
program in liver transplant recipients. Medicine and Science in Sport and 
Exercise, 35, S319. 
 
Park, S., Lehmkuhl, L.A.A., Tanner, D.A., Jastremski, C.A., and 
Wallace, J.P. FACSM (2002).  Effects of exercise treatment on 
ambulatory blood pressure and diurnal variation in nocturnal non-
dipping hypertension, Medicine and Science in Sports and Exercise: 
34, S12. 
   
Zakutansky, D. W., Park, S., Lehmkuhl, L. A. A., Jastremski, C. A., & 
Wallace, J. P. (2002). Reproducibility of dipping and non-dipping nocturnal 
ambulatory systolic blood pressures in borderline hypertensive adults. 
Medicine and Science in Sport and Exercise: 34, S12. 
 
Park, S., Lehmkuhl, L.A.A., Tanner, D.A., and Wallace, J.P. FACSM 
(2001).  Reproducibility of quantifying the circadian blood pressure 
patterns utilizing cumulative sums in borderline hypertensive adults, 
Medicine and Science in Sports and Exercise: 33, S28. 
   
Park, S., and Brechue, W.F., FACSM (2000).  Changes in calf volume 
alter plantar flexion torque production, Medicine and Science in Sports 
and Exercise: 32, S361.  
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2000).  Reliability and validity of a field test for determination of OBLA in 
soccer players, Medicine and Science in Sports and Exercise: 32, S319. 
 
 
vi) EXTRAMULAR FUNDING  
 
Exercise Intervention in Prehypertension:  
Principle investigator: Saejong Park, MS     
 
Blood pressure reduction following the accumulation of physical activity 
versus one long bout of exercise in prehypertension (2004 & 2005).  
Doctoral Student Grant-in-Aid, Indiana University, $1,000 [funded] 
 
Accumulation of physical activity versus exercise: blood pressure 
reduction in prehypertension (2004).  Gatorade Sports Science Institute 
Student Grant-in-Aid ($1,500) [funded] 
 
 
 Exercise Intervention in Hypertension:   
Principle investigator: Janet P. Wallace, Ph.D., FACSM 
     
A comparison of a single exercise treatment to a physical activity 
treatment in hypertension and prehypertension (January 2004).  
American Heart Association, $65,980 [not funded] 
 
The influence of time of day for exercise on diurnal blood pressure in 
dipping and non-dipping hypertension (January 2002).  American Heart 
Association, $214,354 [not funded] 
 
The influence of time of day for exercise on diurnal blood pressure in 
dipping and non-dipping hypertension (July 2001).  American Heart 
Association, $213,637 [not funded] 
 
 
Exercise Intervention in Diabetes:   
Principle investigator: Janet P. Wallace, Ph.D., FACSM     
 
Exercise intervention on integrative nerve function in diabetes (January 
2001).  National Institute of Health, $1,077,405 [not funded] 
 
Effect of exercise on integrative nerve function in diabetes (April 2000).  
National Institute of Health, $1,171,063 [not funded] 
 
 
 
 
v)   RESEARCH AWARDS 
 
Travel Grant–In–Aid Award (2006) from School of Health, Physical 
Education & Recreation, Indiana University ($200) 
 
Travel Grant–In–Aid Award (2004) from School of Health, Physical 
Education & Recreation, Indiana University ($400) 
 
Summer Research Assistance Award (2003) from the Department of 
Kinesiology, School of Health, Physical Education & Recreation, Indiana 
University ($1,400) 
 
Travel Grant–In–Aid Award (2003) from School of Health, Physical 
Education & Recreation, Indiana University ($310) 
 
 Summer Research Assistance Award (2002) from the Department of 
Kinesiology, School of Health, Physical Education & Recreation, Indiana 
University ($1,400) 
 
Travel Grant–In–Aid Award (2002) from School of Health, Physical 
Education & Recreation, Indiana University ($200) 
 
Research Grant–In–Aid Award (2001) from School of Health, Physical 
Education & Recreation, Indiana University ($615) 
 
Travel Grant–In–Aid Award (2001) from School of Health, Physical 
Education & Recreation, Indiana University ($200) 
  
Research Grant–In–Aid Award (2000) from School of Health, Physical 
Education & Recreation, Indiana University ($874) 
 
Travel Grant–In–Aid Award (2000) from School of Health, Physical 
Education & Recreation, Indiana University ($200) 
 
Research Grant–In–Aid Award (1999) from School of Health, Physical 
Education & Recreation, Indiana University ($200) 
 
The Award of the Excellence for graduate students (1998) from the office 
of International Programs at Indiana University ($848) 
 
 
 
PROFESSIONAL AFFILIATIONS 
 
American College of Sports Medicine (1998 - ) 
Korean Alliance for Health, Physical Education, Recreation and Dance 
(2005 - ) 
 Korean Society of Exercise Physiology (2005 - ) 
 
 
 
LICENSE OR CERTIFICATION 
 
Exercise Specialist – American College of Sports Medicine (2003 - 
present) 
 CPR Certification – American Heart Association (2000 - present) 
 AED Certification – American Heart Association (2001 - present) 
 First Aid Certification 
Science Teaching License for the Secondary School in Korea (1996) 
